<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Alpha‐2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery - Duncan, D - 2018 | Cochrane Library</title> <meta content="Alpha‐2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery - Duncan, D - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004126.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Alpha‐2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery - Duncan, D - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004126.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004126.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Alpha‐2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery" name="citation_title"/> <meta content="Dallas Duncan" name="citation_author"/> <meta content="University of Toronto" name="citation_author_institution"/> <meta content="Ashwin Sankar" name="citation_author"/> <meta content="University of Toronto" name="citation_author_institution"/> <meta content="W Scott Beattie" name="citation_author"/> <meta content="Toronto General Hospital, University Health Network" name="citation_author_institution"/> <meta content="Duminda N Wijeysundera" name="citation_author"/> <meta content="St. Michael's Hospital" name="citation_author_institution"/> <meta content="d.wijeysundera@utoronto.ca" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD004126.pub3" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/03/06" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004126.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004126.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004126.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Adrenergic alpha‐Agonists [adverse effects, *therapeutic use]; Clonidine [therapeutic use]; Dexmedetomidine [therapeutic use]; Heart Diseases [mortality, *prevention &amp; control]; Imidazoles [therapeutic use]; Intraoperative Complications [mortality, prevention &amp; control]; Myocardial Infarction [mortality, prevention &amp; control]; Postoperative Complications [mortality, *prevention &amp; control]; Randomized Controlled Trials as Topic; Stress, Physiological [drug effects]; Stroke [mortality]; Surgical Procedures, Operative [*adverse effects, mortality]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004126.pub3&amp;doi=10.1002/14651858.CD004126.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="XwNPMGod";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004126\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004126\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004126\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004126\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","pt","ms","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004126.pub3",title:"Alpha\\u20102 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery",firstPublishedDate:"Mar 6, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Anaesthesia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=XwNPMGod&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004126.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004126.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004126.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004126.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004126.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004126.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004126.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004126.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004126.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004126.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>32852 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004126.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/full#CD004126-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/full#CD004126-sec-0126"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/full#CD004126-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/full#CD004126-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/full#CD004126-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/full#CD004126-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/full#CD004126-sec-0062"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/full#CD004126-sec-0118"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/appendices#CD004126-sec-0131"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/table_n/CD004126StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/table_n/CD004126StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Alpha‐2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/information#CD004126-cr-0002">Dallas Duncan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/information#CD004126-cr-0003">Ashwin Sankar</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/information#CD004126-cr-0004">W Scott Beattie</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004126.pub3/information#CD004126-cr-0005"><i class="icon corresponding-author fa fa-envelope"></i>Duminda N Wijeysundera</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/information/en#CD004126-sec-0142">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 06 March 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004126.pub3">https://doi.org/10.1002/14651858.CD004126.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004126-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004126-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004126-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004126-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/pt#CD004126-abs-0003">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004126-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004126-abs-0001" lang="en"> <section id="CD004126-sec-0001"> <h3 class="title" id="CD004126-sec-0001">Background</h3> <p>The surgical stress response plays an important role on the pathogenesis of perioperative cardiac complications. Alpha‐2 adrenergic agonists attenuate this response and may help prevent postoperative cardiac complications. </p> </section> <section id="CD004126-sec-0002"> <h3 class="title" id="CD004126-sec-0002">Objectives</h3> <p>To determine the efficacy and safety of α‐2 adrenergic agonists for reducing mortality and cardiac complications in adults undergoing cardiac surgery and non‐cardiac surgery. </p> </section> <section id="CD004126-sec-0003"> <h3 class="title" id="CD004126-sec-0003">Search methods</h3> <p>We searched CENTRAL (2017, Issue 4), MEDLINE (1950 to April Week 4, 2017), Embase (1980 to May 2017), the Science Citation Index, clinical trial registries, and reference lists of included articles. </p> </section> <section id="CD004126-sec-0004"> <h3 class="title" id="CD004126-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials that compared α‐2 adrenergic agonists (i.e. clonidine, dexmedetomidine or mivazerol) against placebo or non‐α‐2 adrenergic agonists. Included trials had to evaluate the efficacy and safety of α‐2 adrenergic agonists for preventing perioperative mortality or cardiac complications (or both), or measure one or more relevant outcomes (i.e. death, myocardial infarction, heart failure, acute stroke, supraventricular tachyarrhythmia and myocardial ischaemia). </p> </section> <section id="CD004126-sec-0005"> <h3 class="title" id="CD004126-sec-0005">Data collection and analysis</h3> <p>Two authors independently assessed trial quality, extracted data and independently performed computer entry of abstracted data. We contacted study authors for additional information. Adverse event data were gathered from the trials. We evaluated included studies using the Cochrane 'Risk of bias' tool, and the quality of the evidence underlying pooled treatment effects using GRADE methodology. Given the clinical heterogeneity between cardiac and non‐cardiac surgery, we analysed these subgroups separately. We expressed treatment effects as pooled risk ratios (RR) with 95% confidence intervals (CI). </p> </section> <section id="CD004126-sec-0006"> <h3 class="title" id="CD004126-sec-0006">Main results</h3> <p>We included 47 trials with 17,039 participants. Of these studies, 24 trials only included participants undergoing cardiac surgery, 23 only included participants undergoing non‐cardiac surgery and eight only included participants undergoing vascular surgery. The α‐2 adrenergic agonist studied was clonidine in 21 trials, dexmedetomidine in 24 trials and mivazerol in two trials. </p> <p>In non‐cardiac surgery, there was high quality evidence that α‐2 adrenergic agonists led to a similar risk of all‐cause mortality compared with control groups (1.3% with α‐2 adrenergic agonists versus 1.7% with control; RR 0.80, 95% CI 0.61 to 1.04; participants = 14,081; studies = 16). Additionally, the risk of cardiac mortality was similar between treatment groups (0.8% with α‐2 adrenergic agonists versus 1.0% with control; RR 0.86, 95% CI 0.60 to 1.23; participants = 12,525; studies = 5, high quality evidence). The risk of myocardial infarction was probably similar between treatment groups (RR 0.94, 95% CI 0.69 to 1.27; participants = 13,907; studies = 12, moderate quality evidence). There was no associated effect on the risk of stroke (RR 0.93, 95% CI 0.55 to 1.56; participants = 11,542; studies = 7; high quality evidence). Conversely, α‐2 adrenergic agonists probably increase the risks of clinically significant bradycardia (RR 1.59, 95% CI 1.18 to 2.13; participants = 14,035; studies = 16) and hypotension (RR 1.24, 95% CI 1.03 to 1.48; participants = 13,738; studies = 15), based on moderate quality evidence. </p> <p>There was insufficient evidence to determine the effect of α‐2 adrenergic agonists on all‐cause mortality in cardiac surgery (RR 0.52, 95% CI 0.26 to 1.04; participants = 1947; studies = 16) and myocardial infarction (RR 1.01, 95% CI 0.43 to 2.40; participants = 782; studies = 8), based on moderate quality evidence. There was one cardiac death in the clonidine arm of a study of 22 participants. Based on very limited data, α‐2 adrenergic agonists may have reduced the risk of stroke (RR 0.37, 95% CI 0.15 to 0.93; participants = 1175; studies = 7; outcome events = 18; low quality evidence). Conversely, α‐2 adrenergic agonists increased the risk of bradycardia from 6.4% to 12.0% (RR 1.88, 95% CI 1.35 to 2.62; participants = 1477; studies = 10; moderate quality evidence), but their effect on hypotension was uncertain (RR 1.19, 95% CI 0.87 to 1.64; participants = 1413; studies = 9; low quality evidence). </p> <p>These results were qualitatively unchanged in subgroup analyses and sensitivity analyses.</p> </section> <section id="CD004126-sec-0007"> <h3 class="title" id="CD004126-sec-0007">Authors' conclusions</h3> <p>Our review concludes that prophylactic α‐2 adrenergic agonists generally do not prevent perioperative death or major cardiac complications. For non‐cardiac surgery, there is moderate‐to‐high quality evidence that these agents do not prevent death, myocardial infarction or stroke. Conversely, there is moderate quality evidence that these agents have important adverse effects, namely increased risks of hypotension and bradycardia. For cardiac surgery, there is moderate quality evidence that α‐2 adrenergic agonists have no effect on the risk of mortality or myocardial infarction, and that they increase the risk of bradycardia. The quality of evidence was inadequate to draw conclusions regarding the effects of alpha‐2 agonists on stroke or hypotension during cardiac surgery. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004126-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004126-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004126-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004126-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD004126-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD004126-abs-0007">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004126-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004126-abs-0005" lang="en"> <h3>Using alpha‐2 adrenergic agonists to prevent heart complications after major surgery</h3> <p><b>Review question</b> </p> <p>Do alpha‐2 adrenergic agonists (clonidine, dexmedetomidine and mivazerol) reduce the number of deaths and heart complications when given around the time of surgery? </p> <p><b>Background</b> </p> <p>Heart‐related complications can lead to death and long hospital stays after surgery. Each year, about 300 million people undergo major surgery, of whom nine million experience serious heart complications. These complications may occur, in part, because surgery places a large stress on the heart. This stress can lead to high blood pressure and high heart rates during surgery, neither of which are good for the heart. Alpha‐2 adrenergic agonists are a group of medicines that can prevent the blood pressure and heart rate from increasing during surgery. Thus, these medicines may also protect the heart from the stress of surgery. We wanted to find out if giving these medicines around the time of surgery could protect the heart from the stress of surgery and thus prevent major heart complications. </p> <p><b>Study characteristics</b> </p> <p>We found 47 studies that were published up to May 2017. These studies involved 17,039 adults who had major surgery. Twenty‐four studies involved 2672 adults having heart surgery. Twenty‐three studies involved 14,367 adults undergoing major operations other than heart surgery. Forty studies compared alpha‐2 adrenergic agonists to dummy treatment (placebo). The other seven studies compared them to other medicines. Twenty‐one studies tested an alpha‐2 adrenergic agonist medicine called clonidine, 24 studied another medicine called dexmedetomidine and two studied another medicine called mivazerol. The duration of alpha‐2 adrenergic agonist medicine studied varied from one dose before surgery to three days of treatment. Most people who took part in these studies were men, and their average age was 60 to 70 years old. Fourteen studies reported receiving money from the company that manufactured the medicine being tested in the same study. Another 15 studies did not report where they received the money needed to fund the study. The number of people who took part in each study varied between 20 participants to as many as 10,000 participants. Nineteen studies included more than 100 participants. </p> <p><b>Key results</b> </p> <p>We found that alpha‐2 adrenergic agonists generally had no clear benefits for preventing death or major complications after surgery. For people having major operations other than heart surgery, alpha‐2 adrenergic agonists did not lower their chances of dying, having a heart attack or having a stroke after surgery. We did not find sufficient evidence that, in people having heart surgery, alpha‐2 adrenergic lowered the risk of dying or having a heart attack after surgery. There was some very limited evidence that these medicines might prevent strokes after heart surgery. Nonetheless, more research is needed before we can be certain that alpha‐2 adrenergic agonists truly have this benefit. These medicines also had some important side effects. People who received alpha‐2 adrenergic agonists were much more likely to have low blood pressures or low heart rates during or after surgery. </p> <p><b>Quality of evidence</b> </p> <p>We assessed the quality of all studies we identified using a specialized tool called the GRADE criteria. In general, we found that most of the evidence in these studies was moderate or high quality. Thus, based on our results, we can be reasonably certain that alpha‐2 adrenergic agonists are not helpful for reducing the numbers of deaths or major heart complications that happen after surgery. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004126-sec-0126" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004126-sec-0126">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004126-sec-0191">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004126-sec-0126"></div> <h3 class="title" id="CD004126-sec-0127">Implications for practice</h3> <section id="CD004126-sec-0127"> <p>Our study found high‐quality data to firmly conclude that there are no compelling reasons for employing perioperative α‐2 adrenergic agonists to reduce the risks of perioperative death or major cardiac complications in people undergoing surgery. These agents do not reduce the risks of death, myocardial infarction (MI) or acute stroke after surgery. Furthermore, they are associated with important adverse effects, namely increased risks of hypotension and bradycardia. </p> </section> <h3 class="title" id="CD004126-sec-0128">Implications for research</h3> <section id="CD004126-sec-0128"> <p>First, randomized controlled trials (RCTs) of clonidine for reducing perioperative cardiovascular risk should not be performed in the future because the Perioperative Ischemic Evaluation ‐ 2 (POISE‐2) trial provides compelling evidence that this specific agent lacks benefit. Second, while it is presently unclear whether more selective α‐2 adrenergic agonists, such as dexmedetomidine or mivazerol, have differing effects on clinical outcomes in comparison to clonidine, there are at least theoretical reasons to pursue this hypothesis in future trials. Thus, future RCTs of perioperative α‐2 adrenergic agonists should focus on these more selective agents. Any such future trial should also adhere to quality standards for RCTs including blinding (participants, caregivers, outcome adjudicators), allocation concealment and intention‐to‐treat analysis. Third, appropriately designed future RCTs are needed to determine whether more selective α‐2 adrenergic agonists can help prevent perioperative stroke or all‐cause death after cardiac surgery. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD004126-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD004126-sec-0029"></div> <div class="table" id="CD004126-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Alpha‐2 adrenergic agonists compared to control in non‐cardiac surgery</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Alpha‐2 adrenergic agonists compared to control in non‐cardiac surgery</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults undergoing non‐cardiac surgery<br/> <b>Setting:</b> hospital inpatient care<br/> <b>Intervention:</b> α‐2 adrenergic agonist<br/> <b>Comparison:</b> placebo or inactive control </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Risk ratio<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with α‐2 adrenergic agonists</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All‐cause mortality</b> </p> <p>(within 30‐days after surgery: any reported death)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.80</b><br/> (0.61 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>14,081<br/> (16 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>13 per 1000<br/> (10 to 17) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Cardiac mortality</b> </p> <p>(within 30‐days after surgery: sudden death or death resulting from a primarily identifiable cardiac cause.) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.86</b><br/> (0.60 to 1.23) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>12,525<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>8 per 1000<br/> (6 to 12) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Myocardial infarction</b> </p> <p>(within 30‐days after surgery: as detected on an electrocardiogram or trans‐oesophageal echocardiogram) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.94</b><br/> (0.69 to 1.27) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>13,907<br/> (12 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>59 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>55 per 1000<br/> (41 to 75) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acute stroke</b> </p> <p>(within 30‐days after surgery: new focal neurologic deficit with signs and symptoms lasting longer than 24 hours) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.93</b><br/> (0.55 to 1.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>11,542<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000<br/> (3 to 8) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Bradycardia</b> </p> <p>(requiring pharmacological or pacemaker treatment during the period of study drug administration) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.59</b><br/> (1.18 to 2.13) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>14,035<br/> (16 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1,2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>75 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>119 per 1000<br/> (89 to 160) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Hypotension</b> </p> <p>(requiring treatment with inotropes or vasopressors during the period of study drug administration) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.24</b><br/> (1.03 to 1.48) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>13,738<br/> (15 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1,2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>304 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>377 per 1000<br/> (313 to 450) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Risk of bias was not serious. Although multiple studies lacked proper allocation concealment and blinding, outcome unlikely to be influenced. Not downgraded. </p> <p><sup>2</sup>Indirectness not serious. Intervention (mivazerol) used in one large study not available for clinical use. Not downgraded. </p> <p><sup>3</sup>Evidence of publication bias in funnel plot of analysis. Downgraded by one level. </p> <p><sup>4</sup>Serious inconsistency between studies indicated by substantial heterogeneity. Downgraded by one level. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004126-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Alpha‐2 adrenergic agonists compared to control in cardiac surgery</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Alpha‐2 adrenergic agonists compared to control in cardiac surgery</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults undergoing cardiac surgery<br/> <b>Setting:</b> hospital inpatient care<br/> <b>Intervention:</b> α‐2 adrenergic agonist<br/> <b>Comparison:</b> placebo or inactive control </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with α‐2 adrenergic agonists</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All‐cause mortality</b> </p> <p>(within 30‐days after surgery: any reported death)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.52</b><br/> (0.26 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1947<br/> (16 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 per 1000<br/> (5 to 21) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cardiac mortality</b> </p> <p>(within 30‐days after surgery: sudden death or death resulting from a primarily identifiable cardiac cause) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>1 death from 12 participants in clonidine arm, and no deaths in 10 participants in control arm. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We did not GRADE evidence for this outcome as accurate estimation of RRs is not possible for such low event rates. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Myocardial infarction</b> </p> <p>(within 30‐days after surgery: sudden death or death resulting from a primarily identifiable cardiac cause) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.01<br/> (0.43 to 2.40) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>782<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000<br/> (9 to 49) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acute stroke</b> </p> <p>(within 30‐days after surgery: new focal neurologic deficit with signs and symptoms lasting longer than 24 hours) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.37<br/> (0.15 to 0.93) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1175<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Total of 18 acute stokes reported, with 14 in control group and 4 in treatment group.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9 per 1000<br/> (4 to 22) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Bradycardia</b> </p> <p>(requiring pharmacological or pacemaker treatment during the period of study drug administration) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.88<br/> (1.35 to 2.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1477<br/> (10 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>64 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>120 per 1000<br/> (86 to 167) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Hypotension</b> </p> <p>(requiring treatment with inotropes or vasopressors during the period of study drug administration) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.19<br/> (0.87 to 1.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1413<br/> (9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,2,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>332 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>395 per 1000<br/> (289 to 544) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Risk of bias was not serious. Although multiple studies lack proper allocation concealment and blinding, outcome unlikely to be influenced. Not downgraded. </p> <p><sup>2</sup>Serious imprecision, because analysis was below optimal information size and confidence interval includes significant benefit and harm. Downgraded by one level. </p> <p><sup>3</sup>Very serious imprecision, because analysis is below optimal information size and number of events was very small. Downgraded by two levels. </p> <p><sup>4</sup>Serious imprecision, because analysis was below optimal information size. Downgraded by one level </p> <p><sup>5</sup>Serious inconsistency between studies indicated by substantial heterogeneity. Downgraded one level. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004126-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004126-sec-0030">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004126-sec-0151">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD004126-sec-0030"></div> <section id="CD004126-sec-0031"> <h3 class="title" id="CD004126-sec-0031">Description of the condition</h3> <p>Perioperative cardiac complications are a major health concern for the 312 million people who annually undergo major surgery worldwide (<a href="./references#CD004126-bbs2-0403" title="MearaJG , LeatherAJM , HaganderL , AlkireBC , AlonsoN , AmehEA , et al. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet 21 April 2015;386(99993):569‐624. [PUBMED: 25924834] ">Meara 2015</a>). For example, about 3% of people who undergo major non‐cardiac surgery experience perioperative myocardial infarction (MI) (<a href="./references#CD004126-bbs2-0414" title="Vascular events In noncardiac Surgery patIents cOhort evaluatioN (VISION) Writing Group. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30‐day outcomes. Anesthesiology2014;120(3):564‐78. [PUBMED: 24534856] ">VISION 2014</a>). Major cardiac complications, such as MI, lead to increased mortality, hospital stay and costs (<a href="./references#CD004126-bbs2-0391" title="FleischmannKE , GoldmanL , YoungB , LeeTH . Association between cardiac and noncardiac complications in patients undergoing noncardiac surgery: outcomes and effects on length of stay. American Journal of Medicine2003;115(7):515‐20. [PUBMED: 14599629] ">Fleischmann 2003</a>; <a href="./references#CD004126-bbs2-0393" title="ForceT , HibberdP , WeeksG , KemperAJ , BloomfieldP , TowD , et al. Perioperative myocardial infarction after coronary artery bypass surgery. Clinical significance and approach to risk stratification. Circulation1990;82(3):903‐12. [PUBMED: 2394010] ">Force 1990</a>; <a href="./references#CD004126-bbs2-0414" title="Vascular events In noncardiac Surgery patIents cOhort evaluatioN (VISION) Writing Group. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30‐day outcomes. Anesthesiology2014;120(3):564‐78. [PUBMED: 24534856] ">VISION 2014</a>). The surgical stress response may play an important role in the pathogenesis of these complications. Specifically, surgical stress stimulates the sympathetic nervous system, which in turns leads to increased plasma levels of norepinephrine and epinephrine (<a href="./references#CD004126-bbs2-0397" title="HalterJB , PflugAE , PorteDJ . Mechanism of plasma catecholamine increases during surgical stress in man. Journal of Clinical Endocrinology and Metabolism1977;45(5):936‐44. [PUBMED: 925142] ">Halter 1997</a>). These effects increase blood pressure and heart rate, which can predispose the myocardium to ischaemia, especially in people with decreased coronary blood flow reserve. </p> </section> <section id="CD004126-sec-0032"> <h3 class="title" id="CD004126-sec-0032">Description of the intervention</h3> <p>Alpha‐2 (α‐2) adrenergic agonists selectively bind to presynaptic α‐2 adrenergic receptors to activate a negative feedback mechanism that inhibits central sympathetic outflow (<a href="./references#CD004126-bbs2-0404" title="MuziM , GoffDR , KampineJP , RoerigDL , EbertTJ . Clonidine reduces sympathetic activity but maintains baroreflex responses in normotensive humans. Anesthesiology1992;77(5):864‐71. [PUBMED: 1443738] ">Muzi 1992</a>). These receptors are mainly located in the central nervous system, specifically in the brain stem and locus coeruleus. Activation of these receptors lead to hypotension, bradycardia, central sedation, anxiolysis and analgesia. Three specific α‐2 adrenergic agonists that have been evaluated in people undergoing surgery, namely clonidine, dexmedetomidine and mivazerol. Clonidine and dexmedetomidine are available for clinical use, while the use of mivazerol has been restricted to clinical trials. Clonidine has a half‐life of 12 to 18 hours with excellent bioavailability, lending to its suitability for once daily administration in oral tablet or transdermal patch forms. An intravenous (IV) formulation of clonidine is also available. Dexmedetomidine has a shorter half‐life of only two hours and variable bioavailability, consequently making it more suited for administration as a continuous IV infusion (<a href="./references#CD004126-bbs2-0392" title="FloodP , RathmellJP , ShaferS . Stoelting’s Pharmacology and Physiology in Anesthetic Practice. 5th Edition. Philadelphia (PA): Wolters Kluwer Health, 2015. ">Flood 2015</a>). Similarly, mivazerol is also administered as a continuous IV infusion (<a href="./references#CD004126-bbs2-0027" title="OliverMF , GoldmanL , JulianDG , HolmeI . Effect of mivazerol on perioperative cardiac complications during non‐cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology1999;91(4):951‐61. [PUBMED: 10519497] ">Oliver 1999</a>). </p> </section> <section id="CD004126-sec-0033"> <h3 class="title" id="CD004126-sec-0033">How the intervention might work</h3> <p>As indicated above, α‐2 adrenergic agonists inhibit central sympathetic outflow. Hence, they can attenuate perioperative haemodynamic abnormalities (<a href="./references#CD004126-bbs2-0011" title="EllisJE , DrijversG , PedlowS , LaffSP , SorrentinoMJ , FossJF , et al. Premedication with oral and transdermal clonidine provides safe and efficacious postoperative sympatholysis. Anesthesia and Analgesia1994;79(6):1133‐40. [PUBMED: 7978438] ">Ellis 1994</a>; <a href="./references#CD004126-bbs2-0025" title="McSPI‐Europe Research Group. Perioperative sympatholysis: beneficial effects of the alpha 2‐adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. Anesthesiology1997;86(2):346‐63. [PUBMED: 9054253] ">McSPI‐Europe 1997</a>; <a href="./references#CD004126-bbs2-0039" title="TalkeP , LiJ , JainU , LeungJ , DrasnerK , HollenbergM , et al. Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. Anesthesiology1995;82(3):620‐33. [PUBMED: 7879930] ">Talke 1995</a>), and perhaps also prevent cardiac complications. Furthermore, clonidine has the unique ability to reduce sympathetic activity without blunting the baroreflex, which is critical for responding to the fluctuations in circulating blood volume often encountered during surgery (<a href="./references#CD004126-bbs2-0404" title="MuziM , GoffDR , KampineJP , RoerigDL , EbertTJ . Clonidine reduces sympathetic activity but maintains baroreflex responses in normotensive humans. Anesthesiology1992;77(5):864‐71. [PUBMED: 1443738] ">Muzi 1992</a>). Nonetheless, α‐2 adrenergic agonists have important adverse effects, including hypotension and bradycardia (<a href="./references#CD004126-bbs2-0386" title="BiccardBM , GogaS , deBeursJ . Dexmedetomidine and cardiac protection for non‐cardiac surgery: a meta‐analysis of randomised controlled trials. Anaesthesia2008;63(1):4‐14. [PUBMED: 18086064] ">Biccard 2008</a>). These haemodynamic effects may have clinically important consequences for people undergoing surgery. For example, in the Perioperative Ischemic Evaluation ‐ 1 (POISE‐1) randomized controlled trial (RCT), acute perioperative β‐blockade increased risks of bradycardia, hypotension, acute stroke, and death (<a href="./references#CD004126-bbs2-0406" title="POISE Study Group. Effects of extended‐release metoprolol succinate in patients undergoing non‐cardiac surgery (POISE trial): a randomised controlled trial. Lancet2008;371(9627):1839‐47. [PUBMED: 18479744] ">POISE 2008</a>). Given that α‐2 adrenergic agonists have both potential benefits and adverse effects, a quantitative systematic review may help determine their overall efficacy and safety. </p> </section> <section id="CD004126-sec-0034"> <h3 class="title" id="CD004126-sec-0034">Why it is important to do this review</h3> <p>Previous systematic reviews of perioperative α‐2 adrenergic agonists have been published (<a href="./references#CD004126-bbs2-0386" title="BiccardBM , GogaS , deBeursJ . Dexmedetomidine and cardiac protection for non‐cardiac surgery: a meta‐analysis of randomised controlled trials. Anaesthesia2008;63(1):4‐14. [PUBMED: 18086064] ">Biccard 2008</a>; <a href="./references#CD004126-bbs2-0405" title="NishinaK , MikawaK , UesugiT , ObaraH , MaekawaM , KamaeI , et al. Efficacy of clonidine for prevention of perioperative myocardial ischemia. A critical appraisal and meta‐analysis of the literature. Anesthesiology2002;96(2):323‐9. [PUBMED: 11818763] ">Nishina 2002</a>; <a href="./references#CD004126-bbs2-0411" title="StevensRD , BurriH , TramerMR . Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesthesia and Analgesia2003;97(3):623‐33. [PUBMED: 12933373] ">Stevens 2003</a>). However, two of them were restricted to individual α‐2 adrenergic agonists, namely clonidine (<a href="./references#CD004126-bbs2-0405" title="NishinaK , MikawaK , UesugiT , ObaraH , MaekawaM , KamaeI , et al. Efficacy of clonidine for prevention of perioperative myocardial ischemia. A critical appraisal and meta‐analysis of the literature. Anesthesiology2002;96(2):323‐9. [PUBMED: 11818763] ">Nishina 2002</a>), and dexmedetomidine (<a href="./references#CD004126-bbs2-0386" title="BiccardBM , GogaS , deBeursJ . Dexmedetomidine and cardiac protection for non‐cardiac surgery: a meta‐analysis of randomised controlled trials. Anaesthesia2008;63(1):4‐14. [PUBMED: 18086064] ">Biccard 2008</a>). The other review was restricted to studies published before 2002 (<a href="./references#CD004126-bbs2-0411" title="StevensRD , BurriH , TramerMR . Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesthesia and Analgesia2003;97(3):623‐33. [PUBMED: 12933373] ">Stevens 2003</a>). A systematic review according to the Cochrane methodology is therefore justified. The current review is an update to a previous Cochrane Review that included studies published before August 2008 (<a href="./references#CD004126-bbs2-0418" title="WijeysunderaDN , BenderJS , BeattieWS . Alpha‐2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD004126.pub2] ">Wijeysundera 2009</a>). This update was deemed necessary, in part, given the publication of the largest RCT to‐date of perioperative α‐2 adrenergic agonists, the Perioperative Ischemic Evaluation ‐ 2 (POISE‐2) trial (<a href="./references#CD004126-bbs2-0007" title="DevereauxPJ , SesslerDI , LeslieK , KurzA , MrkobradaM , Alonso‐CoelloP , et al. Clonidine in patients undergoing noncardiac surgery. New England Journal of Medicine2014;370(16):1504‐13. [PUBMED: 24679061] ">Devereaux 2014a</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004126-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004126-sec-0035">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004126-sec-0156">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004126-sec-0035"></div> <p>To determine the efficacy and safety of α‐2 adrenergic agonists for reducing mortality and cardiac complications in adults undergoing cardiac surgery and non‐cardiac surgery. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004126-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004126-sec-0036">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004126-sec-0157">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004126-sec-0036"></div> <section id="CD004126-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004126-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included published RCTs.</p> </section> <section id="CD004126-sec-0039"> <h4 class="title">Types of participants</h4> <p>We included adults (aged 18 years or older) undergoing surgery under general anaesthesia, neuraxial anaesthesia, or both. We excluded surgery performed under local anaesthesia or peripheral nerve blockade alone because such procedures are generally associated with a very low risk of mortality and morbidity. We also excluded surgery performed on pregnant women, organ transplant recipients, or people with substance withdrawal. Organ transplantation procedures may be associated with a high risk of mortality unrelated to cardiovascular causes, thereby masking any potential benefit from α‐2 adrenergic agonists. </p> </section> <section id="CD004126-sec-0040"> <h4 class="title">Types of interventions</h4> <p>The experimental intervention must have included clonidine, mivazerol or dexmedetomidine administration before surgery (within 24 hours), during surgery, or after surgery (within 48 hours). The medications must have been administered via IV, intramuscular, oral or transdermal routes. There were no restrictions on the dose, duration or frequency of the intervention. </p> <p>We permitted active interventions in the comparator group only if the comparator was judged to have minimal to no effect on the primary or secondary outcomes. For example, in a trial where dexmedetomidine was being primarily evaluated for the role of providing postoperative sedation after major surgery, comparison to propofol was judged to be reasonable. </p> </section> <section id="CD004126-sec-0041"> <h4 class="title">Types of outcome measures</h4> <p>Included trials had to evaluate the efficacy or safety of α‐2 adrenergic agonists in reducing perioperative mortality or cardiac complications, or both. Studies were included if they measured one or more relevant outcomes, which included death, MI, heart failure (HF), acute stroke, supraventricular tachyarrhythmia (SVT) or myocardial ischaemia. In addition, studies with similar objectives to our review were included, even if these same studies did not report any relevant outcome events (i.e. death, MI, HF, acute stroke, SVT, myocardial ischaemia). </p> <section id="CD004126-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD004126-list-0001"> <li> <p>All‐cause mortality within 30 days after surgery: any reported death. The time period for outcome ascertainment in each trial was also documented. </p> </li> </ol> </p> </section> <section id="CD004126-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD004126-list-0002"> <li> <p>Cardiac mortality within 30 days after surgery: sudden death or death resulting from a primarily identifiable cardiac cause. The time period for outcome ascertainment in each trial was also documented. </p> </li> <li> <p>MI within 30 days after surgery: definition as per individual study (specific criteria employed were documented). The time period for outcome ascertainment in each trial was also documented. </p> </li> <li> <p>Myocardial ischaemia within 30 days after surgery: as detected on an electrocardiogram (ECG) or trans‐oesophageal echocardiogram (specific criteria employed were documented). The time period for outcome ascertainment in each trial was also documented. </p> </li> <li> <p>SVT within 30 days after surgery: SVT, atrial fibrillation or atrial flutter. The time period for outcome ascertainment in each trial was also documented. </p> </li> <li> <p>HF within 30 days after surgery: clinical diagnosis of HF or need for postoperative intra‐aortic balloon pump support (applicable only for cardiac surgery). The time period for outcome ascertainment in each trial was also documented. </p> </li> </ol> </p> <section id="CD004126-sec-0044"> <h6 class="title">Adverse effects from treatment</h6> <p> <ol id="CD004126-list-0003"> <li> <p>Acute stroke within 30 days after surgery: new focal neurological deficit with signs and symptoms lasting longer than 24 hours. The time period for outcome ascertainment in each trial was also documented. </p> </li> </ol> </p> </section> <section id="CD004126-sec-0045"> <h6 class="title">Physiological effects of treatment</h6> <p> <ol id="CD004126-list-0004"> <li> <p>Bradycardia requiring pharmacological or pacemaker treatment during the period of study drug administration. </p> </li> <li> <p>Hypotension requiring treatment with inotropes or vasopressors during the period of study drug administration. </p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD004126-sec-0046"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD004126-sec-0047"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL, 2017, Issue 4), MEDLINE (1950 to April week 4 2017), Embase (1980 to May 2017), the Science Citation Index and reference lists of articles. The Ovid platform was used for searching the electronic databases. </p> <p>We searched MEDLINE using the search terms presented in <a href="./appendices#CD004126-sec-0132">Appendix 1</a>. We then limited the studies to those identified simultaneously by a highly sensitive search strategy for identifying RCTs in MEDLINE (<a href="./references#CD004126-bbs2-0389" title="DickersinK , SchererR , LefebvreC . Identifying relevant studies for systematic reviews. BMJ1994;309:1286‐91. [PUBMED: 7718048] ">Dickersin 1994</a>). Our search strategies for CENTRAL and Embase are presented in <a href="./appendices#CD004126-sec-0132">Appendix 1</a>. </p> </section> <section id="CD004126-sec-0048"> <h4 class="title">Searching other resources</h4> <p>We entered all trials selected for inclusion into the Science Citation Index to identify any additional relevant articles. The bibliographies of all included articles and published reviews were searched to identify any other potentially relevant studies for inclusion. Additionally, we searched clinical trial registries, namely ClinicalTrials.gov and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP), for published studies meeting our inclusion criteria. These additional searches were completed in May 2017. </p> </section> </section> <section id="CD004126-sec-0049"> <h3 class="title" id="CD004126-sec-0049">Data collection and analysis</h3> <section id="CD004126-sec-0050"> <h4 class="title">Selection of studies</h4> <p>Two authors (DD, AS) independently performed literature searches for potentially relevant RCTs. All identified published full papers and abstracts were assessed independently for inclusion by the same two authors. We applied no language restrictions. We documented the reasons for exclusion for all excluded studies. We resolved all disagreements by consensus or involvement of a third author (DNW). </p> </section> <section id="CD004126-sec-0051"> <h4 class="title">Data extraction and management</h4> <p>Two authors (DD, AS) independently extracted data from the included studies on a predesigned data abstraction form (<a href="./appendices#CD004126-sec-0133">Appendix 2</a>). These same two authors independently entered all data into Review Manager 5 (<a href="./references#CD004126-bbs2-0408" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We were not blinded to study authors, institution or journal when performing data abstraction. Where necessary, we contacted authors of published trials to provide any additional information required for the analyses (see <a href="#CD004126-sec-0036">Methods</a> of the review). </p> </section> <section id="CD004126-sec-0052"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two authors (DD, AS) independently evaluated the quality of all included trials using the criteria recommended by the Cochrane Anaesthesia, Critical and Emergency Care (ACE) Group. These criteria emphasize the adequacy of allocation concealment, randomization, blinding and intention‐to‐treat (ITT) analysis. Each included study was evaluated using the Cochrane 'Risk of bias' tool (<a href="./references#CD004126-bbs2-0400" title="HigginsJP , AltmanDG , GotzschePC , JuniP , MoherD , OxmanAD , et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ2011;343:d5928. [PUBMED: 22008217] ">Higgins 2011a</a>). We were not blinded to study authors, institution or journal when performing quality assessment. </p> </section> <section id="CD004126-sec-0053"> <h4 class="title">Measures of treatment effect</h4> <p>We performed all statistical analyses using Review Manager 5 (<a href="./references#CD004126-bbs2-0408" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). Given that all outcomes and adverse effects were dichotomous, all treatment effects were expressed as pooled risk ratios (RR) with 95% confidence intervals (CI). </p> </section> <section id="CD004126-sec-0054"> <h4 class="title">Unit of analysis issues</h4> <p>We excluded cross‐over trials and cluster randomized trials in this review. If a study had multiple treatment arms, comparisons were made between α‐2 adrenergic agonist and placebo, or between α‐2 adrenergic agonist and inactive control. </p> </section> <section id="CD004126-sec-0055"> <h4 class="title">Dealing with missing data</h4> <p>If a study had missing relevant data in the published report, we attempted to contact the study authors up to three times to obtain these data. If data were missing due to participant attrition, and imputation methods were not used in the published report, we employed complete case analysis when importing the data. </p> </section> <section id="CD004126-sec-0056"> <h4 class="title">Assessment of heterogeneity</h4> <p>We measured heterogeneity using the I<sup>2</sup> statistic: the proportion of total variation explained by between‐study variation as opposed to chance (<a href="./references#CD004126-bbs2-0398" title="HigginsJP , ThompsonSG . Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine2002;21(11):1539‐58. [PUBMED: 12111919] ">Higgins 2002</a>; <a href="./references#CD004126-bbs2-0399" title="HigginsJP , ThompsonSG , DeeksJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [PUBMED: 12958120] ">Higgins 2003</a>). Higher I<sup>2</sup> statistics imply more heterogeneity between studies than would be expected by chance alone. </p> </section> <section id="CD004126-sec-0057"> <h4 class="title">Assessment of reporting biases</h4> <p>We carried out funnel plot analyses to assess for publication bias (<a href="./references#CD004126-bbs2-0390" title="EggerM , DaveySG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315(7109):629‐34. [PUBMED: 9310563] ">Egger 1997</a>), with formal tests for asymmetry being performed only if meta‐analyses pooled data from 10 or more studies (<a href="./references#CD004126-bbs2-0401" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). </p> </section> <section id="CD004126-sec-0058"> <h4 class="title">Data synthesis</h4> <p>Given the clinical heterogeneity between cardiac and non‐cardiac surgery, we conducted analyses for these two subgroups separately. If an individual study included both cardiac and non‐cardiac surgery procedures, we attempted to obtain subgroup‐specific results from the authors. If such data were not available, and greater than 75% of participants underwent cardiac surgical procedures, the specific study was allocated to the cardiac surgery subgroup. Conversely, the study was allocated to the non‐cardiac surgery subgroup if greater than 75% of participants underwent non‐cardiac surgical procedures. In all other cases, the specific study was excluded from the review. In the presence of low heterogeneity (I<sup>2</sup> statistic 25% or less) (<a href="./references#CD004126-bbs2-0399" title="HigginsJP , ThompsonSG , DeeksJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [PUBMED: 12958120] ">Higgins 2003</a>), pooled RRs were calculated using the fixed‐effect model. In the presence of moderate‐to‐significant heterogeneity (I<sup>2</sup> statistic greater than 25%) (<a href="./references#CD004126-bbs2-0399" title="HigginsJP , ThompsonSG , DeeksJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [PUBMED: 12958120] ">Higgins 2003</a>), we used the random‐effects model and carried out post‐hoc analyses to attempt to explain the heterogeneity. </p> </section> <section id="CD004126-sec-0059"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>A priori, we planned several subgroup analyses to determine the potential influence of the surgical procedure, the specific α‐2 adrenergic agonist employed and coexistent therapies on the overall results. Subgroup‐specific results were only calculated if there were two or more studies within the subgroup. These subgroup analyses were as follows. </p> <p> <ol id="CD004126-list-0005"> <li> <p>Treatment effects of α‐2 adrenergic agonists on mortality (all‐cause and cardiac‐cause), MI and ischaemia based on the type of non‐cardiac surgical procedure, namely vascular versus non‐vascular non‐cardiac surgery. If a variety of surgical procedures were included in a study, we attempted to obtain subgroup‐specific results from the authors. If such data were not available, and greater than 75% of participants underwent the same class of surgery, the specific study was allocated to that specific subgroup. Failing that, the specific study was excluded from the subgroup analysis based on procedure type. We used statistical tests of interaction to assess for the presence of any subgroup effects. </p> </li> <li> <p>We calculated treatment effects for each of clonidine, mivazerol and dexmedetomidine on mortality (all‐cause and cardiac‐cause), and MI in non‐cardiac surgery. Statistical tests of interaction were used to assess for the presence of any subgroup effects. </p> </li> </ol> </p> </section> <section id="CD004126-sec-0060"> <h4 class="title">Sensitivity analysis</h4> <p>We planned several sensitivity analyses a priori to characterize the influence of study quality and outcome definitions on the overall results. </p> <p> <ol id="CD004126-list-0006"> <li> <p>We restricted the meta‐analyses to the subset of studies that clearly reported methods for blinding and allocation concealment. </p> </li> <li> <p>We determined the effect of α‐2 adrenergic agonists on MI in the subset of RCTs that strictly defined MI a priori as either significant new Q waves on an ECG or significant elevations in enzymatic markers of cardiac injury (MB isoenzyme of creatinine kinase, troponin‐I, troponin‐T). </p> </li> <li> <p>We determined the effect of α‐2 adrenergic agonists on myocardial ischaemia in the subset of RCTs that strictly defined ischaemia a priori as ST segment depression or elevation of 0.1 mV or greater for one minute or longer. </p> </li> </ol> </p> <p>In addition, we performed four additional post‐hoc analyses.</p> <p> <ol id="CD004126-list-0007"> <li> <p>Significant statistical heterogeneity was identified when calculating the pooled effect of α‐2 adrenergic agonists on hypotension during non‐cardiac surgery. To explore potential explanations for this heterogeneity, we conducted subgroup analyses based on the specific agent (i.e. clonidine, mivazerol or dexmedetomidine) in the included trials. A statistical test of interaction was used to assess for the presence of a subgroup effect. </p> </li> <li> <p>During the course of the review, we identified several very large included RCTs that might have highly influenced the overall pooled estimates. Therefore, we conducted a sensitivity analysis that excluded these very large RCTs. </p> </li> <li> <p>Mivazerol is an experimental α‐2 adrenergic agonist that was studied in several relatively large trials, but never proceeded through the approval process for clinical use. At the request of external peer reviewers of this review, we conducted a sensitivity analysis that excluded trials that evaluated mivazerol. </p> </li> <li> <p>Several relevant studies were conducted prior to 1997, during a period when perioperative practice might not necessarily be generalizable to contemporary practice. At the request of external peer reviewers of this review, we conducted a sensitivity analysis that excluded trials where data were collected prior to 1997. </p> </li> </ol> </p> <section id="CD004126-sec-0061"> <h5 class="title">'Summary of findings' tables and GRADE</h5> <p>To characterize the confidence in the pooled estimated treatment effects better, we used GRADE methodology to assess the quality of evidence (<a href="./references#CD004126-bbs2-0396" title='GuyattGH , OxmanAD , KunzR , VistGE , Falck‐YtterY , SchunemannHJ . What is "quality of evidence" and why is it important to clinicians?. BMJ (Clinical Research Ed.)2008;336(7651):995‐8. [PUBMED: 18456631] '>Guyatt 2008</a>). We generated 'Summary of findings' tables that separately presented pooled treatment effect estimates for the subgroups of participants who underwent non‐cardiac surgery and cardiac surgery. To facilitate this process, data from the meta‐analyses in Review Manager 5 (<a href="./references#CD004126-bbs2-0408" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), were initially exported into <a href="./references#CD004126-bbs2-0395" title="GRADE Working Group. GRADEpro Guideline Development Tool. McMaster University (developed by Evidence Prime Inc.), 2015. ">GRADEpro</a>. The GRADE approach rates quality of evidence as high, moderate, low or very low (<a href="./references#CD004126-bbs2-0394" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s) . GRADE handbook for grading quality of evidence and strength of recommendations. Available from guidelinedevelopment.org/handbook: The GRADE Working Group, October 2013. ">GRADE Handbook 2013</a>). Since all data included in this review were from RCTs, the quality of evidence for each outcome of interest was initially rated as high level, and then potentially downgraded up to three levels based on any deficiencies in the quality of the underlying evidence. The quality of evidence underlying each pooled treatment effect estimate was assessed with respect to the risk of bias, inconsistency, indirectness, imprecision and publication bias (<a href="./references#CD004126-bbs2-0385" title="BalshemH , HelfandM , SchünemannHJ , OxmanAD , KunzR , BrozekJ , et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology2011;64(4):401‐6. [PUBMED: 21208779] ">Balshem 2011</a>). The anticipated risk for comparison of each outcome was determined based on the event rate in the control group. Only outcomes judged as critically important, based on their impact on patient health or clinical decision‐making, were chosen for presentation in the 'Summary of findings' tables. In this present review, we included the following outcomes in the 'Summary of findings' tables, provided that relevant estimated pooled treatment effects were present: all‐cause mortality, cardiac mortality, MI, acute stroke, bradycardia and hypotension. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004126-sec-0062" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004126-sec-0062"></div> <section id="CD004126-sec-0063"> <h3 class="title">Description of studies</h3> <section id="CD004126-sec-0064"> <h4 class="title">Results of the search</h4> <p>Our search results are presented in <a href="#CD004126-fig-0001">Figure 1</a>. The authors identified 3099 separate papers in the literature search and three additional papers from other sources and in total read 389 papers in full. </p> <div class="figure" id="CD004126-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD004126-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD004126-sec-0065"> <h4 class="title">Included studies</h4> <p>We included 47 trials, which encompassed 17,039 participants (<a href="./references#CD004126-bbs2-0001" title="Abi‐JaoudeF , BrussetA , CeddahaA , SchlumbergerS , RaffinL , DuboisC , et al. Clonidine premedication for coronary artery bypass grafting under high‐dose alfentanil anesthesia: intraoperative and postoperative hemodynamic study. Journal of Cardiothoracic and Vascular Anesthesia1993;7(1):35‐40. [PUBMED: 8431573] BrussetA , Abi‐JaoudeF , CeddahaA , SchlumbergerS , RaffinL , FischlerM . Clonidine aggravates the postoperative hemodynamic profile after coronary bypass: randomized, double‐blind study. Annales Françaises d'Anesthèsie et de Rèanimation1989;8 Suppl:R215. [PUBMED: 2690688] BrussetA , Abi‐JaoudeF , RaffinL , CeddahaA , SchlumbergerS , FischlerM . Clonidine modifies the hemodynamic profile in coronary bypass: double‐blind, randomized study. Annales Françaises d'Anesthèsie et de Rèanimation1989;8 Suppl:R214. [PUBMED: 2690687] ">Abi‐Jaoude 1993</a>; <a href="./references#CD004126-bbs2-0002" title="AmmarA , MahmoudK , KasemyZ , HelwaM . Cardiac and renal protective effects of dexmedetomidine in cardiac surgeries: a randomized controlled trial. Saudi Journal of Anaesthesia2016;10(4):395‐401. [EMBASE: 612358144] ">Ammar 2016</a>; <a href="./references#CD004126-bbs2-0003" title="BergeseS , CandiottiK , BokeschP , ZuraA , WisemandleW , BekkerA . A phase IIIb, randomized, double‐blind, placebo‐controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586‐95. [PUBMED: 20535016] ">Bergese 2010</a>; <a href="./references#CD004126-bbs2-0004" title="ChiX , LiaoM , ChenX , ZhaoY , YangL , LuoA , et al. Dexmedetomidine attenuates myocardial injury in off‐pump coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2016;30(1):44‐50. [PUBMED: 26429360] ">Chi 2016</a>; <a href="./references#CD004126-bbs2-0005" title="ChoJS , ShimJK , SohS , KimMK , KwakYL . Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery. Kidney International2016;89(3):693‐700. [PUBMED: 26444030] ">Cho 2016</a>; <a href="./references#CD004126-bbs2-0006" title="CorbettSM , RebuckJA , GreeneCM , CallasPW , NealeBW , HealeyMA , et al. Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Critical Care Medicine2005;33(5):940‐5. [PUBMED: 15891317] ">Corbett 2005</a>; <a href="./references#CD004126-bbs2-0007" title="DevereauxPJ , SesslerDI , LeslieK , KurzA , MrkobradaM , Alonso‐CoelloP , et al. Clonidine in patients undergoing noncardiac surgery. New England Journal of Medicine2014;370(16):1504‐13. [PUBMED: 24679061] ">Devereaux 2014a</a>; <a href="./references#CD004126-bbs2-0008" title="DjaianiG , SilvertonN , FedorkoL , CarrollJ , StyraR , RaoV , et al. Dexmedetomidine versus propofol sedation reduces delirium after cardiac surgery: a randomized controlled trial. Anesthesiology2016;124(2):362‐8. [PUBMED: 26575144] ">Djaiani 2016</a>; <a href="./references#CD004126-bbs2-0009" title="DormanBH , ZuckerJR , VerrierED , GartmanDM , SlachmanFN . Clonidine improves perioperative myocardial ischemia, reduces anesthetic requirement, and alters hemodynamic parameters in patients undergoing coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):386‐95. [PUBMED: 8400091] ">Dorman 1993</a>; <a href="./references#CD004126-bbs2-0010" title="El‐KardawyH , GoudaN , KamalH , DossL . Dexmedetomidine as anaesthetic adjunct for patients undergoing off‐pump coronary artery bypass grafting. Egyptian Journal of Anaesthesia2004;20(1):29‐34. [EMBASE: 2004089519] ">El‐Kerdawy 2004</a>; <a href="./references#CD004126-bbs2-0011" title="EllisJE , DrijversG , PedlowS , LaffSP , SorrentinoMJ , FossJF , et al. Premedication with oral and transdermal clonidine provides safe and efficacious postoperative sympatholysis. Anesthesia and Analgesia1994;79(6):1133‐40. [PUBMED: 7978438] ">Ellis 1994</a>; <a href="./references#CD004126-bbs2-0012" title="GhignoneM , QuintinL , DukePC , KehlerCH , CalvilloO . Effects of clonidine on narcotic requirements and hemodynamic response during induction of fentanyl anesthesia and endotracheal intubation. Anesthesiology1986;64(1):36‐42. [PUBMED: 3942335] ">Ghignone 1986</a>; <a href="./references#CD004126-bbs2-0013" title="GhignoneM , CalvilloO , QuintinL . Anesthesia and hypertension: the effect of clonidine on perioperative hemodynamics and isoflurane requirements. Anesthesiology1987;67(1):3‐10. [PUBMED: 3605732] ">Ghignone 1987</a>; <a href="./references#CD004126-bbs2-0014" title="Helbo‐HansenS , FletcherR , LundbergD , NordstromL , WernerO , StahlE , et al. Clonidine and the sympatico‐adrenal response to coronary artery by‐pass surgery. Acta Anaesthesiologica Scandinavica1986;30(3):235‐42. [PUBMED: 3017039] ">Helbo‐Hansen 1986</a>; <a href="./references#CD004126-bbs2-0015" title="HerrDL , Sum‐PingST , EnglandM . ICU sedation after coronary artery bypass graft surgery: dexmedetomidine‐based versus propofol‐based sedation regimens. Journal of Cardiothoracic and Vascular Anesthesia2003;17(5):576‐84. [PUBMED: 14579210] ">Herr 2003</a>; <a href="./references#CD004126-bbs2-0016" title="JalonenJ , HynynenM , KuitunenA , HeikkilaH , PerttilaJ , SalmenperaM , et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology1997;86(2):331‐45. [PUBMED: 9054252] ">Jalonen 1997</a>; <a href="./references#CD004126-bbs2-0017" title="KhalilM , Abdel AzeemM . The impact of dexmedetomidine infusion in sparing morphine consumption in off‐pump coronary artery bypass grafting. Seminars in Cardiothoracic and Vascular Anesthesia2013;17(1):66‐71. [PUBMED: 23108415] ">Khalil 2013</a>; <a href="./references#CD004126-bbs2-0018" title="KimHJ , KimWH , KimG , KimE , ParkMH , ShinBS , et al. A comparison among infusion of lidocaine and dexmedetomidine alone and in combination in subjects undergoing coronary artery bypass graft: a randomized trial. Contemporary Clinical Trials2014;39(2):303‐9. [PUBMED: 25447444] ">Kim 2014a</a>; <a href="./references#CD004126-bbs2-0019" title="LeeC , KimYD , KimJN . Antihyperalgesic effects of dexmedetomidine on high‐dose remifentanil‐induced hyperalgesia. Korean Journal of Anesthesiology2013;64(4):301‐7. [PUBMED: 23646238] ">Lee 2013a</a>; <a href="./references#CD004126-bbs2-0020" title="LiX , YangJ , NieXL , ZhangY , LiXY , LiLH , et al. Impact of dexmedetomidine on the incidence of delirium in elderly patients after cardiac surgery: a randomized controlled trial. PloS One2017;12(2):e0170757. [NCT02267538; PUBMED: 28182690] ">Li 2017</a>; <a href="./references#CD004126-bbs2-0021" title="LipszycM , EngelmanE . Clonidine does not prevent myocardial ischemia during noncardiac surgery. Anesthesiology1991;75:A93. ">Lipszyc 1991</a>; <a href="./references#CD004126-bbs2-0022" title="LiuX , ZhangK , WangW , XieG , FangX . Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial. Critical Care2016;20(1):298. [EMBASE: 612244138] ">Liu 2016</a>; <a href="./references#CD004126-bbs2-0023" title="LoickHM , SchmidtC , VanAkenH , JunkerR , ErrenM , BerendesE , et al. High thoracic epidural anesthesia, but not clonidine, attenuates the perioperative stress response via sympatholysis and reduces the release of troponin T in patients undergoing coronary artery bypass grafting. Anesthesia and Analgesia1999;88(4):701‐9. [PUBMED: 10195508] ">Loick 1999</a>; <a href="./references#CD004126-bbs2-0024" title="MatotI , SichelJY , YofeV , GozalY . The effect of clonidine premedication on hemodynamic responses to microlaryngoscopy and rigid bronchoscopy. Anesthesia and Analgesia2000;91(4):828‐33. [PUBMED: 11004033] ">Matot 2000</a>; <a href="./references#CD004126-bbs2-0025" title="McSPI‐Europe Research Group. Perioperative sympatholysis: beneficial effects of the alpha 2‐adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. Anesthesiology1997;86(2):346‐63. [PUBMED: 9054253] ">McSPI‐Europe 1997</a>; <a href="./references#CD004126-bbs2-0026" title="MylesPS , HuntJO , HoldgaardHO , McRaeR , BucklandMR , MoloneyJ , et al. Clonidine and cardiac surgery: haemodynamic and metabolic effects, myocardial ischaemia and recovery. Anaesthesia and Intensive Care1999;27(2):137‐47. [PUBMED: 10212709] ">Myles 1999</a>; <a href="./references#CD004126-bbs2-0027" title="OliverMF , GoldmanL , JulianDG , HolmeI . Effect of mivazerol on perioperative cardiac complications during non‐cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology1999;91(4):951‐61. [PUBMED: 10519497] ">Oliver 1999</a>; <a href="./references#CD004126-bbs2-0028" title="ParkJ , BangS , CheeH , KimJ , LeeS , ShinJ . Efficacy and safety of dexmedetomidine for postoperative delirium in adult cardiac surgery on cardiopulmonary bypass. Korean Journal of Thoracic and Cardiovascular Surgery2014;47(3):249‐54. [CENTRAL: 01305779] ">Park 2014</a>; <a href="./references#CD004126-bbs2-0029" title="PatelJ , ThosaniR , KothariJ , GargP , PandyaH . Clonidine and ketamine for stable hemodynamics in off‐pump coronary artery bypass. Asian Cardiovascular and Thoracic Annals2016;24(7):638‐46. [MEDLINE: 27471314] ">Patel 2016</a>; <a href="./references#CD004126-bbs2-0030" title="PawlikMT , HansenE , WaldhauserD , SeligC , KuehnelTS . Clonidine premedication in patients with sleep apnea syndrome: a randomized, double‐blind, placebo‐controlled study. Anesthesia and Analgesia2005;101(5):1374‐80. [PUBMED: 16243997] ">Pawlik 2005</a>; <a href="./references#CD004126-bbs2-0031" title="PluskwaF , BonnetF , SaadaM , Macquin‐MavierI , BecqueminJP , CatoireP . Effects of clonidine on variation of arterial blood pressure and heart rate during carotid artery surgery. Journal of Cardiothoracic and Vascular Anesthesia1991;5(5):431‐36. [PUBMED: 1932647] ">Pluskwa 1991</a>; <a href="./references#CD004126-bbs2-0032" title="QuintinL , CicalaR , KentM , ThomsenB . Effect of clonidine on myocardial ischaemia: a double‐blind pilot trial. Canadian Journal of Anaesthesia1993;40(1):85‐6. [PUBMED: 7980723] ">Quintin 1993</a>; <a href="./references#CD004126-bbs2-0033" title="QuintinL , BouillocX , ButinE , BayonMC , BrudonJR , LevronJC , et al. Clonidine for major vascular surgery in hypertensive patients: a double‐blind, controlled, randomized study. Anesthesia and Analgesia1996;83(4):687‐95. [PUBMED: 8831304] ">Quintin 1996</a>; <a href="./references#CD004126-bbs2-0034" title="RenJ , ZhangH , HuangL , LiuY , LiuF , DongZ . Protective effect of dexmedetomidine in coronary artery bypass grafting surgery. Experimental and Therapeutic Medicine2013;6(2):497‐502. [PUBMED: 24137215] ">Ren 2013</a>; <a href="./references#CD004126-bbs2-0035" title="ShehabiY , GrantP , WolfendenH , HammondN , BassF , CampbellM , et al. Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine compared to morphine‐DEXCOM study). Anesthesiology2009;111(5):1075‐84. [PUBMED: 19786862] ">Shehabi 2009</a>; <a href="./references#CD004126-bbs2-0036" title="SolimanR , ZohryG . The myocardial protective effect of dexmedetomidine in high‐risk patients undergoing aortic vascular surgery. Annals of Cardiac Anaesthesia2016;19(4):606‐13. [MEDLINE: 27716690] ">Soliman 2016</a>; <a href="./references#CD004126-bbs2-0037" title="StuhmeierKD , MainzerB , CierpkaJ , SandmannW , TarnowJ . Small, oral dose of clonidine reduces the incidence of intraoperative myocardial ischemia in patients having vascular surgery. Anesthesiology1996;85(4):706‐12. [PUBMED: 8873539] ">Stuhmeier 1996</a>; <a href="./references#CD004126-bbs2-0038" title="SuX , MengZT , WuXH , CuiF , LiHL , WangDX , et al. Dexmedetomidine for prevention of delirium in elderly patients after non‐cardiac surgery: a randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10054):1893‐902. [EMBASE: 613271791] ">Su 2016</a>; <a href="./references#CD004126-bbs2-0039" title="TalkeP , LiJ , JainU , LeungJ , DrasnerK , HollenbergM , et al. Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. Anesthesiology1995;82(3):620‐33. [PUBMED: 7879930] ">Talke 1995</a>; <a href="./references#CD004126-bbs2-0040" title="TalkeP , ChenR , ThomasB , AggarwallA , GottliebA , ThorborgP , et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesthesia and Analgesia2000;90(4):834‐9. [PUBMED: 10735784] ">Talke 2000</a>; <a href="./references#CD004126-bbs2-0041" title="VennRM , BradshawCJ , SpencerR , BrealeyD , CaudwellE , NaughtonC , et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia1999;54(12):1136‐42. [PUBMED: 10594409] VennRM , HellJ , GroundsRM . Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Critical Care2000;4(5):302‐8. [PUBMED: 11056756] ">Venn 1999</a>; <a href="./references#CD004126-bbs2-0042" title="VennRM , BryantA , HallGM , GroundsRM . Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post‐operative patients needing sedation in the intensive care unit. British Journal of Anaesthesia2001;86(5):650‐6. [PUBMED: 11575340] VennRM , GroundsRM . Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. British Journal of Anaesthesia2001;87(5):684‐90. [PUBMED: 11878517] ">Venn 2001</a>; <a href="./references#CD004126-bbs2-0043" title="VivianoE , ReniusM , RuckertJ , C , BlochA , MeiselC , Harbeck‐seuA , et al. Selective neurogenic blockade and perioperative immune reactivity in patients undergoing lung resection. Journal of International Medical Research2012;40(1):141‐56. [EMBASE: 2012137611; PUBMED: 22429354] ">Viviano 2012</a>; <a href="./references#CD004126-bbs2-0044" title="WallaceAW , GalindezD , SalahiehA , LayugEL , LazoEA , HaratonikKA , et al. Effects of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology2004;101(2):284‐93. [PUBMED: 15277909] ">Wallace 2004</a>; <a href="./references#CD004126-bbs2-0045" title="WijeysunderaDN , ChoiPT , BadnerNH , BrasherPM , DresserGK , DelgadoDH , et al. A randomized feasibility trial of clonidine to reduce perioperative cardiac risk in patients on chronic beta‐blockade: the EPIC study. Canadian Journal of Anaesthesia2014;61(11):995‐1003. [PUBMED: 25189430] ">Wijeysundera 2014a</a>; <a href="./references#CD004126-bbs2-0046" title="XuL , HuZ , ShenJ , McQuillanPM . Does dexmedetomidine have a cardiac protective effect during non‐cardiac surgery? A randomised controlled trial. Clinical and Experimental Pharmacology and Physiology2014;41(11):879‐83. [EMBASE: 2014925423; PUBMED: 25132247] ">Xu 2014</a>; <a href="./references#CD004126-bbs2-0047" title="YinYC , ChowLH , TsaoCM , ChuCC , TsouMY , ChanKH , et al. Oral clonidine reduces myocardial ischemia in patients with coronary artery disease undergoing noncardiac surgery. Acta Anaesthesiologica Sinica2002;40(4):197‐203. [PUBMED: 12596619] ">Yin 2002</a>). These studies are described in detail in the <a href="./references#CD004126-sec-0149" title="">Characteristics of included studies</a> tables. </p> <p>Twenty four studies with 2672 participants involved cardiac surgery alone (<a href="./references#CD004126-bbs2-0001" title="Abi‐JaoudeF , BrussetA , CeddahaA , SchlumbergerS , RaffinL , DuboisC , et al. Clonidine premedication for coronary artery bypass grafting under high‐dose alfentanil anesthesia: intraoperative and postoperative hemodynamic study. Journal of Cardiothoracic and Vascular Anesthesia1993;7(1):35‐40. [PUBMED: 8431573] BrussetA , Abi‐JaoudeF , CeddahaA , SchlumbergerS , RaffinL , FischlerM . Clonidine aggravates the postoperative hemodynamic profile after coronary bypass: randomized, double‐blind study. Annales Françaises d'Anesthèsie et de Rèanimation1989;8 Suppl:R215. [PUBMED: 2690688] BrussetA , Abi‐JaoudeF , RaffinL , CeddahaA , SchlumbergerS , FischlerM . Clonidine modifies the hemodynamic profile in coronary bypass: double‐blind, randomized study. Annales Françaises d'Anesthèsie et de Rèanimation1989;8 Suppl:R214. [PUBMED: 2690687] ">Abi‐Jaoude 1993</a>; <a href="./references#CD004126-bbs2-0002" title="AmmarA , MahmoudK , KasemyZ , HelwaM . Cardiac and renal protective effects of dexmedetomidine in cardiac surgeries: a randomized controlled trial. Saudi Journal of Anaesthesia2016;10(4):395‐401. [EMBASE: 612358144] ">Ammar 2016</a>; <a href="./references#CD004126-bbs2-0004" title="ChiX , LiaoM , ChenX , ZhaoY , YangL , LuoA , et al. Dexmedetomidine attenuates myocardial injury in off‐pump coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2016;30(1):44‐50. [PUBMED: 26429360] ">Chi 2016</a>; <a href="./references#CD004126-bbs2-0005" title="ChoJS , ShimJK , SohS , KimMK , KwakYL . Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery. Kidney International2016;89(3):693‐700. [PUBMED: 26444030] ">Cho 2016</a>; <a href="./references#CD004126-bbs2-0006" title="CorbettSM , RebuckJA , GreeneCM , CallasPW , NealeBW , HealeyMA , et al. Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Critical Care Medicine2005;33(5):940‐5. [PUBMED: 15891317] ">Corbett 2005</a>; <a href="./references#CD004126-bbs2-0008" title="DjaianiG , SilvertonN , FedorkoL , CarrollJ , StyraR , RaoV , et al. Dexmedetomidine versus propofol sedation reduces delirium after cardiac surgery: a randomized controlled trial. Anesthesiology2016;124(2):362‐8. [PUBMED: 26575144] ">Djaiani 2016</a>; <a href="./references#CD004126-bbs2-0009" title="DormanBH , ZuckerJR , VerrierED , GartmanDM , SlachmanFN . Clonidine improves perioperative myocardial ischemia, reduces anesthetic requirement, and alters hemodynamic parameters in patients undergoing coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):386‐95. [PUBMED: 8400091] ">Dorman 1993</a>; <a href="./references#CD004126-bbs2-0010" title="El‐KardawyH , GoudaN , KamalH , DossL . Dexmedetomidine as anaesthetic adjunct for patients undergoing off‐pump coronary artery bypass grafting. Egyptian Journal of Anaesthesia2004;20(1):29‐34. [EMBASE: 2004089519] ">El‐Kerdawy 2004</a>; <a href="./references#CD004126-bbs2-0012" title="GhignoneM , QuintinL , DukePC , KehlerCH , CalvilloO . Effects of clonidine on narcotic requirements and hemodynamic response during induction of fentanyl anesthesia and endotracheal intubation. Anesthesiology1986;64(1):36‐42. [PUBMED: 3942335] ">Ghignone 1986</a>; <a href="./references#CD004126-bbs2-0014" title="Helbo‐HansenS , FletcherR , LundbergD , NordstromL , WernerO , StahlE , et al. Clonidine and the sympatico‐adrenal response to coronary artery by‐pass surgery. Acta Anaesthesiologica Scandinavica1986;30(3):235‐42. [PUBMED: 3017039] ">Helbo‐Hansen 1986</a>; <a href="./references#CD004126-bbs2-0015" title="HerrDL , Sum‐PingST , EnglandM . ICU sedation after coronary artery bypass graft surgery: dexmedetomidine‐based versus propofol‐based sedation regimens. Journal of Cardiothoracic and Vascular Anesthesia2003;17(5):576‐84. [PUBMED: 14579210] ">Herr 2003</a>; <a href="./references#CD004126-bbs2-0016" title="JalonenJ , HynynenM , KuitunenA , HeikkilaH , PerttilaJ , SalmenperaM , et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology1997;86(2):331‐45. [PUBMED: 9054252] ">Jalonen 1997</a>; <a href="./references#CD004126-bbs2-0017" title="KhalilM , Abdel AzeemM . The impact of dexmedetomidine infusion in sparing morphine consumption in off‐pump coronary artery bypass grafting. Seminars in Cardiothoracic and Vascular Anesthesia2013;17(1):66‐71. [PUBMED: 23108415] ">Khalil 2013</a>; <a href="./references#CD004126-bbs2-0018" title="KimHJ , KimWH , KimG , KimE , ParkMH , ShinBS , et al. A comparison among infusion of lidocaine and dexmedetomidine alone and in combination in subjects undergoing coronary artery bypass graft: a randomized trial. Contemporary Clinical Trials2014;39(2):303‐9. [PUBMED: 25447444] ">Kim 2014a</a>; <a href="./references#CD004126-bbs2-0020" title="LiX , YangJ , NieXL , ZhangY , LiXY , LiLH , et al. Impact of dexmedetomidine on the incidence of delirium in elderly patients after cardiac surgery: a randomized controlled trial. PloS One2017;12(2):e0170757. [NCT02267538; PUBMED: 28182690] ">Li 2017</a>; <a href="./references#CD004126-bbs2-0022" title="LiuX , ZhangK , WangW , XieG , FangX . Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial. Critical Care2016;20(1):298. [EMBASE: 612244138] ">Liu 2016</a>; <a href="./references#CD004126-bbs2-0023" title="LoickHM , SchmidtC , VanAkenH , JunkerR , ErrenM , BerendesE , et al. High thoracic epidural anesthesia, but not clonidine, attenuates the perioperative stress response via sympatholysis and reduces the release of troponin T in patients undergoing coronary artery bypass grafting. Anesthesia and Analgesia1999;88(4):701‐9. [PUBMED: 10195508] ">Loick 1999</a>; <a href="./references#CD004126-bbs2-0026" title="MylesPS , HuntJO , HoldgaardHO , McRaeR , BucklandMR , MoloneyJ , et al. Clonidine and cardiac surgery: haemodynamic and metabolic effects, myocardial ischaemia and recovery. Anaesthesia and Intensive Care1999;27(2):137‐47. [PUBMED: 10212709] ">Myles 1999</a>; <a href="./references#CD004126-bbs2-0028" title="ParkJ , BangS , CheeH , KimJ , LeeS , ShinJ . Efficacy and safety of dexmedetomidine for postoperative delirium in adult cardiac surgery on cardiopulmonary bypass. Korean Journal of Thoracic and Cardiovascular Surgery2014;47(3):249‐54. [CENTRAL: 01305779] ">Park 2014</a>; <a href="./references#CD004126-bbs2-0029" title="PatelJ , ThosaniR , KothariJ , GargP , PandyaH . Clonidine and ketamine for stable hemodynamics in off‐pump coronary artery bypass. Asian Cardiovascular and Thoracic Annals2016;24(7):638‐46. [MEDLINE: 27471314] ">Patel 2016</a>; <a href="./references#CD004126-bbs2-0032" title="QuintinL , CicalaR , KentM , ThomsenB . Effect of clonidine on myocardial ischaemia: a double‐blind pilot trial. Canadian Journal of Anaesthesia1993;40(1):85‐6. [PUBMED: 7980723] ">Quintin 1993</a>; <a href="./references#CD004126-bbs2-0034" title="RenJ , ZhangH , HuangL , LiuY , LiuF , DongZ . Protective effect of dexmedetomidine in coronary artery bypass grafting surgery. Experimental and Therapeutic Medicine2013;6(2):497‐502. [PUBMED: 24137215] ">Ren 2013</a>; <a href="./references#CD004126-bbs2-0035" title="ShehabiY , GrantP , WolfendenH , HammondN , BassF , CampbellM , et al. Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine compared to morphine‐DEXCOM study). Anesthesiology2009;111(5):1075‐84. [PUBMED: 19786862] ">Shehabi 2009</a>; <a href="./references#CD004126-bbs2-0041" title="VennRM , BradshawCJ , SpencerR , BrealeyD , CaudwellE , NaughtonC , et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia1999;54(12):1136‐42. [PUBMED: 10594409] VennRM , HellJ , GroundsRM . Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Critical Care2000;4(5):302‐8. [PUBMED: 11056756] ">Venn 1999</a>). In all cases, the procedure involved was coronary artery bypass graft surgery or valve replacement surgery. </p> <p>Of the 23 studies with 14,367 participants that involved non‐cardiac surgery (<a href="./references#CD004126-bbs2-0003" title="BergeseS , CandiottiK , BokeschP , ZuraA , WisemandleW , BekkerA . A phase IIIb, randomized, double‐blind, placebo‐controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586‐95. [PUBMED: 20535016] ">Bergese 2010</a>; <a href="./references#CD004126-bbs2-0007" title="DevereauxPJ , SesslerDI , LeslieK , KurzA , MrkobradaM , Alonso‐CoelloP , et al. Clonidine in patients undergoing noncardiac surgery. New England Journal of Medicine2014;370(16):1504‐13. [PUBMED: 24679061] ">Devereaux 2014a</a>; <a href="./references#CD004126-bbs2-0011" title="EllisJE , DrijversG , PedlowS , LaffSP , SorrentinoMJ , FossJF , et al. Premedication with oral and transdermal clonidine provides safe and efficacious postoperative sympatholysis. Anesthesia and Analgesia1994;79(6):1133‐40. [PUBMED: 7978438] ">Ellis 1994</a>; <a href="./references#CD004126-bbs2-0013" title="GhignoneM , CalvilloO , QuintinL . Anesthesia and hypertension: the effect of clonidine on perioperative hemodynamics and isoflurane requirements. Anesthesiology1987;67(1):3‐10. [PUBMED: 3605732] ">Ghignone 1987</a>; <a href="./references#CD004126-bbs2-0019" title="LeeC , KimYD , KimJN . Antihyperalgesic effects of dexmedetomidine on high‐dose remifentanil‐induced hyperalgesia. Korean Journal of Anesthesiology2013;64(4):301‐7. [PUBMED: 23646238] ">Lee 2013a</a>; <a href="./references#CD004126-bbs2-0021" title="LipszycM , EngelmanE . Clonidine does not prevent myocardial ischemia during noncardiac surgery. Anesthesiology1991;75:A93. ">Lipszyc 1991</a>; <a href="./references#CD004126-bbs2-0024" title="MatotI , SichelJY , YofeV , GozalY . The effect of clonidine premedication on hemodynamic responses to microlaryngoscopy and rigid bronchoscopy. Anesthesia and Analgesia2000;91(4):828‐33. [PUBMED: 11004033] ">Matot 2000</a>; <a href="./references#CD004126-bbs2-0025" title="McSPI‐Europe Research Group. Perioperative sympatholysis: beneficial effects of the alpha 2‐adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. Anesthesiology1997;86(2):346‐63. [PUBMED: 9054253] ">McSPI‐Europe 1997</a>; <a href="./references#CD004126-bbs2-0027" title="OliverMF , GoldmanL , JulianDG , HolmeI . Effect of mivazerol on perioperative cardiac complications during non‐cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology1999;91(4):951‐61. [PUBMED: 10519497] ">Oliver 1999</a>; <a href="./references#CD004126-bbs2-0030" title="PawlikMT , HansenE , WaldhauserD , SeligC , KuehnelTS . Clonidine premedication in patients with sleep apnea syndrome: a randomized, double‐blind, placebo‐controlled study. Anesthesia and Analgesia2005;101(5):1374‐80. [PUBMED: 16243997] ">Pawlik 2005</a>; <a href="./references#CD004126-bbs2-0031" title="PluskwaF , BonnetF , SaadaM , Macquin‐MavierI , BecqueminJP , CatoireP . Effects of clonidine on variation of arterial blood pressure and heart rate during carotid artery surgery. Journal of Cardiothoracic and Vascular Anesthesia1991;5(5):431‐36. [PUBMED: 1932647] ">Pluskwa 1991</a>; <a href="./references#CD004126-bbs2-0033" title="QuintinL , BouillocX , ButinE , BayonMC , BrudonJR , LevronJC , et al. Clonidine for major vascular surgery in hypertensive patients: a double‐blind, controlled, randomized study. Anesthesia and Analgesia1996;83(4):687‐95. [PUBMED: 8831304] ">Quintin 1996</a>; <a href="./references#CD004126-bbs2-0036" title="SolimanR , ZohryG . The myocardial protective effect of dexmedetomidine in high‐risk patients undergoing aortic vascular surgery. Annals of Cardiac Anaesthesia2016;19(4):606‐13. [MEDLINE: 27716690] ">Soliman 2016</a>; <a href="./references#CD004126-bbs2-0037" title="StuhmeierKD , MainzerB , CierpkaJ , SandmannW , TarnowJ . Small, oral dose of clonidine reduces the incidence of intraoperative myocardial ischemia in patients having vascular surgery. Anesthesiology1996;85(4):706‐12. [PUBMED: 8873539] ">Stuhmeier 1996</a>; <a href="./references#CD004126-bbs2-0038" title="SuX , MengZT , WuXH , CuiF , LiHL , WangDX , et al. Dexmedetomidine for prevention of delirium in elderly patients after non‐cardiac surgery: a randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10054):1893‐902. [EMBASE: 613271791] ">Su 2016</a>; <a href="./references#CD004126-bbs2-0039" title="TalkeP , LiJ , JainU , LeungJ , DrasnerK , HollenbergM , et al. Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. Anesthesiology1995;82(3):620‐33. [PUBMED: 7879930] ">Talke 1995</a>; <a href="./references#CD004126-bbs2-0040" title="TalkeP , ChenR , ThomasB , AggarwallA , GottliebA , ThorborgP , et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesthesia and Analgesia2000;90(4):834‐9. [PUBMED: 10735784] ">Talke 2000</a>; <a href="./references#CD004126-bbs2-0042" title="VennRM , BryantA , HallGM , GroundsRM . Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post‐operative patients needing sedation in the intensive care unit. British Journal of Anaesthesia2001;86(5):650‐6. [PUBMED: 11575340] VennRM , GroundsRM . Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. British Journal of Anaesthesia2001;87(5):684‐90. [PUBMED: 11878517] ">Venn 2001</a>; <a href="./references#CD004126-bbs2-0043" title="VivianoE , ReniusM , RuckertJ , C , BlochA , MeiselC , Harbeck‐seuA , et al. Selective neurogenic blockade and perioperative immune reactivity in patients undergoing lung resection. Journal of International Medical Research2012;40(1):141‐56. [EMBASE: 2012137611; PUBMED: 22429354] ">Viviano 2012</a>; <a href="./references#CD004126-bbs2-0044" title="WallaceAW , GalindezD , SalahiehA , LayugEL , LazoEA , HaratonikKA , et al. Effects of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology2004;101(2):284‐93. [PUBMED: 15277909] ">Wallace 2004</a>; <a href="./references#CD004126-bbs2-0045" title="WijeysunderaDN , ChoiPT , BadnerNH , BrasherPM , DresserGK , DelgadoDH , et al. A randomized feasibility trial of clonidine to reduce perioperative cardiac risk in patients on chronic beta‐blockade: the EPIC study. Canadian Journal of Anaesthesia2014;61(11):995‐1003. [PUBMED: 25189430] ">Wijeysundera 2014a</a>; <a href="./references#CD004126-bbs2-0046" title="XuL , HuZ , ShenJ , McQuillanPM . Does dexmedetomidine have a cardiac protective effect during non‐cardiac surgery? A randomised controlled trial. Clinical and Experimental Pharmacology and Physiology2014;41(11):879‐83. [EMBASE: 2014925423; PUBMED: 25132247] ">Xu 2014</a>; <a href="./references#CD004126-bbs2-0047" title="YinYC , ChowLH , TsaoCM , ChuCC , TsouMY , ChanKH , et al. Oral clonidine reduces myocardial ischemia in patients with coronary artery disease undergoing noncardiac surgery. Acta Anaesthesiologica Sinica2002;40(4):197‐203. [PUBMED: 12596619] ">Yin 2002</a>), eight involved vascular procedures exclusively (<a href="./references#CD004126-bbs2-0021" title="LipszycM , EngelmanE . Clonidine does not prevent myocardial ischemia during noncardiac surgery. Anesthesiology1991;75:A93. ">Lipszyc 1991</a>; <a href="./references#CD004126-bbs2-0025" title="McSPI‐Europe Research Group. Perioperative sympatholysis: beneficial effects of the alpha 2‐adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. Anesthesiology1997;86(2):346‐63. [PUBMED: 9054253] ">McSPI‐Europe 1997</a>; <a href="./references#CD004126-bbs2-0031" title="PluskwaF , BonnetF , SaadaM , Macquin‐MavierI , BecqueminJP , CatoireP . Effects of clonidine on variation of arterial blood pressure and heart rate during carotid artery surgery. Journal of Cardiothoracic and Vascular Anesthesia1991;5(5):431‐36. [PUBMED: 1932647] ">Pluskwa 1991</a>; <a href="./references#CD004126-bbs2-0033" title="QuintinL , BouillocX , ButinE , BayonMC , BrudonJR , LevronJC , et al. Clonidine for major vascular surgery in hypertensive patients: a double‐blind, controlled, randomized study. Anesthesia and Analgesia1996;83(4):687‐95. [PUBMED: 8831304] ">Quintin 1996</a>; <a href="./references#CD004126-bbs2-0036" title="SolimanR , ZohryG . The myocardial protective effect of dexmedetomidine in high‐risk patients undergoing aortic vascular surgery. Annals of Cardiac Anaesthesia2016;19(4):606‐13. [MEDLINE: 27716690] ">Soliman 2016</a>; <a href="./references#CD004126-bbs2-0037" title="StuhmeierKD , MainzerB , CierpkaJ , SandmannW , TarnowJ . Small, oral dose of clonidine reduces the incidence of intraoperative myocardial ischemia in patients having vascular surgery. Anesthesiology1996;85(4):706‐12. [PUBMED: 8873539] ">Stuhmeier 1996</a>; <a href="./references#CD004126-bbs2-0039" title="TalkeP , LiJ , JainU , LeungJ , DrasnerK , HollenbergM , et al. Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. Anesthesiology1995;82(3):620‐33. [PUBMED: 7879930] ">Talke 1995</a>; <a href="./references#CD004126-bbs2-0040" title="TalkeP , ChenR , ThomasB , AggarwallA , GottliebA , ThorborgP , et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesthesia and Analgesia2000;90(4):834‐9. [PUBMED: 10735784] ">Talke 2000</a>), and seven involved non‐vascular procedures exclusively (<a href="./references#CD004126-bbs2-0013" title="GhignoneM , CalvilloO , QuintinL . Anesthesia and hypertension: the effect of clonidine on perioperative hemodynamics and isoflurane requirements. Anesthesiology1987;67(1):3‐10. [PUBMED: 3605732] ">Ghignone 1987</a>; <a href="./references#CD004126-bbs2-0019" title="LeeC , KimYD , KimJN . Antihyperalgesic effects of dexmedetomidine on high‐dose remifentanil‐induced hyperalgesia. Korean Journal of Anesthesiology2013;64(4):301‐7. [PUBMED: 23646238] ">Lee 2013a</a>; <a href="./references#CD004126-bbs2-0024" title="MatotI , SichelJY , YofeV , GozalY . The effect of clonidine premedication on hemodynamic responses to microlaryngoscopy and rigid bronchoscopy. Anesthesia and Analgesia2000;91(4):828‐33. [PUBMED: 11004033] ">Matot 2000</a>; <a href="./references#CD004126-bbs2-0030" title="PawlikMT , HansenE , WaldhauserD , SeligC , KuehnelTS . Clonidine premedication in patients with sleep apnea syndrome: a randomized, double‐blind, placebo‐controlled study. Anesthesia and Analgesia2005;101(5):1374‐80. [PUBMED: 16243997] ">Pawlik 2005</a>; <a href="./references#CD004126-bbs2-0042" title="VennRM , BryantA , HallGM , GroundsRM . Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post‐operative patients needing sedation in the intensive care unit. British Journal of Anaesthesia2001;86(5):650‐6. [PUBMED: 11575340] VennRM , GroundsRM . Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. British Journal of Anaesthesia2001;87(5):684‐90. [PUBMED: 11878517] ">Venn 2001</a>; <a href="./references#CD004126-bbs2-0043" title="VivianoE , ReniusM , RuckertJ , C , BlochA , MeiselC , Harbeck‐seuA , et al. Selective neurogenic blockade and perioperative immune reactivity in patients undergoing lung resection. Journal of International Medical Research2012;40(1):141‐56. [EMBASE: 2012137611; PUBMED: 22429354] ">Viviano 2012</a>; <a href="./references#CD004126-bbs2-0046" title="XuL , HuZ , ShenJ , McQuillanPM . Does dexmedetomidine have a cardiac protective effect during non‐cardiac surgery? A randomised controlled trial. Clinical and Experimental Pharmacology and Physiology2014;41(11):879‐83. [EMBASE: 2014925423; PUBMED: 25132247] ">Xu 2014</a>). One non‐cardiac surgery study presented subgroup‐specific results for both vascular and non‐vascular procedures (<a href="./references#CD004126-bbs2-0027" title="OliverMF , GoldmanL , JulianDG , HolmeI . Effect of mivazerol on perioperative cardiac complications during non‐cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology1999;91(4):951‐61. [PUBMED: 10519497] ">Oliver 1999</a>). </p> <section id="CD004126-sec-0066"> <h5 class="title">Sample size</h5> <p>The sample sizes of the included trials ranged from 20 participants to 10,010 participants. Fourteen studies had fewer than 50 participants (<a href="./references#CD004126-bbs2-0001" title="Abi‐JaoudeF , BrussetA , CeddahaA , SchlumbergerS , RaffinL , DuboisC , et al. Clonidine premedication for coronary artery bypass grafting under high‐dose alfentanil anesthesia: intraoperative and postoperative hemodynamic study. Journal of Cardiothoracic and Vascular Anesthesia1993;7(1):35‐40. [PUBMED: 8431573] BrussetA , Abi‐JaoudeF , CeddahaA , SchlumbergerS , RaffinL , FischlerM . Clonidine aggravates the postoperative hemodynamic profile after coronary bypass: randomized, double‐blind study. Annales Françaises d'Anesthèsie et de Rèanimation1989;8 Suppl:R215. [PUBMED: 2690688] BrussetA , Abi‐JaoudeF , RaffinL , CeddahaA , SchlumbergerS , FischlerM . Clonidine modifies the hemodynamic profile in coronary bypass: double‐blind, randomized study. Annales Françaises d'Anesthèsie et de Rèanimation1989;8 Suppl:R214. [PUBMED: 2690687] ">Abi‐Jaoude 1993</a>; <a href="./references#CD004126-bbs2-0009" title="DormanBH , ZuckerJR , VerrierED , GartmanDM , SlachmanFN . Clonidine improves perioperative myocardial ischemia, reduces anesthetic requirement, and alters hemodynamic parameters in patients undergoing coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):386‐95. [PUBMED: 8400091] ">Dorman 1993</a>; <a href="./references#CD004126-bbs2-0012" title="GhignoneM , QuintinL , DukePC , KehlerCH , CalvilloO . Effects of clonidine on narcotic requirements and hemodynamic response during induction of fentanyl anesthesia and endotracheal intubation. Anesthesiology1986;64(1):36‐42. [PUBMED: 3942335] ">Ghignone 1986</a>; <a href="./references#CD004126-bbs2-0013" title="GhignoneM , CalvilloO , QuintinL . Anesthesia and hypertension: the effect of clonidine on perioperative hemodynamics and isoflurane requirements. Anesthesiology1987;67(1):3‐10. [PUBMED: 3605732] ">Ghignone 1987</a>; <a href="./references#CD004126-bbs2-0014" title="Helbo‐HansenS , FletcherR , LundbergD , NordstromL , WernerO , StahlE , et al. Clonidine and the sympatico‐adrenal response to coronary artery by‐pass surgery. Acta Anaesthesiologica Scandinavica1986;30(3):235‐42. [PUBMED: 3017039] ">Helbo‐Hansen 1986</a>; <a href="./references#CD004126-bbs2-0021" title="LipszycM , EngelmanE . Clonidine does not prevent myocardial ischemia during noncardiac surgery. Anesthesiology1991;75:A93. ">Lipszyc 1991</a>; <a href="./references#CD004126-bbs2-0024" title="MatotI , SichelJY , YofeV , GozalY . The effect of clonidine premedication on hemodynamic responses to microlaryngoscopy and rigid bronchoscopy. Anesthesia and Analgesia2000;91(4):828‐33. [PUBMED: 11004033] ">Matot 2000</a>; <a href="./references#CD004126-bbs2-0030" title="PawlikMT , HansenE , WaldhauserD , SeligC , KuehnelTS . Clonidine premedication in patients with sleep apnea syndrome: a randomized, double‐blind, placebo‐controlled study. Anesthesia and Analgesia2005;101(5):1374‐80. [PUBMED: 16243997] ">Pawlik 2005</a>; <a href="./references#CD004126-bbs2-0031" title="PluskwaF , BonnetF , SaadaM , Macquin‐MavierI , BecqueminJP , CatoireP . Effects of clonidine on variation of arterial blood pressure and heart rate during carotid artery surgery. Journal of Cardiothoracic and Vascular Anesthesia1991;5(5):431‐36. [PUBMED: 1932647] ">Pluskwa 1991</a>; <a href="./references#CD004126-bbs2-0032" title="QuintinL , CicalaR , KentM , ThomsenB . Effect of clonidine on myocardial ischaemia: a double‐blind pilot trial. Canadian Journal of Anaesthesia1993;40(1):85‐6. [PUBMED: 7980723] ">Quintin 1993</a>; <a href="./references#CD004126-bbs2-0033" title="QuintinL , BouillocX , ButinE , BayonMC , BrudonJR , LevronJC , et al. Clonidine for major vascular surgery in hypertensive patients: a double‐blind, controlled, randomized study. Anesthesia and Analgesia1996;83(4):687‐95. [PUBMED: 8831304] ">Quintin 1996</a>; <a href="./references#CD004126-bbs2-0039" title="TalkeP , LiJ , JainU , LeungJ , DrasnerK , HollenbergM , et al. Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. Anesthesiology1995;82(3):620‐33. [PUBMED: 7879930] ">Talke 1995</a>; <a href="./references#CD004126-bbs2-0040" title="TalkeP , ChenR , ThomasB , AggarwallA , GottliebA , ThorborgP , et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesthesia and Analgesia2000;90(4):834‐9. [PUBMED: 10735784] ">Talke 2000</a>; <a href="./references#CD004126-bbs2-0042" title="VennRM , BryantA , HallGM , GroundsRM . Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post‐operative patients needing sedation in the intensive care unit. British Journal of Anaesthesia2001;86(5):650‐6. [PUBMED: 11575340] VennRM , GroundsRM . Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. British Journal of Anaesthesia2001;87(5):684‐90. [PUBMED: 11878517] ">Venn 2001</a>), 14 studies had 50 to 100 participants (<a href="./references#CD004126-bbs2-0002" title="AmmarA , MahmoudK , KasemyZ , HelwaM . Cardiac and renal protective effects of dexmedetomidine in cardiac surgeries: a randomized controlled trial. Saudi Journal of Anaesthesia2016;10(4):395‐401. [EMBASE: 612358144] ">Ammar 2016</a>; <a href="./references#CD004126-bbs2-0004" title="ChiX , LiaoM , ChenX , ZhaoY , YangL , LuoA , et al. Dexmedetomidine attenuates myocardial injury in off‐pump coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2016;30(1):44‐50. [PUBMED: 26429360] ">Chi 2016</a>; <a href="./references#CD004126-bbs2-0006" title="CorbettSM , RebuckJA , GreeneCM , CallasPW , NealeBW , HealeyMA , et al. Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Critical Care Medicine2005;33(5):940‐5. [PUBMED: 15891317] ">Corbett 2005</a>; <a href="./references#CD004126-bbs2-0010" title="El‐KardawyH , GoudaN , KamalH , DossL . Dexmedetomidine as anaesthetic adjunct for patients undergoing off‐pump coronary artery bypass grafting. Egyptian Journal of Anaesthesia2004;20(1):29‐34. [EMBASE: 2004089519] ">El‐Kerdawy 2004</a>; <a href="./references#CD004126-bbs2-0011" title="EllisJE , DrijversG , PedlowS , LaffSP , SorrentinoMJ , FossJF , et al. Premedication with oral and transdermal clonidine provides safe and efficacious postoperative sympatholysis. Anesthesia and Analgesia1994;79(6):1133‐40. [PUBMED: 7978438] ">Ellis 1994</a>; <a href="./references#CD004126-bbs2-0016" title="JalonenJ , HynynenM , KuitunenA , HeikkilaH , PerttilaJ , SalmenperaM , et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology1997;86(2):331‐45. [PUBMED: 9054252] ">Jalonen 1997</a>; <a href="./references#CD004126-bbs2-0017" title="KhalilM , Abdel AzeemM . The impact of dexmedetomidine infusion in sparing morphine consumption in off‐pump coronary artery bypass grafting. Seminars in Cardiothoracic and Vascular Anesthesia2013;17(1):66‐71. [PUBMED: 23108415] ">Khalil 2013</a>; <a href="./references#CD004126-bbs2-0019" title="LeeC , KimYD , KimJN . Antihyperalgesic effects of dexmedetomidine on high‐dose remifentanil‐induced hyperalgesia. Korean Journal of Anesthesiology2013;64(4):301‐7. [PUBMED: 23646238] ">Lee 2013a</a>; <a href="./references#CD004126-bbs2-0022" title="LiuX , ZhangK , WangW , XieG , FangX . Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial. Critical Care2016;20(1):298. [EMBASE: 612244138] ">Liu 2016</a>; <a href="./references#CD004126-bbs2-0023" title="LoickHM , SchmidtC , VanAkenH , JunkerR , ErrenM , BerendesE , et al. High thoracic epidural anesthesia, but not clonidine, attenuates the perioperative stress response via sympatholysis and reduces the release of troponin T in patients undergoing coronary artery bypass grafting. Anesthesia and Analgesia1999;88(4):701‐9. [PUBMED: 10195508] ">Loick 1999</a>; <a href="./references#CD004126-bbs2-0029" title="PatelJ , ThosaniR , KothariJ , GargP , PandyaH . Clonidine and ketamine for stable hemodynamics in off‐pump coronary artery bypass. Asian Cardiovascular and Thoracic Annals2016;24(7):638‐46. [MEDLINE: 27471314] ">Patel 2016</a>; <a href="./references#CD004126-bbs2-0043" title="VivianoE , ReniusM , RuckertJ , C , BlochA , MeiselC , Harbeck‐seuA , et al. Selective neurogenic blockade and perioperative immune reactivity in patients undergoing lung resection. Journal of International Medical Research2012;40(1):141‐56. [EMBASE: 2012137611; PUBMED: 22429354] ">Viviano 2012</a>; <a href="./references#CD004126-bbs2-0046" title="XuL , HuZ , ShenJ , McQuillanPM . Does dexmedetomidine have a cardiac protective effect during non‐cardiac surgery? A randomised controlled trial. Clinical and Experimental Pharmacology and Physiology2014;41(11):879‐83. [EMBASE: 2014925423; PUBMED: 25132247] ">Xu 2014</a>; <a href="./references#CD004126-bbs2-0047" title="YinYC , ChowLH , TsaoCM , ChuCC , TsouMY , ChanKH , et al. Oral clonidine reduces myocardial ischemia in patients with coronary artery disease undergoing noncardiac surgery. Acta Anaesthesiologica Sinica2002;40(4):197‐203. [PUBMED: 12596619] ">Yin 2002</a>), and 19 studies had greater than 100 participants (<a href="./references#CD004126-bbs2-0003" title="BergeseS , CandiottiK , BokeschP , ZuraA , WisemandleW , BekkerA . A phase IIIb, randomized, double‐blind, placebo‐controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586‐95. [PUBMED: 20535016] ">Bergese 2010</a>; <a href="./references#CD004126-bbs2-0005" title="ChoJS , ShimJK , SohS , KimMK , KwakYL . Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery. Kidney International2016;89(3):693‐700. [PUBMED: 26444030] ">Cho 2016</a>; <a href="./references#CD004126-bbs2-0007" title="DevereauxPJ , SesslerDI , LeslieK , KurzA , MrkobradaM , Alonso‐CoelloP , et al. Clonidine in patients undergoing noncardiac surgery. New England Journal of Medicine2014;370(16):1504‐13. [PUBMED: 24679061] ">Devereaux 2014a</a>; <a href="./references#CD004126-bbs2-0008" title="DjaianiG , SilvertonN , FedorkoL , CarrollJ , StyraR , RaoV , et al. Dexmedetomidine versus propofol sedation reduces delirium after cardiac surgery: a randomized controlled trial. Anesthesiology2016;124(2):362‐8. [PUBMED: 26575144] ">Djaiani 2016</a>; <a href="./references#CD004126-bbs2-0015" title="HerrDL , Sum‐PingST , EnglandM . ICU sedation after coronary artery bypass graft surgery: dexmedetomidine‐based versus propofol‐based sedation regimens. Journal of Cardiothoracic and Vascular Anesthesia2003;17(5):576‐84. [PUBMED: 14579210] ">Herr 2003</a>; <a href="./references#CD004126-bbs2-0018" title="KimHJ , KimWH , KimG , KimE , ParkMH , ShinBS , et al. A comparison among infusion of lidocaine and dexmedetomidine alone and in combination in subjects undergoing coronary artery bypass graft: a randomized trial. Contemporary Clinical Trials2014;39(2):303‐9. [PUBMED: 25447444] ">Kim 2014a</a>; <a href="./references#CD004126-bbs2-0020" title="LiX , YangJ , NieXL , ZhangY , LiXY , LiLH , et al. Impact of dexmedetomidine on the incidence of delirium in elderly patients after cardiac surgery: a randomized controlled trial. PloS One2017;12(2):e0170757. [NCT02267538; PUBMED: 28182690] ">Li 2017</a>; <a href="./references#CD004126-bbs2-0025" title="McSPI‐Europe Research Group. Perioperative sympatholysis: beneficial effects of the alpha 2‐adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. Anesthesiology1997;86(2):346‐63. [PUBMED: 9054253] ">McSPI‐Europe 1997</a>; <a href="./references#CD004126-bbs2-0026" title="MylesPS , HuntJO , HoldgaardHO , McRaeR , BucklandMR , MoloneyJ , et al. Clonidine and cardiac surgery: haemodynamic and metabolic effects, myocardial ischaemia and recovery. Anaesthesia and Intensive Care1999;27(2):137‐47. [PUBMED: 10212709] ">Myles 1999</a>; <a href="./references#CD004126-bbs2-0027" title="OliverMF , GoldmanL , JulianDG , HolmeI . Effect of mivazerol on perioperative cardiac complications during non‐cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology1999;91(4):951‐61. [PUBMED: 10519497] ">Oliver 1999</a>; <a href="./references#CD004126-bbs2-0028" title="ParkJ , BangS , CheeH , KimJ , LeeS , ShinJ . Efficacy and safety of dexmedetomidine for postoperative delirium in adult cardiac surgery on cardiopulmonary bypass. Korean Journal of Thoracic and Cardiovascular Surgery2014;47(3):249‐54. [CENTRAL: 01305779] ">Park 2014</a>; <a href="./references#CD004126-bbs2-0034" title="RenJ , ZhangH , HuangL , LiuY , LiuF , DongZ . Protective effect of dexmedetomidine in coronary artery bypass grafting surgery. Experimental and Therapeutic Medicine2013;6(2):497‐502. [PUBMED: 24137215] ">Ren 2013</a>; <a href="./references#CD004126-bbs2-0035" title="ShehabiY , GrantP , WolfendenH , HammondN , BassF , CampbellM , et al. Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine compared to morphine‐DEXCOM study). Anesthesiology2009;111(5):1075‐84. [PUBMED: 19786862] ">Shehabi 2009</a>; <a href="./references#CD004126-bbs2-0036" title="SolimanR , ZohryG . The myocardial protective effect of dexmedetomidine in high‐risk patients undergoing aortic vascular surgery. Annals of Cardiac Anaesthesia2016;19(4):606‐13. [MEDLINE: 27716690] ">Soliman 2016</a>; <a href="./references#CD004126-bbs2-0037" title="StuhmeierKD , MainzerB , CierpkaJ , SandmannW , TarnowJ . Small, oral dose of clonidine reduces the incidence of intraoperative myocardial ischemia in patients having vascular surgery. Anesthesiology1996;85(4):706‐12. [PUBMED: 8873539] ">Stuhmeier 1996</a>; <a href="./references#CD004126-bbs2-0038" title="SuX , MengZT , WuXH , CuiF , LiHL , WangDX , et al. Dexmedetomidine for prevention of delirium in elderly patients after non‐cardiac surgery: a randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10054):1893‐902. [EMBASE: 613271791] ">Su 2016</a>; <a href="./references#CD004126-bbs2-0041" title="VennRM , BradshawCJ , SpencerR , BrealeyD , CaudwellE , NaughtonC , et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia1999;54(12):1136‐42. [PUBMED: 10594409] VennRM , HellJ , GroundsRM . Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Critical Care2000;4(5):302‐8. [PUBMED: 11056756] ">Venn 1999</a>; <a href="./references#CD004126-bbs2-0044" title="WallaceAW , GalindezD , SalahiehA , LayugEL , LazoEA , HaratonikKA , et al. Effects of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology2004;101(2):284‐93. [PUBMED: 15277909] ">Wallace 2004</a>; <a href="./references#CD004126-bbs2-0045" title="WijeysunderaDN , ChoiPT , BadnerNH , BrasherPM , DresserGK , DelgadoDH , et al. A randomized feasibility trial of clonidine to reduce perioperative cardiac risk in patients on chronic beta‐blockade: the EPIC study. Canadian Journal of Anaesthesia2014;61(11):995‐1003. [PUBMED: 25189430] ">Wijeysundera 2014a</a>). </p> </section> <section id="CD004126-sec-0067"> <h5 class="title">Demographics of sample</h5> <p>The mean age of participants in most studies was 60 to 70 years. In addition, the ratio of men to women in the included studies was skewed, with trials generally recruiting disproportionally more men (<a href="./references#CD004126-sec-0149" title="">Characteristics of included studies</a> table). </p> </section> <section id="CD004126-sec-0068"> <h5 class="title">Intervention and comparators</h5> <p>The number of studies that assessed dexmedetomidine was 24, clonidine was 21 and mivazerol was two. Treatment duration ranged from a single preoperative dose to a 72‐hour course of treatment. With the exception of seven studies (<a href="./references#CD004126-bbs2-0006" title="CorbettSM , RebuckJA , GreeneCM , CallasPW , NealeBW , HealeyMA , et al. Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Critical Care Medicine2005;33(5):940‐5. [PUBMED: 15891317] ">Corbett 2005</a>; <a href="./references#CD004126-bbs2-0008" title="DjaianiG , SilvertonN , FedorkoL , CarrollJ , StyraR , RaoV , et al. Dexmedetomidine versus propofol sedation reduces delirium after cardiac surgery: a randomized controlled trial. Anesthesiology2016;124(2):362‐8. [PUBMED: 26575144] ">Djaiani 2016</a>; <a href="./references#CD004126-bbs2-0015" title="HerrDL , Sum‐PingST , EnglandM . ICU sedation after coronary artery bypass graft surgery: dexmedetomidine‐based versus propofol‐based sedation regimens. Journal of Cardiothoracic and Vascular Anesthesia2003;17(5):576‐84. [PUBMED: 14579210] ">Herr 2003</a>; <a href="./references#CD004126-bbs2-0022" title="LiuX , ZhangK , WangW , XieG , FangX . Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial. Critical Care2016;20(1):298. [EMBASE: 612244138] ">Liu 2016</a>; <a href="./references#CD004126-bbs2-0028" title="ParkJ , BangS , CheeH , KimJ , LeeS , ShinJ . Efficacy and safety of dexmedetomidine for postoperative delirium in adult cardiac surgery on cardiopulmonary bypass. Korean Journal of Thoracic and Cardiovascular Surgery2014;47(3):249‐54. [CENTRAL: 01305779] ">Park 2014</a>; <a href="./references#CD004126-bbs2-0035" title="ShehabiY , GrantP , WolfendenH , HammondN , BassF , CampbellM , et al. Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine compared to morphine‐DEXCOM study). Anesthesiology2009;111(5):1075‐84. [PUBMED: 19786862] ">Shehabi 2009</a>; <a href="./references#CD004126-bbs2-0042" title="VennRM , BryantA , HallGM , GroundsRM . Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post‐operative patients needing sedation in the intensive care unit. British Journal of Anaesthesia2001;86(5):650‐6. [PUBMED: 11575340] VennRM , GroundsRM . Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. British Journal of Anaesthesia2001;87(5):684‐90. [PUBMED: 11878517] ">Venn 2001</a>), all trials compared α‐2 adrenergic agonists against inactive control. Of the four studies with active controls, one compared dexmedetomidine to morphine (<a href="./references#CD004126-bbs2-0035" title="ShehabiY , GrantP , WolfendenH , HammondN , BassF , CampbellM , et al. Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine compared to morphine‐DEXCOM study). Anesthesiology2009;111(5):1075‐84. [PUBMED: 19786862] ">Shehabi 2009</a>), whereas the remainder were comparisons of dexmedetomidine versus propofol. </p> <p>All studies that evaluated dexmedetomidine employed the IV route of administration. Dexmedetomidine was administered intraoperatively in 15 studies, with administration being continued postoperatively in nine of them. The duration of postoperative administration varied across these nine studies, ranging from continuation until arrival to the critical care unit, to continuation for 48 hours. Nine additional studies investigated dexmedetomidine that was administered entirely after surgery in the critical care unit. Both studies of mivazerol administered the drug IV starting from the intraoperative period, with continuation until 72 hours after surgery. </p> <p>There was considerable variation in the administration regimens used in trials that assessed clonidine. It was administered intraoperatively by the IV route in three studies, with one of these studies also administering an oral loading dose before surgery. A single study used IV clonidine that was administered only preoperatively (i.e. 30 minutes prior to surgery). Four studies employed clonidine administered using the combination of an oral preoperative loading dose, and subsequent maintenance via the transdermal route for 72 hours. Finally, 12 studies administered clonidine orally before surgery, with three of them administering an additional intraoperative dose via the nasogastric route. </p> </section> <section id="CD004126-sec-0069"> <h5 class="title">Funding</h5> <p>Thirty‐two studies reported their funding sources, whereas 15 did not (<a href="./references#CD004126-bbs2-0001" title="Abi‐JaoudeF , BrussetA , CeddahaA , SchlumbergerS , RaffinL , DuboisC , et al. Clonidine premedication for coronary artery bypass grafting under high‐dose alfentanil anesthesia: intraoperative and postoperative hemodynamic study. Journal of Cardiothoracic and Vascular Anesthesia1993;7(1):35‐40. [PUBMED: 8431573] BrussetA , Abi‐JaoudeF , CeddahaA , SchlumbergerS , RaffinL , FischlerM . Clonidine aggravates the postoperative hemodynamic profile after coronary bypass: randomized, double‐blind study. Annales Françaises d'Anesthèsie et de Rèanimation1989;8 Suppl:R215. [PUBMED: 2690688] BrussetA , Abi‐JaoudeF , RaffinL , CeddahaA , SchlumbergerS , FischlerM . Clonidine modifies the hemodynamic profile in coronary bypass: double‐blind, randomized study. Annales Françaises d'Anesthèsie et de Rèanimation1989;8 Suppl:R214. [PUBMED: 2690687] ">Abi‐Jaoude 1993</a>; <a href="./references#CD004126-bbs2-0004" title="ChiX , LiaoM , ChenX , ZhaoY , YangL , LuoA , et al. Dexmedetomidine attenuates myocardial injury in off‐pump coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2016;30(1):44‐50. [PUBMED: 26429360] ">Chi 2016</a>; <a href="./references#CD004126-bbs2-0005" title="ChoJS , ShimJK , SohS , KimMK , KwakYL . Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery. Kidney International2016;89(3):693‐700. [PUBMED: 26444030] ">Cho 2016</a>; <a href="./references#CD004126-bbs2-0010" title="El‐KardawyH , GoudaN , KamalH , DossL . Dexmedetomidine as anaesthetic adjunct for patients undergoing off‐pump coronary artery bypass grafting. Egyptian Journal of Anaesthesia2004;20(1):29‐34. [EMBASE: 2004089519] ">El‐Kerdawy 2004</a>; <a href="./references#CD004126-bbs2-0012" title="GhignoneM , QuintinL , DukePC , KehlerCH , CalvilloO . Effects of clonidine on narcotic requirements and hemodynamic response during induction of fentanyl anesthesia and endotracheal intubation. Anesthesiology1986;64(1):36‐42. [PUBMED: 3942335] ">Ghignone 1986</a>; <a href="./references#CD004126-bbs2-0013" title="GhignoneM , CalvilloO , QuintinL . Anesthesia and hypertension: the effect of clonidine on perioperative hemodynamics and isoflurane requirements. Anesthesiology1987;67(1):3‐10. [PUBMED: 3605732] ">Ghignone 1987</a>; <a href="./references#CD004126-bbs2-0021" title="LipszycM , EngelmanE . Clonidine does not prevent myocardial ischemia during noncardiac surgery. Anesthesiology1991;75:A93. ">Lipszyc 1991</a>; <a href="./references#CD004126-bbs2-0023" title="LoickHM , SchmidtC , VanAkenH , JunkerR , ErrenM , BerendesE , et al. High thoracic epidural anesthesia, but not clonidine, attenuates the perioperative stress response via sympatholysis and reduces the release of troponin T in patients undergoing coronary artery bypass grafting. Anesthesia and Analgesia1999;88(4):701‐9. [PUBMED: 10195508] ">Loick 1999</a>; <a href="./references#CD004126-bbs2-0026" title="MylesPS , HuntJO , HoldgaardHO , McRaeR , BucklandMR , MoloneyJ , et al. Clonidine and cardiac surgery: haemodynamic and metabolic effects, myocardial ischaemia and recovery. Anaesthesia and Intensive Care1999;27(2):137‐47. [PUBMED: 10212709] ">Myles 1999</a>; <a href="./references#CD004126-bbs2-0028" title="ParkJ , BangS , CheeH , KimJ , LeeS , ShinJ . Efficacy and safety of dexmedetomidine for postoperative delirium in adult cardiac surgery on cardiopulmonary bypass. Korean Journal of Thoracic and Cardiovascular Surgery2014;47(3):249‐54. [CENTRAL: 01305779] ">Park 2014</a>; <a href="./references#CD004126-bbs2-0031" title="PluskwaF , BonnetF , SaadaM , Macquin‐MavierI , BecqueminJP , CatoireP . Effects of clonidine on variation of arterial blood pressure and heart rate during carotid artery surgery. Journal of Cardiothoracic and Vascular Anesthesia1991;5(5):431‐36. [PUBMED: 1932647] ">Pluskwa 1991</a>; <a href="./references#CD004126-bbs2-0032" title="QuintinL , CicalaR , KentM , ThomsenB . Effect of clonidine on myocardial ischaemia: a double‐blind pilot trial. Canadian Journal of Anaesthesia1993;40(1):85‐6. [PUBMED: 7980723] ">Quintin 1993</a>; <a href="./references#CD004126-bbs2-0034" title="RenJ , ZhangH , HuangL , LiuY , LiuF , DongZ . Protective effect of dexmedetomidine in coronary artery bypass grafting surgery. Experimental and Therapeutic Medicine2013;6(2):497‐502. [PUBMED: 24137215] ">Ren 2013</a>; <a href="./references#CD004126-bbs2-0037" title="StuhmeierKD , MainzerB , CierpkaJ , SandmannW , TarnowJ . Small, oral dose of clonidine reduces the incidence of intraoperative myocardial ischemia in patients having vascular surgery. Anesthesiology1996;85(4):706‐12. [PUBMED: 8873539] ">Stuhmeier 1996</a>; <a href="./references#CD004126-bbs2-0043" title="VivianoE , ReniusM , RuckertJ , C , BlochA , MeiselC , Harbeck‐seuA , et al. Selective neurogenic blockade and perioperative immune reactivity in patients undergoing lung resection. Journal of International Medical Research2012;40(1):141‐56. [EMBASE: 2012137611; PUBMED: 22429354] ">Viviano 2012</a>). Fourteen studies reported operational funding from pharmaceutical companies (<a href="./references#CD004126-bbs2-0003" title="BergeseS , CandiottiK , BokeschP , ZuraA , WisemandleW , BekkerA . A phase IIIb, randomized, double‐blind, placebo‐controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586‐95. [PUBMED: 20535016] ">Bergese 2010</a>; <a href="./references#CD004126-bbs2-0008" title="DjaianiG , SilvertonN , FedorkoL , CarrollJ , StyraR , RaoV , et al. Dexmedetomidine versus propofol sedation reduces delirium after cardiac surgery: a randomized controlled trial. Anesthesiology2016;124(2):362‐8. [PUBMED: 26575144] ">Djaiani 2016</a>; <a href="./references#CD004126-bbs2-0014" title="Helbo‐HansenS , FletcherR , LundbergD , NordstromL , WernerO , StahlE , et al. Clonidine and the sympatico‐adrenal response to coronary artery by‐pass surgery. Acta Anaesthesiologica Scandinavica1986;30(3):235‐42. [PUBMED: 3017039] ">Helbo‐Hansen 1986</a>; <a href="./references#CD004126-bbs2-0015" title="HerrDL , Sum‐PingST , EnglandM . ICU sedation after coronary artery bypass graft surgery: dexmedetomidine‐based versus propofol‐based sedation regimens. Journal of Cardiothoracic and Vascular Anesthesia2003;17(5):576‐84. [PUBMED: 14579210] ">Herr 2003</a>; <a href="./references#CD004126-bbs2-0016" title="JalonenJ , HynynenM , KuitunenA , HeikkilaH , PerttilaJ , SalmenperaM , et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology1997;86(2):331‐45. [PUBMED: 9054252] ">Jalonen 1997</a>; <a href="./references#CD004126-bbs2-0020" title="LiX , YangJ , NieXL , ZhangY , LiXY , LiLH , et al. Impact of dexmedetomidine on the incidence of delirium in elderly patients after cardiac surgery: a randomized controlled trial. PloS One2017;12(2):e0170757. [NCT02267538; PUBMED: 28182690] ">Li 2017</a>; <a href="./references#CD004126-bbs2-0025" title="McSPI‐Europe Research Group. Perioperative sympatholysis: beneficial effects of the alpha 2‐adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. Anesthesiology1997;86(2):346‐63. [PUBMED: 9054253] ">McSPI‐Europe 1997</a>; <a href="./references#CD004126-bbs2-0027" title="OliverMF , GoldmanL , JulianDG , HolmeI . Effect of mivazerol on perioperative cardiac complications during non‐cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology1999;91(4):951‐61. [PUBMED: 10519497] ">Oliver 1999</a>; <a href="./references#CD004126-bbs2-0033" title="QuintinL , BouillocX , ButinE , BayonMC , BrudonJR , LevronJC , et al. Clonidine for major vascular surgery in hypertensive patients: a double‐blind, controlled, randomized study. Anesthesia and Analgesia1996;83(4):687‐95. [PUBMED: 8831304] ">Quintin 1996</a>; <a href="./references#CD004126-bbs2-0038" title="SuX , MengZT , WuXH , CuiF , LiHL , WangDX , et al. Dexmedetomidine for prevention of delirium in elderly patients after non‐cardiac surgery: a randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10054):1893‐902. [EMBASE: 613271791] ">Su 2016</a>; <a href="./references#CD004126-bbs2-0039" title="TalkeP , LiJ , JainU , LeungJ , DrasnerK , HollenbergM , et al. Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. Anesthesiology1995;82(3):620‐33. [PUBMED: 7879930] ">Talke 1995</a>; <a href="./references#CD004126-bbs2-0040" title="TalkeP , ChenR , ThomasB , AggarwallA , GottliebA , ThorborgP , et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesthesia and Analgesia2000;90(4):834‐9. [PUBMED: 10735784] ">Talke 2000</a>; <a href="./references#CD004126-bbs2-0041" title="VennRM , BradshawCJ , SpencerR , BrealeyD , CaudwellE , NaughtonC , et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia1999;54(12):1136‐42. [PUBMED: 10594409] VennRM , HellJ , GroundsRM . Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Critical Care2000;4(5):302‐8. [PUBMED: 11056756] ">Venn 1999</a>; <a href="./references#CD004126-bbs2-0042" title="VennRM , BryantA , HallGM , GroundsRM . Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post‐operative patients needing sedation in the intensive care unit. British Journal of Anaesthesia2001;86(5):650‐6. [PUBMED: 11575340] VennRM , GroundsRM . Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. British Journal of Anaesthesia2001;87(5):684‐90. [PUBMED: 11878517] ">Venn 2001</a>), and the remaining 18 studies reported that no pharmaceutical funds were used to complete the research (<a href="./references#CD004126-bbs2-0002" title="AmmarA , MahmoudK , KasemyZ , HelwaM . Cardiac and renal protective effects of dexmedetomidine in cardiac surgeries: a randomized controlled trial. Saudi Journal of Anaesthesia2016;10(4):395‐401. [EMBASE: 612358144] ">Ammar 2016</a>; <a href="./references#CD004126-bbs2-0006" title="CorbettSM , RebuckJA , GreeneCM , CallasPW , NealeBW , HealeyMA , et al. Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Critical Care Medicine2005;33(5):940‐5. [PUBMED: 15891317] ">Corbett 2005</a>; <a href="./references#CD004126-bbs2-0007" title="DevereauxPJ , SesslerDI , LeslieK , KurzA , MrkobradaM , Alonso‐CoelloP , et al. Clonidine in patients undergoing noncardiac surgery. New England Journal of Medicine2014;370(16):1504‐13. [PUBMED: 24679061] ">Devereaux 2014a</a>; <a href="./references#CD004126-bbs2-0009" title="DormanBH , ZuckerJR , VerrierED , GartmanDM , SlachmanFN . Clonidine improves perioperative myocardial ischemia, reduces anesthetic requirement, and alters hemodynamic parameters in patients undergoing coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):386‐95. [PUBMED: 8400091] ">Dorman 1993</a>; <a href="./references#CD004126-bbs2-0011" title="EllisJE , DrijversG , PedlowS , LaffSP , SorrentinoMJ , FossJF , et al. Premedication with oral and transdermal clonidine provides safe and efficacious postoperative sympatholysis. Anesthesia and Analgesia1994;79(6):1133‐40. [PUBMED: 7978438] ">Ellis 1994</a>; <a href="./references#CD004126-bbs2-0017" title="KhalilM , Abdel AzeemM . The impact of dexmedetomidine infusion in sparing morphine consumption in off‐pump coronary artery bypass grafting. Seminars in Cardiothoracic and Vascular Anesthesia2013;17(1):66‐71. [PUBMED: 23108415] ">Khalil 2013</a>; <a href="./references#CD004126-bbs2-0018" title="KimHJ , KimWH , KimG , KimE , ParkMH , ShinBS , et al. A comparison among infusion of lidocaine and dexmedetomidine alone and in combination in subjects undergoing coronary artery bypass graft: a randomized trial. Contemporary Clinical Trials2014;39(2):303‐9. [PUBMED: 25447444] ">Kim 2014a</a>; <a href="./references#CD004126-bbs2-0019" title="LeeC , KimYD , KimJN . Antihyperalgesic effects of dexmedetomidine on high‐dose remifentanil‐induced hyperalgesia. Korean Journal of Anesthesiology2013;64(4):301‐7. [PUBMED: 23646238] ">Lee 2013a</a>; <a href="./references#CD004126-bbs2-0022" title="LiuX , ZhangK , WangW , XieG , FangX . Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial. Critical Care2016;20(1):298. [EMBASE: 612244138] ">Liu 2016</a>; <a href="./references#CD004126-bbs2-0024" title="MatotI , SichelJY , YofeV , GozalY . The effect of clonidine premedication on hemodynamic responses to microlaryngoscopy and rigid bronchoscopy. Anesthesia and Analgesia2000;91(4):828‐33. [PUBMED: 11004033] ">Matot 2000</a>; <a href="./references#CD004126-bbs2-0029" title="PatelJ , ThosaniR , KothariJ , GargP , PandyaH . Clonidine and ketamine for stable hemodynamics in off‐pump coronary artery bypass. Asian Cardiovascular and Thoracic Annals2016;24(7):638‐46. [MEDLINE: 27471314] ">Patel 2016</a>; <a href="./references#CD004126-bbs2-0030" title="PawlikMT , HansenE , WaldhauserD , SeligC , KuehnelTS . Clonidine premedication in patients with sleep apnea syndrome: a randomized, double‐blind, placebo‐controlled study. Anesthesia and Analgesia2005;101(5):1374‐80. [PUBMED: 16243997] ">Pawlik 2005</a>; <a href="./references#CD004126-bbs2-0035" title="ShehabiY , GrantP , WolfendenH , HammondN , BassF , CampbellM , et al. Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine compared to morphine‐DEXCOM study). Anesthesiology2009;111(5):1075‐84. [PUBMED: 19786862] ">Shehabi 2009</a>; <a href="./references#CD004126-bbs2-0036" title="SolimanR , ZohryG . The myocardial protective effect of dexmedetomidine in high‐risk patients undergoing aortic vascular surgery. Annals of Cardiac Anaesthesia2016;19(4):606‐13. [MEDLINE: 27716690] ">Soliman 2016</a>; <a href="./references#CD004126-bbs2-0044" title="WallaceAW , GalindezD , SalahiehA , LayugEL , LazoEA , HaratonikKA , et al. Effects of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology2004;101(2):284‐93. [PUBMED: 15277909] ">Wallace 2004</a>; <a href="./references#CD004126-bbs2-0045" title="WijeysunderaDN , ChoiPT , BadnerNH , BrasherPM , DresserGK , DelgadoDH , et al. A randomized feasibility trial of clonidine to reduce perioperative cardiac risk in patients on chronic beta‐blockade: the EPIC study. Canadian Journal of Anaesthesia2014;61(11):995‐1003. [PUBMED: 25189430] ">Wijeysundera 2014a</a>; <a href="./references#CD004126-bbs2-0046" title="XuL , HuZ , ShenJ , McQuillanPM . Does dexmedetomidine have a cardiac protective effect during non‐cardiac surgery? A randomised controlled trial. Clinical and Experimental Pharmacology and Physiology2014;41(11):879‐83. [EMBASE: 2014925423; PUBMED: 25132247] ">Xu 2014</a>; <a href="./references#CD004126-bbs2-0047" title="YinYC , ChowLH , TsaoCM , ChuCC , TsouMY , ChanKH , et al. Oral clonidine reduces myocardial ischemia in patients with coronary artery disease undergoing noncardiac surgery. Acta Anaesthesiologica Sinica2002;40(4):197‐203. [PUBMED: 12596619] ">Yin 2002</a>). Several studies in the latter group reported that a pharmaceutical company supplied the study drug as in‐kind support, and explicitly stated no further funds were received from the company. </p> </section> </section> <section id="CD004126-sec-0070"> <h4 class="title">Excluded studies</h4> <p>After the full‐text articles were reviewed, we excluded 337 studies. The reasons for these exclusions are presented in the <a href="./references#CD004126-sec-0150" title="">Characteristics of excluded studies</a> table, as well as the study flow diagram (<a href="#CD004126-fig-0001">Figure 1</a>). The most common reason for exclusion was study objectives that differed from this present review (312 excluded studies). In these cases, the focus of these studies was to answer a question unrelated to the efficacy or safety of α‐2 adrenergic agonists for reducing mortality or cardiac complications (e.g. assessing the efficacy of these drugs for providing analgesia). Of the remaining articles, 14 were excluded because the experimental design was not an RCT, three were excluded since participants did not undergoing surgery and three were excluded due to an ineligible population. Two studies could not be classified into either the cardiac or non‐cardiac surgery subgroups, and were therefore excluded (<a href="./references#CD004126-bbs2-0250" title="MantzJ , French Dexmedetomidine Phase III Group. Phase III study on dexmedetomidine used for postoperative sedation of patients requiring mechanical ventilation for less than 24 hours: the French experience. Middle East Journal of Anesthesiology2002;16(6):597‐606. [PUBMED: 12503263] MartinE , RamsayG , MantzJ , Sum‐PingST . The role of the alpha2‐adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. Journal of Intensive Care Medicine2003;18(1):29‐41. [PUBMED: 15189665] ">Martin 2003</a>; <a href="./references#CD004126-bbs2-0350" title="TriltschAE , WelteM , VonHomeyerP , GrobeJ , GenahrA , MoshirzadehM , et al. Bispectral index‐guided sedation with dexmedetomidine in intensive care: a prospective, randomized, double blind, placebo‐controlled phase II study. Critical Care Medicine2002;30(5):1007‐14. [PUBMED: 12006795] ">Triltsch 2002</a>). A further two studies were excluded because the intervention was administered via an ineligible route (<a href="./references#CD004126-bbs2-0266" title="NaderND , LiCM , DosluogluHH , IgnatowskiTA , SpenglerRN . Adjuvant therapy with intrathecal clonidine improves postoperative pain in patients undergoing coronary artery bypass graft. Clinical Journal of Pain2009;25(2):101‐6. [EMBASE: 2009320482; PUBMED: 19333153] ">Nader 2009</a>; <a href="./references#CD004126-bbs2-0353" title="TzortzopoulouA , KolotouraA , KoudounaE , KyralidouA , AdreottiB , TagaraM , et al. Continuous surgical wound infusion with either ropivacaine or combination of ropivacaine and clonidine via elastomeric pump. A randomized double‐blind study. Pain Practice2009;9:153‐4. [EMBASE: 70207423] ">Tzortzopoulou 2009</a>), while one study was excluded due to lack of a control arm (<a href="./references#CD004126-bbs2-0256" title="MoghadamMJ , OmmiD , MirkheshtiA , ShadnoushM , DabbaghA . The effect of pretreatment with clonidine on propofol consumption in opium abuser and non‐abuser patients undergoing elective leg surgery. Journal of Research in Medical Sciences2012;17(8):728‐31. [EMBASE: 2012537334; PUBMED: 23798938] ">Moghadam 2012</a>). Three reports of two individual studies were excluded due to concerns about scientific misconduct (<a href="./references#CD004126-bbs2-0095" title="BoldtJ , RotheG , SchindlerE , DollC , GorlachG , HempelmannG . Can clonidine, enoximone, and enalaprilat help to protect the myocardium against ischaemia in cardiac surgery?. Heart1996;76(3):207‐13. [PUBMED: 8868976] ">Boldt 1996</a>; <a href="./references#CD004126-bbs2-0360" title="FrumentoRJ , LogginidouHG , WahlanderS , WagenerG , PlayfordHR , SladenRN . Dexmedetomidine infusion is associated with enhanced renal function after thoracic surgery. Journal of Clinical Anesthesia2006;18(6):422‐6. [PUBMED: 16980158] WahlanderS , FrumentoRJ , WagenerG , Saldana‐FerrettiB , JoshiRR , PlayfordHR , et al. A prospective, double‐blind, randomized, placebo‐controlled study of dexmedetomidine as an adjunct to epidural analgesia after thoracic surgery. Journal of Cardiothoracic and Vascular Anesthesia2005;19:630‐5. [PUBMED: 16202898] ">Wahlander 2005</a>). In each of these cases, a lead author was found to have conducted scientific misconduct (<a href="./references#CD004126-bbs2-0384" title='Anon . Retraction notice to "Dexmedetomidine infusion is associated with enhanced renal function after thoracic surgery" (J Clin Anesth 2006;18:422‐6). Journal of Clinical Anesthesia2013;25(5):432. [PUBMED: 24228273] '>Anon 2013</a>; <a href="./references#CD004126-bbs2-0407" title="RasmussenLS , YentisSM , VanAkenH , ShaferSL , EisenachJC , EdmundsLH , et al. Editors‐in‐Chief statement regarding published clinical trials conducted without IRB approval by Joachim Boldt. Minerva Anestesiologica2011;77(5):562‐3. [PUBMED: 21540815] ">Rasmussen 2011</a>; <a href="./references#CD004126-bbs2-0416" title="WiseJ . Boldt: the great pretender. BMJ (Clinical Research Ed.)2013;346:f1738. [PUBMED: 23512099] ">Wise 2013</a>). Notably, both studies had been included in the previous 2009 version of this review (<a href="./references#CD004126-bbs2-0418" title="WijeysunderaDN , BenderJS , BeattieWS . Alpha‐2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD004126.pub2] ">Wijeysundera 2009</a>), at which point these issues with scientific misconduct had not yet been identified (<a href="./references#CD004126-bbs2-0095" title="BoldtJ , RotheG , SchindlerE , DollC , GorlachG , HempelmannG . Can clonidine, enoximone, and enalaprilat help to protect the myocardium against ischaemia in cardiac surgery?. Heart1996;76(3):207‐13. [PUBMED: 8868976] ">Boldt 1996</a>; <a href="./references#CD004126-bbs2-0360" title="FrumentoRJ , LogginidouHG , WahlanderS , WagenerG , PlayfordHR , SladenRN . Dexmedetomidine infusion is associated with enhanced renal function after thoracic surgery. Journal of Clinical Anesthesia2006;18(6):422‐6. [PUBMED: 16980158] WahlanderS , FrumentoRJ , WagenerG , Saldana‐FerrettiB , JoshiRR , PlayfordHR , et al. A prospective, double‐blind, randomized, placebo‐controlled study of dexmedetomidine as an adjunct to epidural analgesia after thoracic surgery. Journal of Cardiothoracic and Vascular Anesthesia2005;19:630‐5. [PUBMED: 16202898] ">Wahlander 2005</a>). </p> <section id="CD004126-sec-0071"> <h5 class="title">Studies awaiting classification</h5> <p>No studies are currently awaiting classification.</p> </section> <section id="CD004126-sec-0072"> <h5 class="title">Ongoing studies</h5> <p>We found no ongoing studies.</p> </section> </section> </section> <section id="CD004126-sec-0073"> <h3 class="title">Risk of bias in included studies</h3> <p>The methodological quality of included studies is shown in the 'Risk of bias' figures (<a href="#CD004126-fig-0002">Figure 2</a>; <a href="#CD004126-fig-0003">Figure 3</a>). A visual summary of judgements about the quality and risk of bias for each trial is presented in <a href="#CD004126-fig-0003">Figure 3</a>. Details explaining the judgements for each domain are presented in the 'Risk of bias' tables (<a href="./references#CD004126-sec-0149" title="">Characteristics of included studies</a>). </p> <div class="figure" id="CD004126-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004126-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD004126-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004126-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD004126-sec-0074"> <h4 class="title">Allocation</h4> <p>Of the 47 included trials, only 28 were judged to have adequate methods of generating allocation sequences. Of the remaining 19 studies, two trials used methods likely to produces bias (<a href="./references#CD004126-bbs2-0014" title="Helbo‐HansenS , FletcherR , LundbergD , NordstromL , WernerO , StahlE , et al. Clonidine and the sympatico‐adrenal response to coronary artery by‐pass surgery. Acta Anaesthesiologica Scandinavica1986;30(3):235‐42. [PUBMED: 3017039] ">Helbo‐Hansen 1986</a>; <a href="./references#CD004126-bbs2-0021" title="LipszycM , EngelmanE . Clonidine does not prevent myocardial ischemia during noncardiac surgery. Anesthesiology1991;75:A93. ">Lipszyc 1991</a>), while the remaining trials were classified as having unclear risk of bias because the methods were not described in adequate detail. Concealment of allocation sequence was generally poor with only 18 studies reporting methods associated with low risk of bias, while six studies described methods associated with a high risk of bias (<a href="./references#CD004126-bbs2-0003" title="BergeseS , CandiottiK , BokeschP , ZuraA , WisemandleW , BekkerA . A phase IIIb, randomized, double‐blind, placebo‐controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586‐95. [PUBMED: 20535016] ">Bergese 2010</a>; <a href="./references#CD004126-bbs2-0006" title="CorbettSM , RebuckJA , GreeneCM , CallasPW , NealeBW , HealeyMA , et al. Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Critical Care Medicine2005;33(5):940‐5. [PUBMED: 15891317] ">Corbett 2005</a>; <a href="./references#CD004126-bbs2-0017" title="KhalilM , Abdel AzeemM . The impact of dexmedetomidine infusion in sparing morphine consumption in off‐pump coronary artery bypass grafting. Seminars in Cardiothoracic and Vascular Anesthesia2013;17(1):66‐71. [PUBMED: 23108415] ">Khalil 2013</a>; <a href="./references#CD004126-bbs2-0019" title="LeeC , KimYD , KimJN . Antihyperalgesic effects of dexmedetomidine on high‐dose remifentanil‐induced hyperalgesia. Korean Journal of Anesthesiology2013;64(4):301‐7. [PUBMED: 23646238] ">Lee 2013a</a>; <a href="./references#CD004126-bbs2-0021" title="LipszycM , EngelmanE . Clonidine does not prevent myocardial ischemia during noncardiac surgery. Anesthesiology1991;75:A93. ">Lipszyc 1991</a>; <a href="./references#CD004126-bbs2-0022" title="LiuX , ZhangK , WangW , XieG , FangX . Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial. Critical Care2016;20(1):298. [EMBASE: 612244138] ">Liu 2016</a>). Only 16 studies reported adequate allocation sequence generation and allocation concealment. </p> </section> <section id="CD004126-sec-0075"> <h4 class="title">Blinding</h4> <p>Although 31 studies described themselves as double‐blind, only 21 clearly reported adequate methods for how blinding was achieved. Of the remaining 26 studies, 14 were open‐label and therefore assessed to be high risk of bias, while the others were judged to have an unclear risk of bias. Outcome assessment was blinded in 21 trials, and therefore judged to be at low risk of bias. Only 16 trials demonstrated blinding of participants, personnel and outcome assessors. </p> </section> <section id="CD004126-sec-0076"> <h4 class="title">Incomplete outcome data</h4> <p>Thirty trials reported no exclusions, exclusions deemed to be appropriate and ITT analysis. For four trials, exclusions (<a href="./references#CD004126-bbs2-0019" title="LeeC , KimYD , KimJN . Antihyperalgesic effects of dexmedetomidine on high‐dose remifentanil‐induced hyperalgesia. Korean Journal of Anesthesiology2013;64(4):301‐7. [PUBMED: 23646238] ">Lee 2013a</a>; <a href="./references#CD004126-bbs2-0027" title="OliverMF , GoldmanL , JulianDG , HolmeI . Effect of mivazerol on perioperative cardiac complications during non‐cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology1999;91(4):951‐61. [PUBMED: 10519497] ">Oliver 1999</a>; <a href="./references#CD004126-bbs2-0033" title="QuintinL , BouillocX , ButinE , BayonMC , BrudonJR , LevronJC , et al. Clonidine for major vascular surgery in hypertensive patients: a double‐blind, controlled, randomized study. Anesthesia and Analgesia1996;83(4):687‐95. [PUBMED: 8831304] ">Quintin 1996</a>; <a href="./references#CD004126-bbs2-0037" title="StuhmeierKD , MainzerB , CierpkaJ , SandmannW , TarnowJ . Small, oral dose of clonidine reduces the incidence of intraoperative myocardial ischemia in patients having vascular surgery. Anesthesiology1996;85(4):706‐12. [PUBMED: 8873539] ">Stuhmeier 1996</a>), were either not reported or judged as being excessive enough to likely cause bias. The remainder either failed to use ITT analysis or adequately account for exclusions. Only 11 studies reported a flow diagram of participants in the trial (<a href="./references#CD004126-bbs2-0003" title="BergeseS , CandiottiK , BokeschP , ZuraA , WisemandleW , BekkerA . A phase IIIb, randomized, double‐blind, placebo‐controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586‐95. [PUBMED: 20535016] ">Bergese 2010</a>; <a href="./references#CD004126-bbs2-0004" title="ChiX , LiaoM , ChenX , ZhaoY , YangL , LuoA , et al. Dexmedetomidine attenuates myocardial injury in off‐pump coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2016;30(1):44‐50. [PUBMED: 26429360] ">Chi 2016</a>; <a href="./references#CD004126-bbs2-0007" title="DevereauxPJ , SesslerDI , LeslieK , KurzA , MrkobradaM , Alonso‐CoelloP , et al. Clonidine in patients undergoing noncardiac surgery. New England Journal of Medicine2014;370(16):1504‐13. [PUBMED: 24679061] ">Devereaux 2014a</a>; <a href="./references#CD004126-bbs2-0018" title="KimHJ , KimWH , KimG , KimE , ParkMH , ShinBS , et al. A comparison among infusion of lidocaine and dexmedetomidine alone and in combination in subjects undergoing coronary artery bypass graft: a randomized trial. Contemporary Clinical Trials2014;39(2):303‐9. [PUBMED: 25447444] ">Kim 2014a</a>; <a href="./references#CD004126-bbs2-0019" title="LeeC , KimYD , KimJN . Antihyperalgesic effects of dexmedetomidine on high‐dose remifentanil‐induced hyperalgesia. Korean Journal of Anesthesiology2013;64(4):301‐7. [PUBMED: 23646238] ">Lee 2013a</a>; <a href="./references#CD004126-bbs2-0020" title="LiX , YangJ , NieXL , ZhangY , LiXY , LiLH , et al. Impact of dexmedetomidine on the incidence of delirium in elderly patients after cardiac surgery: a randomized controlled trial. PloS One2017;12(2):e0170757. [NCT02267538; PUBMED: 28182690] ">Li 2017</a>; <a href="./references#CD004126-bbs2-0022" title="LiuX , ZhangK , WangW , XieG , FangX . Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial. Critical Care2016;20(1):298. [EMBASE: 612244138] ">Liu 2016</a>; <a href="./references#CD004126-bbs2-0035" title="ShehabiY , GrantP , WolfendenH , HammondN , BassF , CampbellM , et al. Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine compared to morphine‐DEXCOM study). Anesthesiology2009;111(5):1075‐84. [PUBMED: 19786862] ">Shehabi 2009</a>; <a href="./references#CD004126-bbs2-0038" title="SuX , MengZT , WuXH , CuiF , LiHL , WangDX , et al. Dexmedetomidine for prevention of delirium in elderly patients after non‐cardiac surgery: a randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10054):1893‐902. [EMBASE: 613271791] ">Su 2016</a>; <a href="./references#CD004126-bbs2-0043" title="VivianoE , ReniusM , RuckertJ , C , BlochA , MeiselC , Harbeck‐seuA , et al. Selective neurogenic blockade and perioperative immune reactivity in patients undergoing lung resection. Journal of International Medical Research2012;40(1):141‐56. [EMBASE: 2012137611; PUBMED: 22429354] ">Viviano 2012</a>; <a href="./references#CD004126-bbs2-0045" title="WijeysunderaDN , ChoiPT , BadnerNH , BrasherPM , DresserGK , DelgadoDH , et al. A randomized feasibility trial of clonidine to reduce perioperative cardiac risk in patients on chronic beta‐blockade: the EPIC study. Canadian Journal of Anaesthesia2014;61(11):995‐1003. [PUBMED: 25189430] ">Wijeysundera 2014a</a>), as is recommended in the CONSORT statement (<a href="./references#CD004126-bbs2-0409" title="SchulzKF , AltmanDG , MoherD , the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ2010;340:c332. [PUBMED: 20332509 ] ">Schulz 2010</a>). </p> </section> <section id="CD004126-sec-0077"> <h4 class="title">Selective reporting</h4> <p>Of the 47 trials, 37 demonstrated concordance between outcomes discussed in the methods or protocol and the outcomes reported. Four studies were judged to be of unclear risk of bias because they reported adverse events without discussing any surveillance methods (<a href="./references#CD004126-bbs2-0022" title="LiuX , ZhangK , WangW , XieG , FangX . Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial. Critical Care2016;20(1):298. [EMBASE: 612244138] ">Liu 2016</a>; <a href="./references#CD004126-bbs2-0028" title="ParkJ , BangS , CheeH , KimJ , LeeS , ShinJ . Efficacy and safety of dexmedetomidine for postoperative delirium in adult cardiac surgery on cardiopulmonary bypass. Korean Journal of Thoracic and Cardiovascular Surgery2014;47(3):249‐54. [CENTRAL: 01305779] ">Park 2014</a>; <a href="./references#CD004126-bbs2-0036" title="SolimanR , ZohryG . The myocardial protective effect of dexmedetomidine in high‐risk patients undergoing aortic vascular surgery. Annals of Cardiac Anaesthesia2016;19(4):606‐13. [MEDLINE: 27716690] ">Soliman 2016</a>; <a href="./references#CD004126-bbs2-0043" title="VivianoE , ReniusM , RuckertJ , C , BlochA , MeiselC , Harbeck‐seuA , et al. Selective neurogenic blockade and perioperative immune reactivity in patients undergoing lung resection. Journal of International Medical Research2012;40(1):141‐56. [EMBASE: 2012137611; PUBMED: 22429354] ">Viviano 2012</a>). The remaining six studies either failed to report major outcomes, or reported major outcomes not discussed in the relevant methods sections (<a href="./references#CD004126-bbs2-0006" title="CorbettSM , RebuckJA , GreeneCM , CallasPW , NealeBW , HealeyMA , et al. Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Critical Care Medicine2005;33(5):940‐5. [PUBMED: 15891317] ">Corbett 2005</a>; <a href="./references#CD004126-bbs2-0009" title="DormanBH , ZuckerJR , VerrierED , GartmanDM , SlachmanFN . Clonidine improves perioperative myocardial ischemia, reduces anesthetic requirement, and alters hemodynamic parameters in patients undergoing coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):386‐95. [PUBMED: 8400091] ">Dorman 1993</a>; <a href="./references#CD004126-bbs2-0014" title="Helbo‐HansenS , FletcherR , LundbergD , NordstromL , WernerO , StahlE , et al. Clonidine and the sympatico‐adrenal response to coronary artery by‐pass surgery. Acta Anaesthesiologica Scandinavica1986;30(3):235‐42. [PUBMED: 3017039] ">Helbo‐Hansen 1986</a>; <a href="./references#CD004126-bbs2-0017" title="KhalilM , Abdel AzeemM . The impact of dexmedetomidine infusion in sparing morphine consumption in off‐pump coronary artery bypass grafting. Seminars in Cardiothoracic and Vascular Anesthesia2013;17(1):66‐71. [PUBMED: 23108415] ">Khalil 2013</a>; <a href="./references#CD004126-bbs2-0027" title="OliverMF , GoldmanL , JulianDG , HolmeI . Effect of mivazerol on perioperative cardiac complications during non‐cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology1999;91(4):951‐61. [PUBMED: 10519497] ">Oliver 1999</a>; <a href="./references#CD004126-bbs2-0037" title="StuhmeierKD , MainzerB , CierpkaJ , SandmannW , TarnowJ . Small, oral dose of clonidine reduces the incidence of intraoperative myocardial ischemia in patients having vascular surgery. Anesthesiology1996;85(4):706‐12. [PUBMED: 8873539] ">Stuhmeier 1996</a>). </p> </section> <section id="CD004126-sec-0078"> <h4 class="title">Other potential sources of bias</h4> <p>Five trials had other sources of bias classified as unclear risk or high risk. Two of the trials had high risk of bias due to significant changes in their methods during the trial recruitment phase. One trial terminated early (<a href="./references#CD004126-bbs2-0011" title="EllisJE , DrijversG , PedlowS , LaffSP , SorrentinoMJ , FossJF , et al. Premedication with oral and transdermal clonidine provides safe and efficacious postoperative sympatholysis. Anesthesia and Analgesia1994;79(6):1133‐40. [PUBMED: 7978438] ">Ellis 1994</a>), while the other changed its selection criteria (<a href="./references#CD004126-bbs2-0027" title="OliverMF , GoldmanL , JulianDG , HolmeI . Effect of mivazerol on perioperative cardiac complications during non‐cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology1999;91(4):951‐61. [PUBMED: 10519497] ">Oliver 1999</a>). Three trials were classified as having unclear risk of bias, because two trials (<a href="./references#CD004126-bbs2-0021" title="LipszycM , EngelmanE . Clonidine does not prevent myocardial ischemia during noncardiac surgery. Anesthesiology1991;75:A93. ">Lipszyc 1991</a>; <a href="./references#CD004126-bbs2-0032" title="QuintinL , CicalaR , KentM , ThomsenB . Effect of clonidine on myocardial ischaemia: a double‐blind pilot trial. Canadian Journal of Anaesthesia1993;40(1):85‐6. [PUBMED: 7980723] ">Quintin 1993</a>), were being published only in abstract form (therefore lacking complete peer‐review), and another lacked reproducible selection criteria (<a href="./references#CD004126-bbs2-0019" title="LeeC , KimYD , KimJN . Antihyperalgesic effects of dexmedetomidine on high‐dose remifentanil‐induced hyperalgesia. Korean Journal of Anesthesiology2013;64(4):301‐7. [PUBMED: 23646238] ">Lee 2013a</a>). </p> </section> </section> <section id="CD004126-sec-0079"> <h3 class="title" id="CD004126-sec-0079">Effects of interventions</h3> <p>See: <a href="./full#CD004126-tbl-0001"><b>Summary of findings for the main comparison</b> Alpha‐2 adrenergic agonists compared to control in non‐cardiac surgery</a>; <a href="./full#CD004126-tbl-0002"><b>Summary of findings 2</b> Alpha‐2 adrenergic agonists compared to control in cardiac surgery</a> </p> <section id="CD004126-sec-0080"> <h4 class="title">Non‐cardiac surgery</h4> <section id="CD004126-sec-0081"> <h5 class="title">Primary outcome</h5> <section id="CD004126-sec-0082"> <h6 class="title">1. All‐cause mortality within 30 days after surgery</h6> <p>Sixteen studies reported all‐cause mortality, with 210 events (1.5%) among 14,081 participants. Alpha‐2 adrenergic agonists had no statistically significant reduction in all‐cause mortality (RR 0.80, 95% CI 0.61 to 1.04, P = 0.10), without any measurable heterogeneity (I<sup>2</sup> = 0%) (<a href="./references#CD004126-fig-0006" title="">Analysis 1.1</a>). The quality of this evidence was high (<a href="./full#CD004126-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> </section> <section id="CD004126-sec-0083"> <h5 class="title">Secondary outcomes</h5> <section id="CD004126-sec-0084"> <h6 class="title">1. Cardiac mortality within 30 days after surgery: sudden death or death resulting from a primarily identifiable cardiac cause </h6> <p>Five studies reported cardiac‐related deaths, with 114 events (0.9%) among 12,525 participants. Alpha‐2 adrenergic agonists did not cause a statistically significant reduction in cardiac‐related mortality (RR 0.86, 95% CI 0.60 to 1.23, P = 0.41) with low measurable heterogeneity (I<sup>2</sup> = 16%) (<a href="./references#CD004126-fig-0007" title="">Analysis 1.2</a>). The quality of evidence was high (<a href="./full#CD004126-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD004126-sec-0085"> <h6 class="title">2. Myocardial infarction within 30 days after surgery (definition as per individual study) </h6> <p>Twelve studies reported MIs, with 835 events (6.0%) among 13,907 participants. Alpha‐2 adrenergic agonists were not associated with any statistically significant difference in the risk of MI (RR 0.94, 95% CI 0.69 to 1.27, P = 0.67) with moderate heterogeneity (I<sup>2</sup> = 37%) (<a href="./references#CD004126-fig-0008" title="">Analysis 1.3</a>). The quality of evidence was moderate (<a href="./full#CD004126-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD004126-sec-0086"> <h6 class="title">3. Myocardial ischaemia within 30 days after surgery: as detected on an electrocardiogram or transoesophageal echocardiogram (definition as per individual study) </h6> <p>Twelve studies reported myocardial ischaemia, with 291 events (21.1%) among 1379 participants. Alpha‐2 adrenergic agonists did not significantly reduced the risk of ischaemia (RR 0.73, 95% CI 0.53 to 1.02, P = 0.06; I<sup>2</sup> = 45%) (<a href="./references#CD004126-fig-0009" title="">Analysis 1.4</a>). </p> </section> <section id="CD004126-sec-0087"> <h6 class="title">4. Supraventricular tachycardia within 30 days after surgery: supraventricular tachycardia, atrial fibrillation or atrial flutter </h6> <p>Two studies reported SVTs, with one event (2.3%) among 44 participants. Both studies evaluated dexmedetomidine. Since there was no events reported in one of the studies (<a href="./references#CD004126-bbs2-0042" title="VennRM , BryantA , HallGM , GroundsRM . Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post‐operative patients needing sedation in the intensive care unit. British Journal of Anaesthesia2001;86(5):650‐6. [PUBMED: 11575340] VennRM , GroundsRM . Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. British Journal of Anaesthesia2001;87(5):684‐90. [PUBMED: 11878517] ">Venn 2001</a>), pooled estimates were not calculated. The remaining trial showed no effect of α‐2 adrenergic agonists on SVT (RR 1.11, 95% CI 0.05 to 24.07) (<a href="./references#CD004126-fig-0010" title="">Analysis 1.5</a>) (<a href="./references#CD004126-bbs2-0039" title="TalkeP , LiJ , JainU , LeungJ , DrasnerK , HollenbergM , et al. Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. Anesthesiology1995;82(3):620‐33. [PUBMED: 7879930] ">Talke 1995</a>). </p> </section> <section id="CD004126-sec-0088"> <h6 class="title">5. Heart failure within 30 days after surgery: clinical diagnosis of heart failure</h6> <p>Eight studies reported episodes of HF, with 107 events (1.0%) among 10,802 participants. There was no significant reduction in congestive heart failure (CHF) with perioperative α‐2 adrenergic agonist use (RR 1.21, 95% CI 0.83 to 1.75, P = 0.32), with negligible heterogeneity (I<sup>2</sup> = 3%) (<a href="./references#CD004126-fig-0011" title="">Analysis 1.6</a>). </p> </section> </section> <section id="CD004126-sec-0089"> <h5 class="title">Adverse effects from treatment</h5> <section id="CD004126-sec-0090"> <h6 class="title">1. Acute stroke within 30 days after surgery: new focal neurological deficit with signs and symptoms lasting longer than 24 hours </h6> <p>Seven studies reported acute strokes, with 56 strokes (0.5%) among 11,542 participants. Alpha‐2 adrenergic agonists had no significant effect on acute stroke (RR 0.93, 95% CI 0.55 to 1.56 P = 0.79) with no measurable heterogeneity (I<sup>2</sup> = 0%) (<a href="./references#CD004126-fig-0012" title="">Analysis 1.7</a>). The quality of evidence for effects on acute stroke was high (<a href="./full#CD004126-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> </section> <section id="CD004126-sec-0091"> <h5 class="title">Physiological effects of treatment</h5> <section id="CD004126-sec-0092"> <h6 class="title">1. Bradycardia requiring pharmacological or pacemaker treatment</h6> <p>Sixteen studies reported bradycardia, with 1349 events (9.6%) in 14,035 participants. Within these 16 studies, α‐2 adrenergic agonists significantly increased the risk of bradycardia (RR 1.59, 95% CI 1.18 to 2.13, P = 0.002), albeit with substantial heterogeneity (I<sup>2</sup> = 53%) (<a href="./references#CD004126-fig-0013" title="">Analysis 1.8</a>). The quality of evidence for treatment effects on bradycardia was moderate (<a href="./full#CD004126-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD004126-sec-0093"> <h6 class="title">2. Hypotension requiring treatment with inotropes or vasopressors</h6> <p>Fifteen studies reported hypotension, with 4766 events (34.7%) in 13,738 participants. Alpha‐2 adrenergic agonists caused a significant increase in the risk of perioperative hypotension (RR 1.24, 95% CI 1.03 to 1.48, P = 0.02), albeit with substantial heterogeneity (I<sup>2</sup> = 54%) (<a href="./references#CD004126-fig-0014" title="">Analysis 1.9</a>). Based on a post‐hoc subgroup analysis, the choice of drug may explain this heterogeneity (<a href="./references#CD004126-fig-0030" title="">Analysis 4.4</a>). Specifically, there was statistically significant evidence of subgroup effects based on whether the studies evaluated clonidine, dexmedetomidine or mivazerol (test of interaction P &lt; 0.001). Clonidine significantly increased the risk of hypotension (RR 1.29, 95% CI 1.23 to 1.35, P &lt; 0.001). Dexmedetomidine was also associated with an increased risk (RR 1.81, 95% CI 1.07 to 3.06, P = 0.03). Conversely, mivazerol did not increase the risk of hypotension (RR 0.95, 95% CI 0.82 to 1.10, P = 0.48). Clonidine and mivazerol subgroup analyses had no measurable heterogeneity (I<sup>2</sup> = 0%), whereas the dexmedetomidine subgroup analysis demonstrated significant heterogeneity (I<sup>2</sup> = 50%). The quality of evidence for treatment effects on hypotension was moderate (<a href="./full#CD004126-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> </section> </section> <section id="CD004126-sec-0094"> <h4 class="title">Cardiac surgery</h4> <section id="CD004126-sec-0095"> <h5 class="title">Primary outcome</h5> <section id="CD004126-sec-0096"> <h6 class="title">1. All‐cause mortality within 30 days after surgery</h6> <p>Sixteen studies reported all‐cause mortality, with 29 events (1.5%) among 1949 participants. Alpha‐2 adrenergic agonists did not result in a statistically significant reduction in all‐cause mortality (RR 0.52, 95% CI 0.26 to 1.04, P = 0.06), without any measurable heterogeneity (I<sup>2</sup> = 0%) (<a href="./references#CD004126-fig-0015" title="">Analysis 2.1</a>). The quality of this evidence was moderate (<a href="./full#CD004126-tbl-0002">summary of findings Table 2</a>). </p> </section> </section> <section id="CD004126-sec-0097"> <h5 class="title">Secondary outcomes</h5> <section id="CD004126-sec-0098"> <h6 class="title">1. Cardiac mortality within 30 days after surgery: sudden death or death resulting from a primarily identifiable cardiac cause </h6> <p>Only one study reported cardiac mortality, with 1 event among the 12 participants in the clonidine arm and no events among the 10 participants in the control arm (<a href="./references#CD004126-bbs2-0023" title="LoickHM , SchmidtC , VanAkenH , JunkerR , ErrenM , BerendesE , et al. High thoracic epidural anesthesia, but not clonidine, attenuates the perioperative stress response via sympatholysis and reduces the release of troponin T in patients undergoing coronary artery bypass grafting. Anesthesia and Analgesia1999;88(4):701‐9. [PUBMED: 10195508] ">Loick 1999</a>). Thus, no pooled analysis was performed. </p> </section> <section id="CD004126-sec-0099"> <h6 class="title">2. Myocardial infarction within 30 days after surgery: definition as per individual study </h6> <p>Eight studies reported MIs, with 16 events (2.0%) among 782 participants. Alpha‐2 adrenergic agonists were not associated with reduced risk of MI (RR 1.01, 95% CI 0.43 to 2.40, P = 0.98) in an analysis with no heterogeneity (I<sup>2</sup> = 0%) (<a href="./references#CD004126-fig-0016" title="">Analysis 2.2</a>). The quality of evidence was moderate (<a href="./full#CD004126-tbl-0002">summary of findings Table 2</a>). </p> </section> <section id="CD004126-sec-0100"> <h6 class="title">3. Myocardial ischaemia within 30 days after surgery: as detected on an electrocardiogram or transoesophageal echocardiogram (definition as per individual study) </h6> <p>Thirteen studies reported myocardial ischaemia, with 243 events (21.4%) among 1134 participants. Alpha‐2 adrenergic agonists significantly reduced the risk of ischaemia (RR 0.69, 95% CI 0.56 to 0.86, P &lt; 0.001) with no heterogeneity (I<sup>2</sup> = 0%) (<a href="./references#CD004126-fig-0017" title="">Analysis 2.3</a>). </p> </section> <section id="CD004126-sec-0101"> <h6 class="title">4. Supraventricular tachycardia within 30 days after surgery: supraventricular tachycardia, atrial fibrillation or atrial flutter </h6> <p>Six studies reported SVTs, with 79 events (7.7%) among 1044 participants. Alpha‐2 adrenergic agonists had no significant effect on the risk of SVT (RR 0.77, 95% CI 0.50 to 1.16, P = 0.21) with low measurable heterogeneity (I<sup>2</sup> = 24%) (<a href="./references#CD004126-fig-0018" title="">Analysis 2.4</a>). </p> </section> <section id="CD004126-sec-0102"> <h6 class="title">5. Heart failure within 30 days after surgery: clinical diagnosis of heart failure or need for postoperative intra‐aortic balloon pump support </h6> <p>Four studies reported 38 HF events (6.9%) among 549 participants. Alpha‐2 adrenergic agonists had no statistically significant effect on the risk of HF (RR 0.90, 95% CI 0.49 to 1.63, P = 0.72) with no measurable heterogeneity (I<sup>2</sup> = 0%) (<a href="./references#CD004126-fig-0019" title="">Analysis 2.5</a>). </p> </section> </section> <section id="CD004126-sec-0103"> <h5 class="title">Adverse effects from treatment</h5> <section id="CD004126-sec-0104"> <h6 class="title">1. Acute stroke within 30 days after surgery: new focal neurological deficit with signs and symptoms lasting longer than 24 hours </h6> <p>Seven studies reported acute stroke, with 18 events (1.5%) among 1175 participants. Alpha‐2 adrenergic agonists significantly reduced the risk of acute stroke (RR 0.37, 95% CI 0.15 to 0.93, P = 0.03; I<sup>2</sup> = 0%) (<a href="./references#CD004126-fig-0020" title="">Analysis 2.6</a>). The quality of evidence was low (<a href="./full#CD004126-tbl-0002">summary of findings Table 2</a>). </p> </section> </section> <section id="CD004126-sec-0105"> <h5 class="title">Physiological effects of treatment</h5> <section id="CD004126-sec-0106"> <h6 class="title">1. Bradycardia requiring pharmacological or pacemaker treatment</h6> <p>Ten studies reported episodes of bradycardia, with 136 events (9.2%) among 1477 participants. Pooled analysis demonstrated that α‐2 adrenergic agonists significantly increased the risk of bradycardia (RR 1.88, 95% CI 1.35 to 2.62, P = 0.0002) with no heterogeneity (I<sup>2</sup> = 0%) (<a href="./references#CD004126-fig-0021" title="">Analysis 2.7</a>). The quality of evidence was moderate (<a href="./full#CD004126-tbl-0002">summary of findings Table 2</a>). </p> </section> <section id="CD004126-sec-0107"> <h6 class="title">2. Hypotension requiring treatment with inotropes or vasopressors</h6> <p>Nine studies reported 494 episodes of hypotension (35%) among 1413 participants. Alpha‐2 adrenergic agonists did not significantly increase the risk of hypotension (RR 1.19, 95% CI 0.87 to 1.64, P = 0.28) in an analysis with substantial heterogeneity (I<sup>2</sup> = 72%) (<a href="./references#CD004126-fig-0022" title="">Analysis 2.8</a>). The quality of evidence was low (<a href="./full#CD004126-tbl-0002">summary of findings Table 2</a>). </p> </section> </section> </section> <section id="CD004126-sec-0108"> <h4 class="title">Subgroup analyses</h4> <section id="CD004126-sec-0109"> <h5 class="title">Vascular versus non‐vascular non‐cardiac surgery</h5> <p>There was no statistically significant evidence of subgroup effects based on procedure type (i.e. vascular versus non‐vascular procedures) with respect to the outcomes of all‐cause mortality (test of interaction P = 0.17; <a href="./references#CD004126-fig-0023" title="">Analysis 3.1</a>), cardiac mortality (test of interaction P = 0.13; <a href="./references#CD004126-fig-0024" title="">Analysis 3.2</a>), MI (test of interaction P = 0.13; <a href="./references#CD004126-fig-0025" title="">Analysis 3.3</a>), and myocardial ischaemia (test of interaction P = 0.17; <a href="./references#CD004126-fig-0026" title="">Analysis 3.4</a>). </p> </section> <section id="CD004126-sec-0110"> <h5 class="title">Drug (i.e. clonidine, mivazerol or dexmedetomidine) evaluated in non‐cardiac surgery</h5> <p>There was no statistically significant evidence of subgroup effects based on the specific α‐2 adrenergic agonist evaluated with respect to the outcomes of all‐cause mortality (test of interaction P = 0.50) (<a href="./references#CD004126-fig-0027" title="">Analysis 4.1</a>), and MI (test of interaction P = 0.48) (<a href="./references#CD004126-fig-0029" title="">Analysis 4.3</a>). Conversely, there was a statistically significant subgroup effect with respect to cardiac mortality (test of interaction P = 0.05) (<a href="./references#CD004126-fig-0028" title="">Analysis 4.2</a>). In these subgroup analyses, mivazerol significantly reduced cardiac mortality (RR 0.51, 95% CI 0.27 to 0.98, P = 0.04), whereas clonidine did not (RR 1.12, 95% CI 0.71 to 1.75, P = 0.63). There were insufficient studies that reported myocardial ischaemia as an outcome for dexmedetomidine or mivazerol to facilitate drug‐specific subgroup analysis for the outcome. </p> </section> </section> <section id="CD004126-sec-0111"> <h4 class="title">Sensitivity analyses</h4> <section id="CD004126-sec-0112"> <h5 class="title">Studies that clearly reported blinding and concealed allocation</h5> <p>The pooled effects of α‐2 adrenergic agonists on all‐cause mortality (RR 0.68, 95% CI 0.41 to 1.11, P = 0.12; participants = 13,066; studies = 7; <a href="./references#CD004126-fig-0031" title="">Analysis 5.1</a>), MI (RR 1.08, 95% CI 0.95 to 1.23, P = 0.26; participants = 13,026; studies = 6; <a href="./references#CD004126-fig-0032" title="">Analysis 5.2</a>), and myocardial ischaemia (RR 0.77, 95% CI 0.40 to 1.48, P = 0.43; participants = 412; studies = 3; <a href="./references#CD004126-fig-0033" title="">Analysis 5.3</a>) were qualitatively similar when analyses were restricted to trials that clearly reported methods for blinding and allocation concealment. </p> </section> <section id="CD004126-sec-0113"> <h5 class="title">Strict definitions of myocardial infarction and ischaemia</h5> <p>When analyses were restricted to trials that strictly defined MI on ECG or enzymatic criteria, pooled treatment effects in non‐cardiac surgery (RR 0.98, 95% CI 0.70 to 1.36, P = 0.90; participants = 13,003; studies = 8) and cardiac surgery (RR 0.76, 95% CI 0.19 to 2.98, P = 0.69; participants = 275; studies = 3) were qualitatively unchanged (<a href="./references#CD004126-fig-0034" title="">Analysis 6.1</a>). When analyses were restricted to studies that strictly defined events of myocardial ischaemia, the effects in non‐cardiac surgery remained non‐significant (RR 0.76, 95% CI 0.54 to 1.07, P = 0.12; participants = 1175; studies = 9). In cardiac surgery, the sensitivity analysis continued to demonstrate a reduction in the risk of ischaemia (RR 0.71, 95% CI 0.55 to 0.91, P = 0.007; participants = 820; studies = 8) (<a href="./references#CD004126-fig-0035" title="">Analysis 6.2</a>). </p> </section> <section id="CD004126-sec-0114"> <h5 class="title">Influence of two large trials</h5> <p>The overall results of this review are likely highly influenced by two large RCTs in non‐cardiac surgery, one of which assessed mivazerol (<a href="./references#CD004126-bbs2-0027" title="OliverMF , GoldmanL , JulianDG , HolmeI . Effect of mivazerol on perioperative cardiac complications during non‐cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology1999;91(4):951‐61. [PUBMED: 10519497] ">Oliver 1999</a>), while the other assessed clonidine (<a href="./references#CD004126-bbs2-0007" title="DevereauxPJ , SesslerDI , LeslieK , KurzA , MrkobradaM , Alonso‐CoelloP , et al. Clonidine in patients undergoing noncardiac surgery. New England Journal of Medicine2014;370(16):1504‐13. [PUBMED: 24679061] ">Devereaux 2014a</a>). Therefore, we performed a post‐hoc sensitivity analysis that excluded these studies. After excluding these two trials, treatment effect on all‐cause mortality became statistically significant (RR 0.45, 95% CI 0.22 to 0.93, P = 0.03; participants = 2174; studies = 14; <a href="./references#CD004126-fig-0036" title="">Analysis 7.1</a>). Conversely, the effect on cardiac mortality (RR 0.47, 95% CI 0.10 to 2.25, P = 0.35; participants = 618; studies = 3; <a href="./references#CD004126-fig-0037" title="">Analysis 7.2</a>), and MI (RR 0.56, 95% CI 0.25 to 1.25, P = 0.16; participants = 2000; studies = 10; <a href="./references#CD004126-fig-0038" title="">Analysis 7.3</a>) were statistically non‐significant, albeit with more optimistic individual point estimates (i.e. pooled treatment effects shifted towards larger risk reductions). </p> </section> <section id="CD004126-sec-0115"> <h5 class="title">Excluding drugs not introduced into clinical practice (i.e. mivazerol)</h5> <p>In post‐hoc sensitivity analyses excluding the two trials that evaluated mivazerol (<a href="./references#CD004126-bbs2-0025" title="McSPI‐Europe Research Group. Perioperative sympatholysis: beneficial effects of the alpha 2‐adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. Anesthesiology1997;86(2):346‐63. [PUBMED: 9054253] ">McSPI‐Europe 1997</a>; <a href="./references#CD004126-bbs2-0027" title="OliverMF , GoldmanL , JulianDG , HolmeI . Effect of mivazerol on perioperative cardiac complications during non‐cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology1999;91(4):951‐61. [PUBMED: 10519497] ">Oliver 1999</a>), there was no change in pooled treatment effects pertaining to all‐cause mortality, cardiac mortality, MI, SVT, HF, stroke, bradycardia, or hypotension (<a href="./references#CD004126-fig-0039" title="">Analysis 8.1</a>; <a href="./references#CD004126-fig-0040" title="">Analysis 8.2</a>; <a href="./references#CD004126-fig-0041" title="">Analysis 8.3</a>; <a href="./references#CD004126-fig-0043" title="">Analysis 8.5</a>; <a href="./references#CD004126-fig-0044" title="">Analysis 8.6</a>; <a href="./references#CD004126-fig-0045" title="">Analysis 8.7</a>; <a href="./references#CD004126-fig-0046" title="">Analysis 8.8</a>; <a href="./references#CD004126-fig-0047" title="">Analysis 8.9</a>). Conversely, the pooled treatment effect on ischaemia became statistically significant (RR 0.68, 95% CI 0.48 to 0.97, P = 0.03; participants = 1079; studies = 11; I<sup>2</sup> = 40%) (<a href="./references#CD004126-fig-0042" title="">Analysis 8.4</a>), albeit in an analysis with moderate heterogeneity and relatively few participants. </p> </section> <section id="CD004126-sec-0116"> <h5 class="title">Restricting studies more representative of contemporary perioperative practice</h5> <p>When analyses pertaining to non‐cardiac surgery were restricted to studies that collected data within the previous 20 years, there was no change in the pooled treatment effects pertaining to all‐cause mortality, cardiac mortality, MI, HF or stroke (<a href="./references#CD004126-fig-0048" title="">Analysis 9.1</a>; <a href="./references#CD004126-fig-0049" title="">Analysis 9.2</a>; <a href="./references#CD004126-fig-0050" title="">Analysis 9.3</a>; <a href="./references#CD004126-fig-0052" title="">Analysis 9.5</a>; <a href="./references#CD004126-fig-0053" title="">Analysis 9.6</a>). Nonetheless, exclusion of older studies resulted in a significant reduction in the risk of myocardial ischaemia (RR 0.51, 95% CI 0.28 to 0.93, P = 0.03; participants = 634; studies = 6; I<sup>2</sup> = 48%) in an analysis with moderate heterogeneity (<a href="./references#CD004126-fig-0051" title="">Analysis 9.4</a>). In cardiac surgery, exclusion of older studies resulted in no substantive effect on the pooled treatment effects for MI, myocardial ischaemia, SVT, HF or stroke (<a href="./references#CD004126-fig-0055" title="">Analysis 10.2</a>; <a href="./references#CD004126-fig-0056" title="">Analysis 10.3</a>; <a href="./references#CD004126-fig-0057" title="">Analysis 10.4</a>; <a href="./references#CD004126-fig-0058" title="">Analysis 10.5</a>; <a href="./references#CD004126-fig-0059" title="">Analysis 10.6</a>). Conversely, the pooled treatment effect on all‐cause mortality became statistically significant (RR 0.47, 95% CI 0.23 to 0.97; participants = 1782; studies = 13; I<sup>2</sup> = 0%) (<a href="./references#CD004126-fig-0054" title="">Analysis 10.1</a>). </p> </section> </section> <section id="CD004126-sec-0117"> <h4 class="title">Funnel plots</h4> <p>Funnel plots of included studies revealed no obvious publication bias with regard to the outcome of mortality (<a href="#CD004126-fig-0004">Figure 4</a>), but some possible bias with regard to MI (<a href="#CD004126-fig-0005">Figure 5</a>). Since this analysis pooled results from only nine studies, formal statistical testing for asymmetry was not conducted. </p> <div class="figure" id="CD004126-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, outcome: 1.1 All‐cause mortality." data-id="CD004126-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, outcome: 1.1 All‐cause mortality. </p> </div> </div> </div> <div class="figure" id="CD004126-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, outcome: 1.3 Myocardial infarction." data-id="CD004126-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, outcome: 1.3 Myocardial infarction. </p> </div> </div> </div> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004126-sec-0118" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004126-sec-0118">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004126-sec-0183">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004126-sec-0118"></div> <section id="CD004126-sec-0119"> <h3 class="title" id="CD004126-sec-0119">Summary of main results</h3> <p>Our present review found high‐quality evidence that perioperative α‐2 adrenergic agonists did not reduce the risk of all‐cause mortality, cardiac mortality or MI in people undergoing non‐cardiac or cardiac surgery (<a href="./full#CD004126-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD004126-tbl-0002">summary of findings Table 2</a>). These findings remained stable in sensitivity analyses restricted to studies that either demonstrated low risks of bias or employed strict definitions of MI. Aside from lacking any beneficial effect on these clinical outcomes, α‐2 adrenergic agonists also conferred important risks, specifically increased rates of hypotension and bradycardia. While these haemodynamic effects were not associated with an increased risk of acute stroke, the 95% CIs for this pooled effect were wide (RR 0.93, 95% CI 0.55 to 1.56), thereby not excluding the possibility of a moderate increase in stroke risk with perioperative α‐2 adrenergic agonists. </p> </section> <section id="CD004126-sec-0120"> <h3 class="title" id="CD004126-sec-0120">Overall completeness and applicability of evidence</h3> <p>The 47 RCTs included in this systematic review encompassed 17,039 participants, a wide range of relevant surgical procedures performed in several different countries internationally and clinically relevant dosing regimens of currently available α‐2 adrenergic agonists (i.e. clonidine, dexmedetomidine). Furthermore, a significant number of participants from the included studies underwent surgery within the past decade. Thus, we are confident that the overall findings of our systematic review, namely that α‐2 adrenergic agonists do not significantly reduce risks of cardiovascular complications or mortality when given prophylactically before major non‐cardiac or cardiac surgery, can be reasonably extrapolated to contemporary perioperative practice. </p> <p>Nonetheless, there were insufficient participants within specific subgroups to conclusively evaluate several potential benefits of α‐2 adrenergic agonists, namely prevention of stroke, myocardial ischaemia and all‐cause mortality after cardiac surgery. The subgroup analysis evaluating effects on stroke during cardiac surgery was small, with only seven included studies that encompassed 1175 participants (<a href="./references#CD004126-fig-0020" title="">Analysis 2.6</a>). The pooled estimate was based on low‐quality data, calculated using very few outcome events (i.e. 18 strokes). Previous research has found that treatment effects are generally overestimated in meta‐analyses that include relatively few outcome events (<a href="./references#CD004126-bbs2-0413" title="ThorlundK , ImbergerG , WalshM , ChuR , GluudC , WetterslevJ , et al. The number of patients and events required to limit the risk of overestimation of intervention effects in meta‐analysis ‐ a simulation study. PloS One2011;6(10):e25491. [PUBMED: 22028777] ">Thorlund 2011</a>). Consistent with this possibility, the magnitude of the pooled estimate was somewhat implausible (RR 0.37, 95% CI 0.15 to 0.93), in that it suggested a 63% relative reduction in the risk of stroke from a single perioperative intervention. Therefore, further research is needed to determine whether α‐2 adrenergic agonists can truly reduce the risk of acute stroke after cardiac surgery. </p> <p>Similarly, the statistically significant pooled treatment effect on all‐cause mortality was observed only in a post‐hoc subset analysis restricted to cardiac surgery trials conducted after 1997 (<a href="./references#CD004126-fig-0054" title="">Analysis 10.1</a>). This subset was relatively small (13 studies encompassing 1782 participants), the pooled estimated was calculated using very few outcome events (i.e. 28 deaths) and the magnitude of the pooled estimate was somewhat implausible (RR 0.47, 95% CI 0.23 to 0.97) for a single intervention. More studies are needed to assess the effect of α‐2 adrenergic agonists on all‐cause mortality after cardiac surgery. </p> <p>In a separate subgroup analysis in cardiac surgery, α‐2 adrenergic agonists also caused a significant reduction in perioperative myocardial ischaemia (<a href="./references#CD004126-fig-0017" title="">Analysis 2.3</a>). Nonetheless, myocardial ischaemia is a surrogate outcome with important associated limitations (<a href="./references#CD004126-bbs2-0412" title="SvenssonS , MenkesDB , LexchinJ . Surrogate outcomes in clinical trials: a cautionary tale. JAMA Internal Medicine2013;173(8):611‐12. [PUBMED: 23529157] ">Svensson 2013</a>). Especially in the absence of associated reductions in clinical important and patient‐relevant outcomes such as mortality or MI, isolated reductions in perioperative myocardial ischaemia are not sufficient justifications for employing α‐2 adrenergic agonists in clinical practice. </p> </section> <section id="CD004126-sec-0121"> <h3 class="title" id="CD004126-sec-0121">Quality of the evidence</h3> <p>This systematic review was supported by 47 RCTs that recruited 17,039 participants. The sample size of the included RCTs varied greatly, ranging from 20 to over 10,000 participants. Nineteen studies had over 100 participants, with only two studies involving over 1000 participants (<a href="./references#CD004126-bbs2-0007" title="DevereauxPJ , SesslerDI , LeslieK , KurzA , MrkobradaM , Alonso‐CoelloP , et al. Clonidine in patients undergoing noncardiac surgery. New England Journal of Medicine2014;370(16):1504‐13. [PUBMED: 24679061] ">Devereaux 2014a</a>; <a href="./references#CD004126-bbs2-0027" title="OliverMF , GoldmanL , JulianDG , HolmeI . Effect of mivazerol on perioperative cardiac complications during non‐cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology1999;91(4):951‐61. [PUBMED: 10519497] ">Oliver 1999</a>). The vast majority of these participants (14,367) were recruited into the 23 included trials in non‐cardiac surgery. By comparison, the remaining 24 RCTs in cardiac surgery involved 2672 participants. </p> <p>Only 16 studies reported adequate methods for random sequence generation and allocation concealment. Furthermore, although 31 studies described themselves as 'double‐blinded,' only 21 studies reported appropriate methods to achieve blinding. Nonetheless, the majority of participants were from well‐designed studies with adequate methods for allocation and blinding, thereby rendering them low risk to be influenced by selection bias, performance bias and detection bias. </p> <p>The analyses pertaining to the primary and secondary outcomes in people undergoing non‐cardiac surgery were generally robust. These findings were judged as moderate to high quality by GRADE methodology (<a href="./full#CD004126-tbl-0001">summary of findings Table for the main comparison</a>). Although many studies failed to report adequate methods to avoid risk of bias, the specific outcomes were unlikely to be influenced and thus no downgrading of quality was necessary. In addition, there was a potential threat of indirectness since the second largest RCT evaluated mivazerol (<a href="./references#CD004126-bbs2-0027" title="OliverMF , GoldmanL , JulianDG , HolmeI . Effect of mivazerol on perioperative cardiac complications during non‐cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology1999;91(4):951‐61. [PUBMED: 10519497] ">Oliver 1999</a>), which is not available for clinical use. However, given the similarity of mivazerol to dexmedetomidine (which is available for clinical use), we reasoned that this risk was likely not serious. Conversely, funnel plots suggested that the pooled treatment effects on MI was affected by publication bias (<a href="#CD004126-fig-0005">Figure 5</a>). The asymmetry in the funnel plots was produced by two small studies with seemingly unrealistic effect sizes (<a href="./references#CD004126-bbs2-0011" title="EllisJE , DrijversG , PedlowS , LaffSP , SorrentinoMJ , FossJF , et al. Premedication with oral and transdermal clonidine provides safe and efficacious postoperative sympatholysis. Anesthesia and Analgesia1994;79(6):1133‐40. [PUBMED: 7978438] ">Ellis 1994</a>; <a href="./references#CD004126-bbs2-0037" title="StuhmeierKD , MainzerB , CierpkaJ , SandmannW , TarnowJ . Small, oral dose of clonidine reduces the incidence of intraoperative myocardial ischemia in patients having vascular surgery. Anesthesiology1996;85(4):706‐12. [PUBMED: 8873539] ">Stuhmeier 1996</a>). While the combined weight of these studies was less than 3% of the pooled analysis, we downgraded the evidence by one level because of suspicion of publication bias for an outcome known to be influenced by performance bias (<a href="./references#CD004126-fig-0008" title="">Analysis 1.3</a>). Finally, the quality of evidence for the physiological effects of bradycardia and hypotension were both downgraded because of substantial heterogeneity (I<sup>2</sup> greater than 50%) in the analyses (<a href="./references#CD004126-fig-0013" title="">Analysis 1.8</a>; <a href="./references#CD004126-fig-0014" title="">Analysis 1.9</a>). </p> <p>The quality of evidence for the effects of α‐2 adrenergic agonists in cardiac surgery was generally lower, largely due to imprecision resulting from significantly fewer participants in the pooled analyses (<a href="./full#CD004126-tbl-0002">summary of findings Table 2</a>). The quality of evidence for all outcomes was downgraded because the optimal information size of 2000 participants was not achieved, and the 95% CIs of the pooled estimates did not rule out clinically significant effects (<a href="./references#CD004126-bbs2-0394" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s) . GRADE handbook for grading quality of evidence and strength of recommendations. Available from guidelinedevelopment.org/handbook: The GRADE Working Group, October 2013. ">GRADE Handbook 2013</a>). Thus, the quality of evidence for the analyses pertaining to all‐cause mortality and MI was moderate. As there were very few outcomes events in the analysis of acute stroke (i.e. 18 strokes), it was downgraded another level and judged as low quality. Finally, the presence of substantial imprecision in pooled analysis pertaining to hypotension led to the quality of this evidence being downgraded to low (I<sup>2</sup> = 72%; <a href="./references#CD004126-fig-0022" title="">Analysis 2.8</a>). Nonetheless, the magnitude of the association between α‐2 adrenergic agonists and hypotension in cardiac surgery (RR 1.19, 95% CI 0.87 to 1.64) was qualitatively very similar to that observed in non‐cardiac surgery (RR 1.24, 95% CI 1.03 to 1.48), where the quality of evidence was moderate. </p> </section> <section id="CD004126-sec-0122"> <h3 class="title" id="CD004126-sec-0122">Potential biases in the review process</h3> <p>There were several limitations to our review process. First, while our search was exhaustive in that it covered all major medical indexes and clinical trial registries, we might have missed some published trials only listed in other less commonly used indices. Nonetheless, we believe it unlikely that our search strategy missed any relevant studies of at least moderate size and quality. Second, we only included studies reporting subgroup‐specific outcome data based on surgical procedure type (i.e. cardiac surgery versus non‐cardiac surgery). Consequently, we excluded any study that did not predominantly include procedures (greater than 75%) from either of these surgical procedure subgroup, unless subgroup‐specific outcome data could be obtained from the authors. Consequently, two otherwise eligible studies could not be included in this systematic review (<a href="./references#CD004126-bbs2-0250" title="MantzJ , French Dexmedetomidine Phase III Group. Phase III study on dexmedetomidine used for postoperative sedation of patients requiring mechanical ventilation for less than 24 hours: the French experience. Middle East Journal of Anesthesiology2002;16(6):597‐606. [PUBMED: 12503263] MartinE , RamsayG , MantzJ , Sum‐PingST . The role of the alpha2‐adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. Journal of Intensive Care Medicine2003;18(1):29‐41. [PUBMED: 15189665] ">Martin 2003</a>; <a href="./references#CD004126-bbs2-0350" title="TriltschAE , WelteM , VonHomeyerP , GrobeJ , GenahrA , MoshirzadehM , et al. Bispectral index‐guided sedation with dexmedetomidine in intensive care: a prospective, randomized, double blind, placebo‐controlled phase II study. Critical Care Medicine2002;30(5):1007‐14. [PUBMED: 12006795] ">Triltsch 2002</a>). In excluding these studies, we balanced the risk of biasing the analyses with the loss of additional data, and chose the latter to maintain the integrity of our analyses. </p> </section> <section id="CD004126-sec-0123"> <h3 class="title" id="CD004126-sec-0123">Agreements and disagreements with other studies or reviews</h3> <p>There are several potential reasons why the theoretically beneficial physiological effects of α‐2 adrenergic agonists did not translate into reduced rates of major postoperative cardiac complications. First, α‐2 adrenergic agonists might not have sufficiently reduced heart rates to mitigate the risks of perioperative MI, as has been previously proposed (<a href="./references#CD004126-bbs2-0007" title="DevereauxPJ , SesslerDI , LeslieK , KurzA , MrkobradaM , Alonso‐CoelloP , et al. Clonidine in patients undergoing noncardiac surgery. New England Journal of Medicine2014;370(16):1504‐13. [PUBMED: 24679061] ">Devereaux 2014a</a>). This hypothesis is supported by the observation that, while perioperative β‐blockers caused more significant bradycardia than α‐2 adrenergic agonists, rates of perioperative MI were reduced with β‐blockers but not α‐2 adrenergic agonists (<a href="./references#CD004126-bbs2-0415" title="WijeysunderaD , DuncanD , Nkonde‐PriceC , ViraniS , WashamJ , FleischmannK , et al. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation2014;130(24):2246‐64. [PUBMED: 25085964] ">Wijeysundera 2014b</a>). Second, the predominant mechanism underlying perioperative MI in many affected people might not be increases in blood pressure and heart rate induced by the surgical stress response. For example, almost 30% of people with postoperative MI do not have significant obstructive coronary artery disease (<a href="./references#CD004126-bbs2-0410" title="ShethT , ChanM , ButlerC , ChowB , TandonV , NageleP , et al. Prognostic capabilities of coronary computed tomographic angiography before non‐cardiac surgery: prospective cohort study. BMJ2015;350:h1907. [PUBMED: 25902738] ">Sheth 2015</a>). It is unlikely that limiting perioperative increases in heart rate would help prevent MI in such people. Third, at a population‐level, the beneficial effects of heart rate reduction in some people undergoing surgery might have been offset by equal numbers of people who experienced deleterious effects from significant perioperative hypotension. </p> <p>Notably, our overall findings with respect to the absence of major reductions in perioperative cardiovascular risk from α‐2 adrenergic agonists was somewhat consistent with results seen with prophylactic therapy with other sympatholytic agents. Specifically, β‐adrenergic blockers have been shown to cause a net harmful effect in non‐cardiac surgery (<a href="./references#CD004126-bbs2-0415" title="WijeysunderaD , DuncanD , Nkonde‐PriceC , ViraniS , WashamJ , FleischmannK , et al. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation2014;130(24):2246‐64. [PUBMED: 25085964] ">Wijeysundera 2014b</a>). It remains to be seen whether any strategy of prophylactically attenuating haemodynamic abnormalities with sympatholytic agents can safely reduce perioperative cardiac risk. Indeed, if future RCTs with either alternative regimens of previously evaluated sympatholytic agents (i.e. α‐2 adrenergic agonists, β‐adrenergic blockers) or alternative negative chronotropic agents (e.g. ivabradine) fail to show net overall benefit, the general strategy for perioperative cardiac risk reduction may have to shift from <i>prophylactic therapy</i> to <i>early treatment</i>. Specifically, as opposed to administering these medications to a broad group of people before surgery, clinicians might instead consider targeting treatment in high‐risk people identified on the basis of ischaemic ECG changes or elevated cardiac troponin concentrations early after surgery. </p> <p>Comparison of our present systematic review on perioperative α‐2 adrenergic agonists with a prior systematic review of perioperative β‐adrenergic blockers in non‐cardiac surgery also provides some potential insights into the mechanisms underlying perioperative stroke (<a href="./references#CD004126-bbs2-0415" title="WijeysunderaD , DuncanD , Nkonde‐PriceC , ViraniS , WashamJ , FleischmannK , et al. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation2014;130(24):2246‐64. [PUBMED: 25085964] ">Wijeysundera 2014b</a>). Specifically, α‐2 adrenergic agonists (RR 1.24, 95% CI 1.03 to 1.48) and β‐adrenergic blockers (RR 1.47, 95% CI 1.34 to 1.60) conferred approximately similar risks of perioperative hypotension. Despite this similarity in haemodynamic effects, β‐blockers (RR 1.86, 95% CI 1.09 to 3.16) conferred significantly increased risks of perioperative acute stroke while α‐2 adrenergic agonists did not (RR 0.93, 95% CI 0.55 to 1.56). These contrasting effects are also evident when comparing two large individual perioperative RCTs of these two different drug classes, namely the POISE‐1 trial of metoprolol (<a href="./references#CD004126-bbs2-0406" title="POISE Study Group. Effects of extended‐release metoprolol succinate in patients undergoing non‐cardiac surgery (POISE trial): a randomised controlled trial. Lancet2008;371(9627):1839‐47. [PUBMED: 18479744] ">POISE 2008</a>) and the POISE‐2 trial of clonidine (<a href="./references#CD004126-bbs2-0007" title="DevereauxPJ , SesslerDI , LeslieK , KurzA , MrkobradaM , Alonso‐CoelloP , et al. Clonidine in patients undergoing noncardiac surgery. New England Journal of Medicine2014;370(16):1504‐13. [PUBMED: 24679061] ">Devereaux 2014a</a>). Specifically, while metoprolol (hazard ratio (HR) 1.55, 95% CI 1.38 to 1.74) and clonidine (HR 1.32, 95% CI 1.24 to 1.40) caused qualitatively similar increases in rates of hypotension, metoprolol significantly increased risks of stroke (HR 2.17, 95% CI 1.26 to 3.74) while clonidine did not (HR 1.06, 95% CI 0.54 to 2.05). These findings suggest that, despite the previously observed association between perioperative hypotension and stroke (<a href="./references#CD004126-bbs2-0406" title="POISE Study Group. Effects of extended‐release metoprolol succinate in patients undergoing non‐cardiac surgery (POISE trial): a randomised controlled trial. Lancet2008;371(9627):1839‐47. [PUBMED: 18479744] ">POISE 2008</a>), the mechanisms underlying perioperative acute stroke are likely more complex than simply a decrease in perfusion pressure. Further research is needed to better delineate these mechanisms, and thereby inform the development of strategies to help prevent this often devastating perioperative complication (<a href="./references#CD004126-bbs2-0406" title="POISE Study Group. Effects of extended‐release metoprolol succinate in patients undergoing non‐cardiac surgery (POISE trial): a randomised controlled trial. Lancet2008;371(9627):1839‐47. [PUBMED: 18479744] ">POISE 2008</a>). </p> <p>Importantly, perioperative α‐2 adrenergic agonists do have other potential benefits that may justify their selective use in some people undergoing surgery. Specifically, in a previous systematic review of 30 small RCTs encompassing 1792 participants, these agents decreased both postoperative pain intensity and morphine consumption (<a href="./references#CD004126-bbs2-0387" title="BlaudszunG , LysakowskiC , EliaN , TramèrMR . Effect of perioperative systemic α2 agonists on postoperative morphine consumption and pain intensity: systematic review and meta‐analysis of randomized controlled trials. Anesthesiology2012;116(6):1312‐22. [PUBMED: 22546966] ">Blaudszun 2012</a>). Our present study provided additional data supporting the safety of using α‐2 adrenergic agonists as an adjunct therapy for managing postoperative acute pain, provided that there is adequate attention to the associated risks of hypotension and bradycardia. </p> <section id="CD004126-sec-0124"> <h4 class="title"><i>Strengths</i> </h4> <p>Our present review had several strengths. The literature search was extensive and encompassed all languages. In addition, our study utilized a substantially larger data set than previous reviews (<a href="./references#CD004126-bbs2-0386" title="BiccardBM , GogaS , deBeursJ . Dexmedetomidine and cardiac protection for non‐cardiac surgery: a meta‐analysis of randomised controlled trials. Anaesthesia2008;63(1):4‐14. [PUBMED: 18086064] ">Biccard 2008</a>; <a href="./references#CD004126-bbs2-0405" title="NishinaK , MikawaK , UesugiT , ObaraH , MaekawaM , KamaeI , et al. Efficacy of clonidine for prevention of perioperative myocardial ischemia. A critical appraisal and meta‐analysis of the literature. Anesthesiology2002;96(2):323‐9. [PUBMED: 11818763] ">Nishina 2002</a>; <a href="./references#CD004126-bbs2-0411" title="StevensRD , BurriH , TramerMR . Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesthesia and Analgesia2003;97(3):623‐33. [PUBMED: 12933373] ">Stevens 2003</a>; <a href="./references#CD004126-bbs2-0417" title="WijeysunderaDN , NaikJS , BeattieWS . Alpha‐2 adrenergic agonists prevent perioperative cardiovascular complications: a meta‐analysis. American Journal of Medicine2003;114:742‐52. ">Wijeysundera 2003</a>; <a href="./references#CD004126-bbs2-0418" title="WijeysunderaDN , BenderJS , BeattieWS . Alpha‐2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD004126.pub2] ">Wijeysundera 2009</a>). Finally, we performed multiple sensitivity analyses to assess the potential influence of study quality, outcome definition and publication bias on our overall conclusions. </p> </section> <section id="CD004126-sec-0125"> <h4 class="title"><i>Limitations</i> </h4> <p>Our review had several limitations that should be considered. First, the results were heavily influenced by two large trials of mivazerol (<a href="./references#CD004126-bbs2-0027" title="OliverMF , GoldmanL , JulianDG , HolmeI . Effect of mivazerol on perioperative cardiac complications during non‐cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology1999;91(4):951‐61. [PUBMED: 10519497] ">Oliver 1999</a>) and clonidine (<a href="./references#CD004126-bbs2-0007" title="DevereauxPJ , SesslerDI , LeslieK , KurzA , MrkobradaM , Alonso‐CoelloP , et al. Clonidine in patients undergoing noncardiac surgery. New England Journal of Medicine2014;370(16):1504‐13. [PUBMED: 24679061] ">Devereaux 2014a</a>) in non‐cardiac surgery. While excluding these large trials from the meta‐analysis resulted in somewhat more optimistic point estimates for individual pooled treatment effects, these pooled estimates remained statistically non‐significant. Second, as with any systematic review, our results may have been affected by publication bias. Though funnel plots indicated no obvious bias in the reporting of death (all‐cause and cardiac‐cause), they did suggest reporting bias may be present for MI. Third, our present analysis pooled trials of α‐2 adrenergic agonists with differing selectivity for their target receptors, namely α‐2 adrenoceptors and non‐adrenergic imidazoline receptors (<a href="./references#CD004126-bbs2-0402" title="KhanZP , FergusonCN , JonesRM . Alpha‐2 and imidazoline receptor agonists. Anaesthesia1999;54(2):146‐65. [PUBMED: 10215710] ">Khan 1999</a>). Specifically, both mivazerol and dexmedetomidine have considerably greater selectivity for these target receptors than clonidine. Furthermore, when comparing the two large individual trials that dominated this meta‐analysis (<a href="./references#CD004126-bbs2-0007" title="DevereauxPJ , SesslerDI , LeslieK , KurzA , MrkobradaM , Alonso‐CoelloP , et al. Clonidine in patients undergoing noncardiac surgery. New England Journal of Medicine2014;370(16):1504‐13. [PUBMED: 24679061] ">Devereaux 2014a</a>; <a href="./references#CD004126-bbs2-0027" title="OliverMF , GoldmanL , JulianDG , HolmeI . Effect of mivazerol on perioperative cardiac complications during non‐cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology1999;91(4):951‐61. [PUBMED: 10519497] ">Oliver 1999</a>), clonidine had no effect on mortality and increased rates of significant perioperative hypotension, while mivazerol, a more selective α‐2 adrenergic agonist that is not currently available for clinical use, was associated with trends towards reduced mortality and had no effect on rates of hypotension. Importantly, these contrasting findings might have also been due to the different time periods when the studies were conducted, differences in study design, differences in participant characteristics or chance. Nonetheless, the contrasting findings still suggest that any future RCT of α‐2 adrenergic agonists for cardiac risk reduction in people undergoing surgery should focus on agents with higher selectivity for α‐2 adrenoceptors, such as dexmedetomidine or mivazerol. </p> </section> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD004126-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD004126-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/full#CD004126-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004126-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/full#CD004126-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004126-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/full#CD004126-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, outcome: 1.1 All‐cause mortality." data-id="CD004126-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, outcome: 1.1 All‐cause mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/full#CD004126-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, outcome: 1.3 Myocardial infarction." data-id="CD004126-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, outcome: 1.3 Myocardial infarction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/full#CD004126-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, Outcome 1 All‐cause mortality." data-id="CD004126-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, Outcome 1 All‐cause mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, Outcome 2 Cardiac mortality." data-id="CD004126-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, Outcome 2 Cardiac mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, Outcome 3 Myocardial infarction." data-id="CD004126-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, Outcome 3 Myocardial infarction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, Outcome 4 Myocardial ischaemia." data-id="CD004126-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, Outcome 4 Myocardial ischaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, Outcome 5 Supraventricular tachyarrhythmia." data-id="CD004126-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, Outcome 5 Supraventricular tachyarrhythmia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, Outcome 6 Heart failure." data-id="CD004126-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, Outcome 6 Heart failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, Outcome 7 Acute stroke." data-id="CD004126-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, Outcome 7 Acute stroke. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, Outcome 8 Bradycardia." data-id="CD004126-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, Outcome 8 Bradycardia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, Outcome 9 Hypotension." data-id="CD004126-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery, Outcome 9 Hypotension. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Alpha‐2 adrenergic agonists versus control in cardiac surgery, Outcome 1 All‐cause mortality." data-id="CD004126-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Alpha‐2 adrenergic agonists versus control in cardiac surgery, Outcome 1 All‐cause mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Alpha‐2 adrenergic agonists versus control in cardiac surgery, Outcome 2 Myocardial infarction." data-id="CD004126-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Alpha‐2 adrenergic agonists versus control in cardiac surgery, Outcome 2 Myocardial infarction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Alpha‐2 adrenergic agonists versus control in cardiac surgery, Outcome 3 Myocardial ischaemia." data-id="CD004126-fig-0017" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Alpha‐2 adrenergic agonists versus control in cardiac surgery, Outcome 3 Myocardial ischaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Alpha‐2 adrenergic agonists versus control in cardiac surgery, Outcome 4 Supraventricular tachyarrhythmia." data-id="CD004126-fig-0018" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Alpha‐2 adrenergic agonists versus control in cardiac surgery, Outcome 4 Supraventricular tachyarrhythmia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Alpha‐2 adrenergic agonists versus control in cardiac surgery, Outcome 5 Heart failure." data-id="CD004126-fig-0019" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Alpha‐2 adrenergic agonists versus control in cardiac surgery, Outcome 5 Heart failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Alpha‐2 adrenergic agonists versus control in cardiac surgery, Outcome 6 Acute stroke." data-id="CD004126-fig-0020" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Alpha‐2 adrenergic agonists versus control in cardiac surgery, Outcome 6 Acute stroke. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Alpha‐2 adrenergic agonists versus control in cardiac surgery, Outcome 7 Bradycardia." data-id="CD004126-fig-0021" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Alpha‐2 adrenergic agonists versus control in cardiac surgery, Outcome 7 Bradycardia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Alpha‐2 adrenergic agonists versus control in cardiac surgery, Outcome 8 Hypotension." data-id="CD004126-fig-0022" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Alpha‐2 adrenergic agonists versus control in cardiac surgery, Outcome 8 Hypotension. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery ‐ stratified by vascular versus non‐vascular surgery, Outcome 1 All‐cause mortality." data-id="CD004126-fig-0023" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery ‐ stratified by vascular versus non‐vascular surgery, Outcome 1 All‐cause mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery ‐ stratified by vascular versus non‐vascular surgery, Outcome 2 Cardiac mortality." data-id="CD004126-fig-0024" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery ‐ stratified by vascular versus non‐vascular surgery, Outcome 2 Cardiac mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery ‐ stratified by vascular versus non‐vascular surgery, Outcome 3 Myocardial infarction." data-id="CD004126-fig-0025" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery ‐ stratified by vascular versus non‐vascular surgery, Outcome 3 Myocardial infarction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery ‐ stratified by vascular versus non‐vascular surgery, Outcome 4 Myocardial ischaemia." data-id="CD004126-fig-0026" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery ‐ stratified by vascular versus non‐vascular surgery, Outcome 4 Myocardial ischaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Alpha‐2 adrenergic agonists (stratified by drug) versus control in non‐cardiac surgery, Outcome 1 All‐cause mortality." data-id="CD004126-fig-0027" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Alpha‐2 adrenergic agonists (stratified by drug) versus control in non‐cardiac surgery, Outcome 1 All‐cause mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Alpha‐2 adrenergic agonists (stratified by drug) versus control in non‐cardiac surgery, Outcome 2 Cardiac mortality." data-id="CD004126-fig-0028" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Alpha‐2 adrenergic agonists (stratified by drug) versus control in non‐cardiac surgery, Outcome 2 Cardiac mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Alpha‐2 adrenergic agonists (stratified by drug) versus control in non‐cardiac surgery, Outcome 3 Myocardial infarction." data-id="CD004126-fig-0029" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Alpha‐2 adrenergic agonists (stratified by drug) versus control in non‐cardiac surgery, Outcome 3 Myocardial infarction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Alpha‐2 adrenergic agonists (stratified by drug) versus control in non‐cardiac surgery, Outcome 4 Hypotension." data-id="CD004126-fig-0030" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Alpha‐2 adrenergic agonists (stratified by drug) versus control in non‐cardiac surgery, Outcome 4 Hypotension. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery studies with blinding and concealed allocation, Outcome 1 All‐cause mortality." data-id="CD004126-fig-0031" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery studies with blinding and concealed allocation, Outcome 1 All‐cause mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery studies with blinding and concealed allocation, Outcome 2 Myocardial infarction." data-id="CD004126-fig-0032" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery studies with blinding and concealed allocation, Outcome 2 Myocardial infarction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery studies with blinding and concealed allocation, Outcome 3 Myocardial ischaemia." data-id="CD004126-fig-0033" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery studies with blinding and concealed allocation, Outcome 3 Myocardial ischaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Alpha‐2 adrenergic agonists versus control in studies that used strict definitions of myocardial infarction or ischaemia, Outcome 1 Myocardial infarction." data-id="CD004126-fig-0034" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Alpha‐2 adrenergic agonists versus control in studies that used strict definitions of myocardial infarction or ischaemia, Outcome 1 Myocardial infarction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Alpha‐2 adrenergic agonists versus control in studies that used strict definitions of myocardial infarction or ischaemia, Outcome 2 Myocardial ischaemia." data-id="CD004126-fig-0035" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Alpha‐2 adrenergic agonists versus control in studies that used strict definitions of myocardial infarction or ischaemia, Outcome 2 Myocardial ischaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery (excluding Oliver 1999 and Devereaux 2014), Outcome 1 All‐cause mortality." data-id="CD004126-fig-0036" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery (excluding Oliver 1999 and Devereaux 2014), Outcome 1 All‐cause mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery (excluding Oliver 1999 and Devereaux 2014), Outcome 2 Cardiac mortality." data-id="CD004126-fig-0037" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery (excluding Oliver 1999 and Devereaux 2014), Outcome 2 Cardiac mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery (excluding Oliver 1999 and Devereaux 2014), Outcome 3 Myocardial infarction." data-id="CD004126-fig-0038" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery (excluding Oliver 1999 and Devereaux 2014), Outcome 3 Myocardial infarction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery, Outcome 1 All‐cause mortality." data-id="CD004126-fig-0039" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery, Outcome 1 All‐cause mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery, Outcome 2 Cardiac mortality." data-id="CD004126-fig-0040" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery, Outcome 2 Cardiac mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery, Outcome 3 Myocardial infarction." data-id="CD004126-fig-0041" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery, Outcome 3 Myocardial infarction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery, Outcome 4 Myocardial ischaemia." data-id="CD004126-fig-0042" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery, Outcome 4 Myocardial ischaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-008-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-008-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery, Outcome 5 Supraventricular tachyarrhythmia." data-id="CD004126-fig-0043" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-008-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8 Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery, Outcome 5 Supraventricular tachyarrhythmia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-008-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-008-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-008-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery, Outcome 6 Heart failure." data-id="CD004126-fig-0044" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-008-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.6</div> <div class="figure-caption"> <p>Comparison 8 Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery, Outcome 6 Heart failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-008-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-008-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-008-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery, Outcome 7 Acute stroke." data-id="CD004126-fig-0045" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-008-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.7</div> <div class="figure-caption"> <p>Comparison 8 Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery, Outcome 7 Acute stroke. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-008-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-008-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-008-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery, Outcome 8 Bradycardia." data-id="CD004126-fig-0046" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-008-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.8</div> <div class="figure-caption"> <p>Comparison 8 Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery, Outcome 8 Bradycardia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-008-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-008-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-008-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery, Outcome 9 Hypotension." data-id="CD004126-fig-0047" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-008-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.9</div> <div class="figure-caption"> <p>Comparison 8 Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery, Outcome 9 Hypotension. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-008-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery within past 20 years, Outcome 1 All‐cause mortality." data-id="CD004126-fig-0048" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery within past 20 years, Outcome 1 All‐cause mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery within past 20 years, Outcome 2 Cardiac mortality." data-id="CD004126-fig-0049" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery within past 20 years, Outcome 2 Cardiac mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery within past 20 years, Outcome 3 Myocardial infarction." data-id="CD004126-fig-0050" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery within past 20 years, Outcome 3 Myocardial infarction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-009-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-009-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery within past 20 years, Outcome 4 Myocardial ischaemia." data-id="CD004126-fig-0051" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-009-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery within past 20 years, Outcome 4 Myocardial ischaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-009-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-009-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-009-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery within past 20 years, Outcome 5 Heart failure." data-id="CD004126-fig-0052" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-009-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery within past 20 years, Outcome 5 Heart failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-009-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-009-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-009-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery within past 20 years, Outcome 6 Acute stroke." data-id="CD004126-fig-0053" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-009-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.6</div> <div class="figure-caption"> <p>Comparison 9 Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery within past 20 years, Outcome 6 Acute stroke. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-009-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Alpha‐2 adrenergic agonists versus control in cardiac surgery within past 20 years, Outcome 1 All‐cause mortality." data-id="CD004126-fig-0054" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Alpha‐2 adrenergic agonists versus control in cardiac surgery within past 20 years, Outcome 1 All‐cause mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Alpha‐2 adrenergic agonists versus control in cardiac surgery within past 20 years, Outcome 2 Myocardial infarction." data-id="CD004126-fig-0055" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Alpha‐2 adrenergic agonists versus control in cardiac surgery within past 20 years, Outcome 2 Myocardial infarction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-010-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-010-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Alpha‐2 adrenergic agonists versus control in cardiac surgery within past 20 years, Outcome 3 Myocardial ischaemia." data-id="CD004126-fig-0056" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-010-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 Alpha‐2 adrenergic agonists versus control in cardiac surgery within past 20 years, Outcome 3 Myocardial ischaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-010-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-010-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-010-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Alpha‐2 adrenergic agonists versus control in cardiac surgery within past 20 years, Outcome 4 Supraventricular tachyarrhythmia." data-id="CD004126-fig-0057" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-010-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.4</div> <div class="figure-caption"> <p>Comparison 10 Alpha‐2 adrenergic agonists versus control in cardiac surgery within past 20 years, Outcome 4 Supraventricular tachyarrhythmia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-010-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-010-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-010-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Alpha‐2 adrenergic agonists versus control in cardiac surgery within past 20 years, Outcome 5 Heart failure." data-id="CD004126-fig-0058" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-010-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.5</div> <div class="figure-caption"> <p>Comparison 10 Alpha‐2 adrenergic agonists versus control in cardiac surgery within past 20 years, Outcome 5 Heart failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-010-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004126-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/urn:x-wiley:14651858:media:CD004126:CD004126-CMP-010-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_t/tCD004126-CMP-010-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Alpha‐2 adrenergic agonists versus control in cardiac surgery within past 20 years, Outcome 6 Acute stroke." data-id="CD004126-fig-0059" src="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-010-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.6</div> <div class="figure-caption"> <p>Comparison 10 Alpha‐2 adrenergic agonists versus control in cardiac surgery within past 20 years, Outcome 6 Acute stroke. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/media/CDSR/CD004126/image_n/nCD004126-CMP-010-06.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD004126-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Alpha‐2 adrenergic agonists compared to control in non‐cardiac surgery</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Alpha‐2 adrenergic agonists compared to control in non‐cardiac surgery</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults undergoing non‐cardiac surgery<br/> <b>Setting:</b> hospital inpatient care<br/> <b>Intervention:</b> α‐2 adrenergic agonist<br/> <b>Comparison:</b> placebo or inactive control </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Risk ratio<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with α‐2 adrenergic agonists</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All‐cause mortality</b> </p> <p>(within 30‐days after surgery: any reported death)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.80</b><br/> (0.61 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>14,081<br/> (16 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>13 per 1000<br/> (10 to 17) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Cardiac mortality</b> </p> <p>(within 30‐days after surgery: sudden death or death resulting from a primarily identifiable cardiac cause.) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.86</b><br/> (0.60 to 1.23) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>12,525<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>8 per 1000<br/> (6 to 12) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Myocardial infarction</b> </p> <p>(within 30‐days after surgery: as detected on an electrocardiogram or trans‐oesophageal echocardiogram) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.94</b><br/> (0.69 to 1.27) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>13,907<br/> (12 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>59 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>55 per 1000<br/> (41 to 75) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acute stroke</b> </p> <p>(within 30‐days after surgery: new focal neurologic deficit with signs and symptoms lasting longer than 24 hours) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.93</b><br/> (0.55 to 1.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>11,542<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000<br/> (3 to 8) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Bradycardia</b> </p> <p>(requiring pharmacological or pacemaker treatment during the period of study drug administration) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.59</b><br/> (1.18 to 2.13) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>14,035<br/> (16 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1,2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>75 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>119 per 1000<br/> (89 to 160) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Hypotension</b> </p> <p>(requiring treatment with inotropes or vasopressors during the period of study drug administration) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.24</b><br/> (1.03 to 1.48) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>13,738<br/> (15 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1,2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>304 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>377 per 1000<br/> (313 to 450) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Risk of bias was not serious. Although multiple studies lacked proper allocation concealment and blinding, outcome unlikely to be influenced. Not downgraded. </p> <p><sup>2</sup>Indirectness not serious. Intervention (mivazerol) used in one large study not available for clinical use. Not downgraded. </p> <p><sup>3</sup>Evidence of publication bias in funnel plot of analysis. Downgraded by one level. </p> <p><sup>4</sup>Serious inconsistency between studies indicated by substantial heterogeneity. Downgraded by one level. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Alpha‐2 adrenergic agonists compared to control in non‐cardiac surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/full#CD004126-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004126-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Alpha‐2 adrenergic agonists compared to control in cardiac surgery</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Alpha‐2 adrenergic agonists compared to control in cardiac surgery</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults undergoing cardiac surgery<br/> <b>Setting:</b> hospital inpatient care<br/> <b>Intervention:</b> α‐2 adrenergic agonist<br/> <b>Comparison:</b> placebo or inactive control </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with α‐2 adrenergic agonists</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All‐cause mortality</b> </p> <p>(within 30‐days after surgery: any reported death)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.52</b><br/> (0.26 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1947<br/> (16 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 per 1000<br/> (5 to 21) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cardiac mortality</b> </p> <p>(within 30‐days after surgery: sudden death or death resulting from a primarily identifiable cardiac cause) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>1 death from 12 participants in clonidine arm, and no deaths in 10 participants in control arm. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We did not GRADE evidence for this outcome as accurate estimation of RRs is not possible for such low event rates. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Myocardial infarction</b> </p> <p>(within 30‐days after surgery: sudden death or death resulting from a primarily identifiable cardiac cause) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.01<br/> (0.43 to 2.40) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>782<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000<br/> (9 to 49) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acute stroke</b> </p> <p>(within 30‐days after surgery: new focal neurologic deficit with signs and symptoms lasting longer than 24 hours) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.37<br/> (0.15 to 0.93) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1175<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Total of 18 acute stokes reported, with 14 in control group and 4 in treatment group.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9 per 1000<br/> (4 to 22) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Bradycardia</b> </p> <p>(requiring pharmacological or pacemaker treatment during the period of study drug administration) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.88<br/> (1.35 to 2.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1477<br/> (10 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>64 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>120 per 1000<br/> (86 to 167) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Hypotension</b> </p> <p>(requiring treatment with inotropes or vasopressors during the period of study drug administration) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.19<br/> (0.87 to 1.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1413<br/> (9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,2,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>332 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>395 per 1000<br/> (289 to 544) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Risk of bias was not serious. Although multiple studies lack proper allocation concealment and blinding, outcome unlikely to be influenced. Not downgraded. </p> <p><sup>2</sup>Serious imprecision, because analysis was below optimal information size and confidence interval includes significant benefit and harm. Downgraded by one level. </p> <p><sup>3</sup>Very serious imprecision, because analysis is below optimal information size and number of events was very small. Downgraded by two levels. </p> <p><sup>4</sup>Serious imprecision, because analysis was below optimal information size. Downgraded by one level </p> <p><sup>5</sup>Serious inconsistency between studies indicated by substantial heterogeneity. Downgraded one level. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Alpha‐2 adrenergic agonists compared to control in cardiac surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/full#CD004126-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004126-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14081</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.61, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Cardiac mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>12525</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.60, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13907</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.69, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Myocardial ischaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1379</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.53, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Supraventricular tachyarrhythmia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.05, 24.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Heart failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10802</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.83, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Acute stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11542</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.55, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Bradycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14035</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.59 [1.18, 2.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13738</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [1.03, 1.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004126-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Alpha‐2 adrenergic agonists versus control in cardiac surgery</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1947</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.26, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>782</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.43, 2.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Myocardial ischaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.56, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Supraventricular tachyarrhythmia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1044</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.50, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Heart failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>549</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.49, 1.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Acute stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1175</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.15, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Bradycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1477</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.88 [1.35, 2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1413</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.87, 1.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Alpha‐2 adrenergic agonists versus control in cardiac surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004126-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery ‐ stratified by vascular versus non‐vascular surgery</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3713</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.40, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Vascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1798</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.25, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Non‐vascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1915</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.46, 1.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Cardiac mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2515</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.27, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Vascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1522</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.16, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Non‐vascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.35, 2.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3539</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.44, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1766</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.27, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Non‐vascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1773</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.55, 2.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Myocardial ischaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>961</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.52, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Vascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>865</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.54, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Non‐vascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.04, 1.34]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery ‐ stratified by vascular versus non‐vascular surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004126-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Alpha‐2 adrenergic agonists (stratified by drug) versus control in non‐cardiac surgery</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14081</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.61, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Clonidine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10787</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.64, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Dexmedetomidine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1097</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.15, 1.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Mivazerol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.42, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Cardiac mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>12525</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.60, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Clonidine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10328</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.71, 1.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Mivazerol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.27, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13907</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.69, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Clonidine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10756</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.57, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Dexmedetomidine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>954</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.20, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Mivazerol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.17, 2.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13738</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [1.03, 1.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Clonidine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10485</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [1.23, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Dexmedetomidine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1056</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.81 [1.07, 3.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Mivazerol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.82, 1.10]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Alpha‐2 adrenergic agonists (stratified by drug) versus control in non‐cardiac surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004126-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery studies with blinding and concealed allocation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13066</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.41, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13026</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.95, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Myocardial ischaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.40, 1.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery studies with blinding and concealed allocation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004126-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Alpha‐2 adrenergic agonists versus control in studies that used strict definitions of myocardial infarction or ischaemia</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Non‐cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.70, 1.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>275</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.19, 2.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Myocardial ischaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Non‐cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1175</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.54, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>820</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.55, 0.91]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Alpha‐2 adrenergic agonists versus control in studies that used strict definitions of myocardial infarction or ischaemia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004126-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery (excluding Oliver 1999 and Devereaux 2014)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.22, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Cardiac mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>618</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.10, 2.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.25, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery (excluding Oliver 1999 and Devereaux 2014)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004126-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11884</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.62, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Cardiac mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10328</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.71, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11710</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.59, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Myocardial ischaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1079</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.48, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Supraventricular tachyarrhythmia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.05, 24.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Heart failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10502</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.85, 1.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Acute stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11242</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.49, 1.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Bradycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11838</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.66 [1.17, 2.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11541</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [1.15, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Alpha‐2 adrenergic agonists (excluding mivazerol) versus control in non‐cardiac surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004126-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery within past 20 years</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13378</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.61, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Cardiac mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11907</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.61, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.93, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Myocardial ischaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>634</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.28, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Heart failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10424</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [0.89, 2.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Acute stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.50, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Alpha‐2 adrenergic agonists versus control in non‐cardiac surgery within past 20 years</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004126-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Alpha‐2 adrenergic agonists versus control in cardiac surgery within past 20 years</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1782</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.23, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>593</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.22, 3.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Myocardial ischaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>908</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.54, 0.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Supraventricular tachyarrhythmia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>964</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.44, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Heart failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>445</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.48, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Acute stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1095</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.14, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Alpha‐2 adrenergic agonists versus control in cardiac surgery within past 20 years</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004126.pub3/references#CD004126-tbl-0012">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004126.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD004126-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004126-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD004126-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD004126-note-0002">Português</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD004126-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004126\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004126\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004126\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004126\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004126\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004126\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004126\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004126\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004126\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004126\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004126\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004126\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004126\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004126\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004126\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004126\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004126\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004126\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=XwNPMGod&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004126.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004126.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004126.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004126.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004126.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714026890"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004126.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714026895"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004126.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d64a02acb937a',t:'MTc0MDcxNDAyNy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 